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Abstract 
This thesis reports the high-resolution structures of four different heme-containing 
enzymes: two dioxygenases (tryptophan 2,3-dioxygenase and a indoleamine 2,3-
dioxygenase), and mutant forms of flavocytochrome b2 and nitric oxide synthase. 
Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) belong 
to an important, but relatively poorly understood, family of dioxygenases. TDO 
catalyzes the dioxygenation of L-tryptophan to N-formyl kynurenine. This reaction is 
the first step in tryptophan catabolism. IDO catalyzes the same reaction except with a 
broader substrate tolerance. 
We have solved the x-ray crystal structure of TDO from Xanthomonas campestris in 
the apo-form (at 2.7 A resolution) and with ferric heme at the active site (at 2.6 A 
resolution). Two 1.6 A and 1.8 A resolution structures of the catalytically active, 
ferrous form of the enzyme in binary complex (respectively with the substrate L-
tryprophan and with the substrate analogue 6-fluoro-tryptophan) have also been 
determined. These data allow important insights into substrate recognition, defining 
the substrate specificity. The structure shows that the enzyme is a tetramer with a 
heme cofactor and a substrate molecule bound at each active site. A second, possibly 
allosteric, L-Trp-binding site is also identified at the tetramer interface. The active site 
is fully formed only in the binary complex, showing that TDO is an induced-fit 
enzyme with significant structural changes on the binding of substrate. 
The structure of TDO in complex with L-Trp revealed that histidine 55 hydrogen 
bonds to substrate, helping to correctly position it in the active site and possibly being 
implicated as a catalytic base during the reaction. Histidine 55 was replaced by 
alanine (H55A) by site-direct mutagenesis. The crystal structure of TDO H55A has 
been solved to 2.15 A resolution in a new crystal form, in the presence of the substrate 
L-Trp. In this different crystal form, the N-terminal region is better defined than in the 
wild-type TDO. Structural and functional studies on the H55A mutant provide 
insights into the molecular mechanism established by TDO to control substrate 
binding to the active site. A structural comparison with wild-type TDO reveals that 
the point mutation causes only small overall structural changes. Biochemical data 
suggest that histidine 55 is not essential for turnover but controls the binding of 
VI 
substrate to the active site. Histidine 55 greatly disfavours the mechanistically 
unproductive binding of L-Trp to the oxidized enzyme, promoting the productive 
binding of L-Trp to the reduced enzyme, regulating the binding of dioxygen and 
allowing precise control of catalysis. 
S04414 from Shewanella oneidensis, is a homolog of human 11)0, but its natural 
substrate has not yet been identified. The crystal structure of the reduced form of this 
putative DO from Shewanella oneidensis was obtained at 2.4 A resolution. Despite 
differing in their sequences (they share only 12% sequence identity), a comparison 
between human DO and the Shewanella homolog reveals great structural similarities, 
both in terms of the overall protein folding and of the active site design, suggesting 
that these two enzymes are likely to share a common mechanism. 
Flavocytochrome b2 is an oxidoreductase that catalyzes the oxidation of L-lactate. The 
flavin-binding and cytochrome domains of flavocytochrome b2 are connected by a 
hinge sequence. In order to study the role of inter-domain mobility during catalysis, 
site-directed mutagenesis was used to engineer a double mutation, asparagine 42 to 
cysteine and lysine 324 to cysteine (N42C:K324C). Limited domain mobility caused 
by disulfide-bridge formation affects electron transfer processes in the enzyme. The 
crystal structure of the N42C:K324C mutant obtained at 3.0 A resolution confirms the 
formation of the disulfide bond and validates the kinetics assays. 
Nitric oxide synthase (NOS) is a cytochrome P450-like oxygenase that catalyzes the 
oxidation of L-arginine to form L-citrulline and NO. Characterization of a functional 
mutant of rat neuronal NOS truncated heme domain (nNOS 0 ), where glycine 586 
was replaced by a serine residue (G586S), led to the detection of a novel reaction 
intermediate, whose UV spectrum resembles that of the ultimate reactive species of 
P450 (compound 1). The crystal structure of the nNOS 0,, G586S mutant determined at 
2.6 A resolution in binary complex with L-Arg confirms the presence of the 
engineered mutation and suggests a new capability of L-Arg for formation of a 
supplementary hydrogen bond with the introduced serine 586, thereby stabilising the 
reaction intermediate, 
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Abbreviations and units 
A. Amino Acids 
Both the single and three letter notations are used. 
Amino acid Three letter code Symbol 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidme His H 
Isoleucine lie I 
Leucme Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanme Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr 	 . T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
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B. Kinetic parameters 
Km Michaelis constant 
kcat Rate constant at saturation 
Kd Dissociation constant 
K.br, Observed rate constant 
Standard units 
m meter °C degree Celsius 
g gram K degree Kelvin 
s second 1 litre 
V volt M molar 
A Angstrom Da Daltons 
Other unit abbreviations 
s' 	first order rate constant 	 ppm 
M's' 	second order rate constant 	 rpm 
M' cm' molar extinction coefficient 	 mw 
v 	volume 	 w 
Hz hertz 
C1 	ohm 
part per million 
revolution per minute 
molecular weight 
weight 
Abbreviations referred to proteins 
IDO indoleamine 2,3-dioxygenase 
NOS nitric oxide synthase 
nNOS neuronal NOS 
nNOS0 oxygenase domain of nNOS 
sIDO Shewanella Oneidensis putative IDO 
TDO tryptophan 2,3-dioxygenas 
Buffers and chemical 
4-PI 	4-phenil imidazole 
5-F-Trp 5-fluoro-D/L-tryptophan 
6-F-Trp 6-fluoro-D/L-tryptophan 
EDTA 	2-[2-(bis (carboxymethyl) amino)ethyl- (carboxymethyl)amino] acetic acid 
Ix 
DMSO dimethyl sulfoxide 
DTT 	dithiothreitol 
GSH 	glutathione 
HEPES 4-(2-hydroxyethyl) piperazme- 1 -ethanesulfonic acid 
IPTG 	isopropyl- -D-thiogalactopyranoside 
L-Trp 	L-tryptophan 
L-Arg 	L-arginme 
MES 	2- [N-morpholino] ethanesulfonic acid 
NOHA Nt0-hydroxy-L-arginine 
PEG 	polyethylene glycol 
PMSF 	phenylmethylsuiphonyl fluoride 
SDS 	sodium dodecyl sulphate 
TCEP 	Tris(2-carboxyethyl) phosphine hydrochloride 
Tris 	2-amino-2-hydroxymethyl-propane- 1 ,3-diol 
G. Other abbreviations 
ESRF European Synchrotron Radiation facility 
FAD flavin adenine dinucleotide 
FMN flavin mononucleotide 
H4B (6R)-tetrahydro-biopterin 
I ionic strength 
NADH 3-nicotmammide adenine dinocleotide 
NMR nuclear magnetic resonance spectroscopy 
OTTLE optically transparent thin layer electrochemistry 
PAGE poly acrylamide gel electrophoresis 
PDB protein data bank 
rms root-mean-square 
SAD single-wavelength anomalous dispersion 
SHE standard hydrogen electrode 
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1.1 Bioenergetic pathways 
Eveiy living organism on Earth faces the problem of energy transformation and storage. 
All life processes, including growth, reproduction and locomotion require energy. 
Energy in nature can be found as light, ion gradients, chemical energy or mechanical 
energy, but to be utilized by living organisms such forms of raw potential energy require 
to be converted into a biologically relevant form. 
Adenosine triphosphate (ATP) is an immediate source of energy for many cellular 
functions. Energy can be stored in the high-energy phosphoester bond of ATP and then 
released in an efficient manner when and where needed. 
Under physiological conditions the hydrolysis of ATP to ADP (adenosine diphosphate) 
+ P, produces about 30.5 kJmol'. ATP hydrolysis is only one of many reactions the cell 
could have selected to store and generate energy. The hydrolysis of [ATP] is coupled to 
the dislocation of [ADP] away from [ATP]. Indeed, ATP hydrolysis generates energy 
through spatial separation of metabolic reactants, because the situation where [ATP]>> 
[ADP] is far from equilibrium 150 
Respiration, fermentation and photosynthesis form the basis of bioenergetic pathways in 
all organisms. Through these processes the potential energy generated by ion-gradients, 
the chemical energy stored in organic molecules and the power of solar energy can be 
converted to ATP pools. The formation of ATP during fermentation involves the direct 
transfer to ADP of a phosphate group from a phosphoiylated high-energy metabolic 
intermediate. In respiration and photosynthesis, the potential energy of an 
electrochemical gradient is converted into ATP. In the two latter pathways the ion-
gradient is generated via electron-transfer reactions 1 . Electrons are sequentially 
transferred from an initial donor to a final acceptor over a large difference of potential, 
via a cascade of oxidation-reduction (redox) reactions. 
2 
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Such electron-transfer reactions are extraordinary examples of chemical evolution by 
natural selection to convert energy into a biologically valuable form. 
Electron-transfer reactions may involve complex chains of redox species (proteins and 
cofactors) closely associated with cellular membranes (periplasmic membranes in 
prokaryotes and membranes of organelles such as mitochondria and chloroplasts in 
eukaryotes). All electron-transfer processes are mediated by enzymes and coenzymes, 
many of which are organized in large complexes and consist of several subunits. Such 
subunits include electron carriers which individually are catalytically active proteins and 
participate in the overall transfer process because they are closely associated with other 
proteins. 
The electron-transfer process in chloroplasts during photosynthesis shows striking 
similarities with mitochondnal respiration, both in terms of structural organization and 
redox partners. While respiration and photosynthesis are perhaps the most complex and 
important biological redox systems, many other redox proteins are involved in 
metabolizing and catabolizing organic molecules through oxidation/reduction reactions. 
Prokaryotic organisms exhibit a great diversity in composition of electron-transfer 
chains and can utilize a great variety of donor/acceptor couples. 
Due to their biological importance, the last decades have seen a growing interest in 
studying the mechanism and architecture of proteins involved in electron-transfer 
pathways. 
To understand the details of electron-transfer reactions in proteins it is necessary to 
know their structural arrangement in great detail. The structure of proteins cannot be 
simply predicted from the amino-acid sequence. Polypeptide chains are organized into a 
three-dimensional structure and folded into a specific functional shape. The final shape 
depends on the molecular interactions that each amino acid has with its neighbours, with 
surrounding water molecules and with other amino acids which are distant in terms of 
sequence, but that become close as a result of folding. X-ray crystallographic studies of 
energy transduction proteins and protein complexes can provide information about 
possible geometries of electron-transfer centres and to determine in a precise and 
3 
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systematic manner the factors that regulate the electron-transfer reactions. Furthermore, 
three-dimensional X-ray structures of catalytically active proteins are often the starting 
point for investigating their function. 
1.2 Electron-transfer reactions 
Electron transfer reactions might be classically described as adiabatic processes: the 
electrons, considered as particles, need to cross an energetic activation barrier before the 
formation of the transition state, which subsequently decays into products. 
In the quantum mechanical view, the electron is described as a wave function that has a 
small but real probability of penetrating the energy bamer 2  In other words, if during a 
reaction the wave penetrates far enough through the energy bamer to reach the acceptor, 
the electron that was localized in the donor, will now be localized at the acceptor. Such 
an event corresponds to the displacement of electrons from the narrow potential energy 
well of the donor, to the well of the acceptor, moving through the energetic barrier rather 
than over it. In quantum mechanics this is defined as "electron tunnelling". Such a view 
contrasts with the classical transition state theory, where thermal energy (generated by 
the collision of the reactants) is required to surmount the energetic barrier. 
Indeed, the equation which describes the electron transfer between weakly coupled 
donor and acceptor is not dependent upon temperature, but only on the distance between 
the redox centres: 
ii2 _ -R 
i1 AB e (eq. 1.1) 
where HAB represents the electronic coupling between the reactants (A and B) and R the 
distance between them. 
When the wave of the donor penetrates the energy barrier of the reaction, the electronic 
orbitals of the redox centres form an "encounter complex" . In this state the electron is 
potentially able to oscillate between the two reactants in a resonant process. The 
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resonance vibration depends on the distance (R) and on the relative energy of the wells 
of the donor/acceptor couple. 
In a biological system, donor and acceptor will have a different energy state, enough to 
break the resonance state and allow the electmn transfer to progress to completion. 
The system has to satisfy both the Franck-Condon and energy conservation principles. 
The Franck-Condon principle states that electronic motions occur rapidly compared with 
the time scale of nuclear transitions 4,5 . During the transition, if electrons are moving to 
a new vibration level this new energy level must be instantaneously equal to the nuclear 
energy configuration. 
1.2.1 Marcus theory 
The conditions for electron transfer, taking the Franck-Condon and energy conservation 
principles into consideration, have been described by Marcus both in classical and 
quantum mechanistic terms 6,7 
The energy configurations (U) of both reactants and products can be represented by a 
parabola plotted against the reaction coordinate (fig 1.1). Both the profiles (reactants in 
blue and products in black) display an energy minimum. Given that reactants and 
products have different minimum energy configurations, the transfer must occur at the 
intersection represented in fig 1,1, where the nuclear configurations are isoenergetic 
(UrUp). The potential energy minimum of the products (black parabola) is shifted to a 
more negative level (AG), than that of the reactants and the difference between these is 
the free energy of the reaction. The variation between the energy state before and after 
the electron transfer described by the AG represents also the driving force of the reaction 















Fig 1.1: Potential energy diagrams during electron transfer: energy surfaces for the 
Reactants and Products state along the reaction. The parabola represents a many-
dimensional potential surface of the reactants plus surrounding medium (Reactants) and 
that of products plus medium (Products,). (A: reorganization energy LIG+:  activation 
energy ilG: free energy). 
To satisfy the Franck-Condon principle, the transfer will only occur at fixed positions 
and momenta of the atoms, and because the potential energy of the reactants (Ur) equals 
the potential energy of the products (Up) at the intersection of the reactants and products 
surfaces, energy is also conserved. 
The energy required for all geometrical adjustments, which are needed in on:ler that 
reactant and product assume the configuration required for the transfer of the electron, is 
the reorganization energy X. Reorganization energy can be illustrated as the energy gap 
between the bottom of the energy profile of the product up to the interception with the 
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energy profile of the product in the same nuclear configuration as the energy minimum 
of the reactant (fig 1.1). 
Marcus theory provides a relationship between the free energy of activation AG+  and the 
standard free energy change AG of a chemical reaction. In electron-transfer reactions 
AG+ is the activation energy required to bring the electmns to the energy level at the 
intersection of the two potential energy surfaces. Upon activation, the reaction can occur 
and then the reactants return to a lower energy state. The activation energy AG+ is 
related to the driving force AG and to the reorganization energy A by the equation: 
AG+=(AG+X) 2 /4A. 	 (eq. 1.2) 
In quantum theory interpretation of electron transfer, the energy potential curves are 
simple harmonic oscillators, where only some energy levels are permitted: these levels 
correspond to the frequency of the oscillator (hw). In this case the transfer depends upon 
the overlap of the harmonic oscillator wave functions of the two reactants. 
1.2.2 Electron-transfer rate 
In the adiabatic case, the electron-transfer rate depends on the activation energy 
according to the equation: 
kET = K exp (AG + )2 / 4X k1 T 	 (eq. 1.3) 
where kET represents the observed electron-transfer rate, K is the electron-transfer rate 
when AG° is zero (maximum rate electron transfer) and kB the Boltzmann constant and 










Fig 1.2: A diagram of the nuclear potential energy ('free energy) vs nuclear coordinates. 
The potential well of the reactants is shown in black and that of the products is shown in 
blue. Case (a) is the normal' region for electron transfer, (b) is activationless 'electron 
transfer and (c) electron transfer in the inverted' region. 
(').' reorganization energy iG6 activation energy zIG: free energy) 
Three possible cases can be observed: 
Normal region (fig 1 .2a): when X > —LG, which means AG + X> 0 
Activationless region (fig 1 .2b): when X = —AG, which means AG + X = 0 
the banier for electron transfer is zero and kET = K 
Inverted region (fig 1 .2c): when X <—AG, which means EG + A < 0 
When the driving fbrce z\G increases, the activation eneigv increases and leads to 
slowing the electron-transfer rate. The electron-transfer rate variation is 








Fig 1.3: Parabolic dependence of in kET  on energy variation ZIG. In kET  reaches a 
maximum where - ZIG = ,, and decreases where -AG > (inverted region). 
In the quantized view the dependence upon temperature (T) of the electron-transfer rate 
in equation (13) is not allowed and T is replaced by the quantum energy of the 
oscillator, hw. 
The factors that control electron movement are influenced by the space separating the 
donor and the acceptor, not only in terms of the distance between the ttactants, but also 
in terms of the medium which contribute to propagating the transfer. The decay of the 
electron-transfer rate due to the medium is related to the distance by the equation: 
K x e /2R 
	
(eq. 1.4) 
where P (expressed in A - ) is the coefficient which describes the decay through the 
medium and R is the travelling distance of the electron. 
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To summarize, electron-transfer theory states that electron-transfer rates are determined 
by two factors: the thermal oscillation necessary to take reactants and products to 
isoenergetic states and the probability of electron tunnelling between these isoenergetic 
states. The thermal oscillation depends on the contribution of the environment to the 
electron charge. The electron tunnelling probability is determined by the chemical nature 
and by the structure of the electron-transfer elements. Theoretical and experimental 
investigations over the last 20 years have confirmed the dependency of electron 
tunnelling reactions on both the distance between the electron donor and acceptor and 
the nature of the molecular bridge separating the reactants 8-11 
1.3 Biological electron transfers 
In biological systems some electron-transfer reactions can move electrons 10 A and 
more between redox cofactors 12  The composition of the propagating medium between 
donor and acceptor, and the primary, secondary, and tertiary structures of the insulating 
protein, all together contribute to determining the rate of electron transfer Two major 
theories predict the most likely routes that electrons take through electron-transfer 
proteins: 
The through-bond electron-transfer theory considers that the interactions 
between the donor and acceptor sites are mediated by covalent bonds or 
hydrogen bonds interconnecting these sites. The electron transfer is then 
happening between colàctors through insulating protein 13 
The through-space electron-transfer theory describes the electronic transfers as 
depending on direct othital overlap between the donor and acceptor sites. 
In biological systems the value of the decay coefficient (13) is much higher in vacuo ([3 = 
2.9 —4.0 A-1) " 15 than in a protein matrix ([3= 1.2 ± 0.2 A-'). The polypeptide chain 
surrounding the redox centre clearly facilitates electron transfer, which is occurring 
10 
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fster than in vacuo and at comparable values to synthetic bridges (like homogeneous 
organic glass) 16 
There has been much debate sunounding the routes that electrons follow through 
electron-transfer proteins. Indeed, both theories of through-bond and the through-space 
electron transfers are supported by experimental evidence, although they both agree on 
the contribution of the polypeptide chain on facilitating electron-transfer rates 10, 17, 18 
In fact, electrons move much slower if they tunnel through empty space. However the 
through-space path can actually be optimal if it enables electrons to take shortcuts. That 
means that electrons may sometimes jump" through space, because this alternative 
route can be shorter (fig 14). 
I 
Through bond 
(3 - 0.7-1.2 A-I) 
hrough space 
3-2.9-4.0k') 
Fig 1.4: Through bond and through space electron transfer. D: electron donor A: 
electron acceptor 
Moser and Dutton 14  suggested that natural selection has favoured electron-transfer in 
proteins where the distance between redox centres is within 14 A. According to equation 
1.4, the electron-transfer rate decreases exponentially with distance. Furthermore they 
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suggested that the polypeptide structure acts as a low-energy route through bonds and 
atoms for productive electron tunnelling, while vacuum space is shown to be effectively 
a barrier. They assign a general value for X (reorganization energy) and 3 (decay 
coefficient), both calculated on the average of the whole electmn-transfer centre and 
protein. 
Metal-labelling techniques 8  have introduced another tool for experimentally 
investigating electron transfer within biological systems. Through this technique it is 
possible to measure the electmn-transfer rates of Ru-labelled proteins, such as 
cytochrome c, cytochrome b562, myoglobins and iron proteins 19  Shining laser light on 
these Ru-modified proteins allows monitoring the movement of electrons in great detail. 
Using such a technique, together with combined quantum mechanical and classical 
calculations, Beratan and co-workers 19  were able to capture electron pathway 
fluctuations. For Beratan and co-workers, in the three-dimensional arrangement of 
electron-transfer protein, several diverse and discontinuous tunnelling pathways between 
donor and acceptor can be identified. This means in other words that electron-transfer 
proteins actually evolved their shapes to allow electrons the alternative of using quantum 
rules, to pass through molecular folds and gaps. 
The effect of distance on productive electmn tunneling is clear and dominant in all the 
theories describing electron transfer. Indeed, the distance ranging from van der Waals 
contact to 14A accommodates over 95% of distances between cofactors performing 
efficient electron transfer thmugh protein. However, new studies on electron-transfer 
rates between heme centres within cytochrome b03 and in a heme-copper oxidase 20 
demonstrate that tunneling medium might be heterogeneous and this can also influence 
the rate of the transfer. 
A multi-pathway view, governed by quantum mechanistic rules, seems at the moment 
the most realistic interpretation of electron-transfer reactions 21  Although how often and 
where nature has evolved specific or multiple pathways routes for electrons remains to 
be established, all the latest studies agree that atomic resolution structural details of 
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electron-Iransfer proteins will be essential to filly understand electron-transfer 
mechanisms 22 
1.4 Electron-transfer proteins 
All biological macromolecules have evolved through a selective pressure to perform 
their specific function. Although electron tunnelling can productively occur through 
peptide bonds, nature has selected much more efficient redox elements. Redox centres 
are often built around metal ions or aromatic groups (e.g. nicotinamide, flavins) which 
can exploit a wide range of reduction potentials. Electron-transfer proteins are 
characterized by redox centres that facilitate rapid and efficient electron transfer with the 
minimum structural change for the protein. 
Biological electron-transfer systems are normally classified on the basis of the chemical 
structure of the prosthetic group and the manner of its attachments to the protein. Redox 
proteins include heme-binding proteins, metalloproteins (such as iron 23,  copper 24 
molybdenum 25,  and nickel proteins 26)  and flavoproteins 27 
1.4.1 Metal cenfres 
Modulated by the protein environment, the redox properties of metals are used to 
catalyze a great variety of biological reactions. Electron-transfer proteins generally have 
metal coordination sites which serve to tune the reduction potential of the metal. 
Furthermore, the reorganization energy (X) (see section 1.2.1) and structural changes 
resulting from oxidationlreduction reactions are minimized. Two representative 
examples of redox metallo-proteins are iron-sulfur proteins and blue copper proteins. 
Iron-sulfur [Fe-S] clusters play a crucial role in many biochemical pathways, including 
respiration, photosynthesis, and amino acid biosynthesis. 
Iron-sulfur clusters mediate a single electron transfer oscillating between ferric (Fe (Ill)) 




ions in the prosthetic centre. Examples of these include rubredoxin [iFe-1S] 28 
ferredoxins [2Fe-2S] that contain two iron atoms and two inorganic sulfides coordinated 
to four cysteine residues 29  furedoxins [4Fe-4S] that contain four iron atoms, four 
inorganic sulfldes, coordinated to the protein in a distorted tetrahedral geometry through 
four cysteines 30 . High-redox potential 4Fe-4S ferredoxins (1-liPiPs) form a family of 
iron-sulfur proteins that function in anaerobic electron transport chains. Fig 1 .5 shows 
examples of these three different types of Fe-S clusters. 
a 	 b 	 C 
Fig 1.5: iron-sulfur cluster centres. iron is bound to the protein by the sulfur atoms of 
cysteine residues. 
a) Crystal structure of rubredoxin from Clostridium pasteurianum showing a fiFe-IS] 
cluster (PDB entry 4RXN) b)[2Fe-2S] ferredoxin-like cluster from Halobacterium 
salinarium (PDB entry JEOZ) c) [3FE-4S] cluster ferredoxin from  Azotobacter 
vinelandii (PDB entry JFDD) 
In the case of copper-binding proteins the metal is often held by the protein matrix in a 
pseudo tetrahedral arrangement, which in this case represents a compromise between the 
copper geometries for Cu 2 (Cu (II)) (which prefers square planar geometry) and Cu' 
(Cu (1)) (which prefers tetrahedral geometry). 
Azurin belong to the class of blue copper proteins, so called because of their remarkable 
blue colour (A - 600 rim). A single copper atom is bound in their active sites. 





three firmly binding residues, two histidines and a cysteine. The strong colour originates 
from the chaige transfer between the Cu atom and the S of the cysteine ligand. 
The crystal structure of azurin 24  (fig 1.6) shows a very irregular tetrahedral coordination 
sphere comprising two sulfurs from methionine and cysteine, and two nitrogens from the 
histidines. Such an irregular and high energy arrangement at the Cu centre in azurm 
corresponds to the entatic state between the tetrahedral and square planar geometries 
configurations of the two oxidation states of Cu and allows enhanced rates of electmn 
transfè r. 
Fig 1.6: Azurin copper centre a) Pseudomonas aeruginosa reduced azurin Cu (1)) 
(PDB entry IJZG) b) Pseudomonas aeruginosa oxidized azurin (Cu (II)) (PDB entry 
IJZF) 
1.4.2 Flavin 
Flavins are compounds containing the 6.7-dimethylisoalloxazine ring. In nature they 
occur as fiavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) where the 










FMN 	 FAD 
1ig 1_ 7: The structures at the oxithzed forms at the coenzvmes 1.4/) (who/c ti'urc) and 
FMiV (orange background). 
The isoalloxazme ring functions as a redox cofactor, and can exist in three different 
redox states. These are fiavoqumone (fully oxidized), fiavosemiquinone (one election 
reduced, half-reduced) and fiavohydroquinone (two electrons reduced, fully reduced) 
(fig 1.8). 
R R 	 R 
I 	 I 
N 1 O 	 ... N N 0 
	
qO NH NNH 
0 	 0 	 0 
Fig 1.8: The electronic structures of the reduced and semiquinone flavin. The three 
different redox states of FM1V filly oxidized (quinone), one-electron reduced 
(semiquinone), and two-electron reduced (hydroquinone). 
Flavins are therefore able to take part in mechanisms involving single electron-tmnsfer 
reactions (flavoquinone is converted to flavosemiquinone or the flavosemiquinone to 
flavohydioquinone), but also in two-electron-translèr reactions (the fiavin oscillates 
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back and forth between fiavoquinone and fiavohydroquinone). Although free 
fiavosemiquinone is chemically unstable and the addition of two electrons would be 
preferred, the semiquinone species is stabilized by the properties of the surrounding 
protein. 
1.4.3 Hemes 
Heme-proteins are metalloproteins containing one or more heme prosthetic groups, 
which may or may not be covalently bound to the polypeptide chain. The heme group is 
a porphyrin and consists of an iron atom coordinated in the centre of four pvrrol rings; 
these four rings are linked by bridging groups in a planar geometly. 
a 	 b 	 c 
Fig 9: Hemes commonly found in biological systems. Heme a (a); heme b (b); heme c (c) 
The most common hemes found in proteins are: heme b, heme c and heme a (fig 1.9): 
1) Heme b (also termed protoheme IX or iron -protopo rphyrin IX) shows four methyl 
groups in positions 1. 3. 5 and 8: at position 2 and 4 are two vinyl groups, while in 
position 6 and 7 two piopionates (fig 1.9b). 
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Heme c is covalently bound to the protem matrix via thioether linkages of the vinyl 
groups in position 2 and 4 with the sulthydiyl portion of cysteine residues (fig 1 .9c). 
Heme a has a hydroxyethylfamesyl side chain in position 2 of the protoporphyrin ring 
and a formyl group at position 8 (fig 1 .9a). 
Heme-proteins can perform an impressive variety of biological functions including 
electron transfer, redox reactions catalysis and diatomic gas transportation and storage. 
The heme iron can normally adopt two oxidation states, Fe (Ii) and Fe (ifi), but the Fe 
(IV) oxidation state has been found in some systems as a reaction intermediate 31, 
Indeed, the oxidation state of the iron plays an essential part in the roles of the heme 
proteins, but such proteins display great functional diversity due to variation of the 
protein environment around the heme. The heme iron atom has two coortlination sites 
not occupied by the porphyrin macrocycle, and the reactivity of the cytochrome and the 
heme iron reduction potential is strongly related to the number and the nature of the 
ligands that ligate iron axial sites. 
Penta-coordination is generally found in enzymes and globms (fig 1.16) 32,  For 
catalytically-active enzymes the heme requires an available coordination site for 
substrate binding, and in globins the sixth position remains free for diatomic gas 
coordination. 
In contrast, electron-transfer proteins need to minimize the reorganization energy at the 
heme centre during electron transfer so the coordination sphere of the iron centres is 
invariably saturated and hexa-coordinated. The axial ligands can be two histidines 
(fig 1.10 and fig 1.15), histidine and methionine (fig 1.12) 	and rarely two methionines 
36 orhistidine and asparagine (fig 1.11). 
The nature of the axial ligands also affects the spin state of the heme iron: the iron will 
generally be high-spin when penta-coordinated or hexa-coordinated with a water 
molecule, while coordination of CO, NO, 02 or CW as a sixth ligand will lead to a 
change to low spin. 
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1.5 Redox proteins 
Two mam categories of redox centres can be distinguished. These are, 1) electron-
transfer sites, and 2) sites that catalyze oxidation-reduction reactions upon substrate 
molecules. 
The first group mainly consists ofcytochromes (section 1.3.2.1). 
The second group comprises several different protein types. These include globins, 
which are heme-proteins, mainly implicated in diatomic gas binding and transportation 
(section 1.3.2.3), and also oxidOreductases. Oxidoreductases such as cytochnme P450 
(section 1.3.2.4.1), nitric oxide synthase (section 1.3.2.4.2), heme oxygenases, 
indoleamine 2,3-dioxygenase, and tryptophan 2,3-dioxygenase (section 1.3.2.4.3) are 
involved in the enzymatic transformation of markedly different substrates. 
Flavocytochrome b2 (section 1.3.2.5) is an oxidoreductase involved in aerobic 
respiration in yeast. 
1.5.1 Cytochromes 
Cytochromes are broadly called proteins that contain one or several heme groups and 
cany out electron transport or catalyze reductive/oxidative reactions 38  Cytochromes 
have been localized in eukaryotes (in the mitochondrial inner membrane u  and in the 
endoplasmic reticulum 39),  in plants (in the chioroplasts 40),  in photosynthetic 
microorganisms 41,  and in bacteria 37, 4246 Indeed, proteins of obviously different 
functions are found in this family. A structural classification can be followed for 
cytochromes, after the type of the porphyrin bound or enclosed by the protein and 
further by sequence similarity 38 
1.5.1.1 Cytochromes b 
Cytochromes b contain a b-type heme group and are mainly involved in enzymatic 
processes or as components in electron-transfer systems. The best known examples of 
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cytochromes b are cytochromes b 5 , which are electron transport proteins found 
ubiquitously in nature. The microsomal and mitochondrial cytochromes b5 are 
membrane associated, while those from prokaryotes or from other animal tissues are 
soluble. 
Flavocytochrome b 2 is a tetramenc L-lactate dehydrogenase found in backer's yeast 
(Saccaromyces cerevisiae) which is localized in the intermembrane space of 
mitochondria. Flavocytochrome b2 shows a bis-His coordinated heme. Flavocytochrome 
b 2 will be described in more detail in section 1.5.5 and chapter 5. 
Fig 1.10.' Rat outer mitochondrial membrane cys'ochrome b 5 (PDB enily 11CC). The 
heme group is represented using sticks and coloured dark red. The two histidines (His39 
and His63) ligating the heme are also represented as sticks coloured by element (co/our 
code: green = carbon, red = oxygen, blue = nitrogen)33. 
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Cytochromes P450 and nitric oxide synthases represent two special classes of 
cytochromes b, which will be described respectively in section 1.5.4.1 and section 
1.5.4.2 of this chapter. 
1.5.1.2 Cytochromes c 
Cytochromes c contain a heme which has at least one thioether bridge between the vinyl 
group(s) of the porphyrin and the cysteine(s) of the protein. The cysteines (Cys) are 
provided by the characteristic sequence motif Cys-X-X-Cys-His, where the histidine 
(His) represents the fifth ligand to the iron 47 . 
This class of cytochromes has been reported in all living organisms, but prokaryotes 
show the highest degree of diversity 48 
Cytochromes c can be classified into six groups, based on their three-dimensional 
arrangement 
1) Class I cytochromes c have an entirely alpha helical fold, with three conserved 
helices enclosing the heme group. In such fold, one edge of the heme remains 
exposed to the solvent. This class comprises the soluble cytochromes c of 
mitochondna and cytochrome c2 from Rhodobacter sphaero ides. The covalent 
attachment sites to the heme are localized close to the N-terminus of the protein, 
while the sixth axial ligand is localized in the C-terminus portion and is generally a 
methionine. An exception to this rule has been reported in sphaeroides heme protein 







Fig 1.11: Crystal structures of the oxygen-binding cytochrome c from Rhodobacter 
sphaeroides heme protein (SHP). a) Oxidized SHP (PDB entry IDWO), b) Reduced SHP 
in complex with nitric oxide (PDB entiylDW2,). The hemes are displayed as sticks and 
coloured dark red. Residues of interest are shown in stick models and coloured by 
element element ('colour code: green = carbon, red = oxygen, blue = nitrogen)51 . 
2) Class II cytochromes c have a four alpha helical bundle fold, with the heme 
attachment site near to the C-terminus 52  . This class includes the high-spin 
histidine-ligated cytochromes c' (which are electron transport proteins broadly 
distributed in photosynthetic and aerobic bacteria) and the low-spin methionine 
ligated cytochromes, such as cytochrome c556 (fig 1.12). 
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Fig 1.12: NMR model of oxidized R. jxilustris cytochrome c 556 The heme is displayed as 
sticks and coloured dark red. Me112 and Hisl2l, ligating the heme, are shown in sticks 
and coloured by element (colour code: blue-green = carbon, red = oxygen, blue = 
nitrogen)35 (PDB entry 1S05). 
3) Class Ill cytochromes c display a low amino acid:heme composition, with only 25-
40 amino acids per heme. This class includes the low reduction potential (0 to -400 
mV), bis-histidine ligated multiheme cytochromes c. Multiheme cytochromes (fig 
1.13) have been found in several bacteria, but in particular in the Desulfovibrio, 







Fig 1.13: Crystal structure at 2.2 A resolution of octaheme cyrochrome c from 
Shewanella oneidensis. The eight heme groups are displayed in the stick representation 
and coloured dark red (PDB entry JSP3)55. 
Class 1V initially comprised all the proteins containing other prosthetic groups 
together with the heme c, such as flavocytochrome c and cytochromes cd. Now this 
class includes only tetraheme proteins, which contains both bis-histidine and 
histidine-methionine coordinated hemes 56 
Class V includes several recently characterized cytochromes c, which have no 
structural homology but share similarities in the distribution of clusters of paired 
hemes. Such an arrangement is thought to be relevant for the type of electron-
transfer processes, in which all of the proteins belonging to this group are involved. 
This class includes cytochrome cj and cytochrome f which function as electron 
carriers in photosynthetic process, hydroxylamine oxidoreductase ((HAO) which 
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contains eight covalently bound hemes 57),  and the tetraheme c554 from 
Nitrosomonas europaea, pentaheme cyto chrome c552 from Sulfitrospirillum 
deleyianum; and the flavocytochrome c3 fumarate reductase from Shewanella species 
(fig 1 . 14) 58 . 
Fig 1.14: C'iystal structure at 1.8 A resolution offlavocytochrome c4frorn Shewanella 
frigidimarina. F/a vocytochrome C3 is composed of the cytochrome domain (binding four 
hemes) in orange, and the fiavin domain (with a non-cova/ently bound FAD) in green. 
Hemes and FAD are shown as sticks and coloured respectively in dark red and yellow 
(PDB ently 1QJD) 59. 
6) In addition to the above classes, there are several cytochromes c that cannot be 
assigned to any of the above groups. Examples includes the decaheme cytochromes c 
from Shewanella oneidensis 61  and the diheme cytochromes c from Pseudomonas 
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aeruginosa 60  Rhodobacter sphaeroides (fig 1.15) and Rhodobacter adriaticum 62 
Fig 1.15. Ciystal structure of the diheme cytochrome c (DHC) from Rhodobacter 
sphaeroides at 2.0 A resolution. 1)HC is arranged into Iwo domains each containing one 
heme. The N-terminal domain (in blue) is a class I cytochrome c, while the C-terminal 
domain (in green) constitutes a novel cytochrome c structural moif The hemes (both 
bis-His coordinated) are displayed as sticks and coloured dark red (PDB entry 2FW5) 
63 
1.5.2 F)avocytochromes 
Electron-transfer proteins can contain more than one redox-active prosthetic group. 
Flavocytochromes contain both flavin and heme. The association of these two cofactors 
results in enzymes with great catalytic versatility. This class of proteins can be involved 
in a wide range of redox processes, from simple electron transfer to oxidation and 
reduction of organic molecules, or activation of molecular oxygen. 
This is the case for P450s (section 1.5.4.1 in this chapter), NOSs (section 1.5.4.2 in this 
chapter) and yeast L-lactate dehydrogenase, also called flavocytochrome b2 (section 
1.5.5 in this chapter). Flavocytochromes can be very different in reactivity, but 
nevertheless share some recurrent features in their structural arrangement. Typically, the 
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reductase and oxidase domains are organized in two distinct regions connected via a 
linker peptide (the larger of these subunits contains the FMN and the smaller the 
heme(s)). This common architecture does not necessarily correlate with a common 
function, but the modulation of substrate and cofactor reactivity and the exact 
positioning of the substrate are key elements in the mode of action of these enzymes. 
1.5.3 Globins 
Globms are heme proteins involved in diatomic gas binding and transportation. This 
large protein family embraces vertebrate hemoglobin and myoglobin, but also 
invertebrate globins and fungal and bacterial flavohemoglobins. Almost all globins 
contain b-type heme, axially coordinated by a histidine side chain. The globin three-
dimensional structure is all alpha-helical (fig 1.1 6a). Their characteristic and 
evolutionanly-conserved six a-helical fold also contributes to preventing rapid oxidation 
of the heme iron. However, globins are capable of reversibly binding 02 to the Fe (II) 
heme (fig 1.1 6b) and such binding results in a transition from high-spin to low-spin state 
of the heme iron. All the globins originate from a common protoglobin ancestor, which 
held a globin-type fold but functioned as redox protein 64, 65 When dioxygen became 
available in the atmosphere, globins evolved their dioxygen binding pmperties to finally 
reach their present function. 
Bacterial fiavohemoglobins 66  contain a heme binding region enclosed in the classical 
globin fold, associated with a FAD-containing NADH dependent reductase extension. 
Like most the eukaryotic globins, the heme in flavohemoglobins is five-coordinated 
through a histidine. 
Interestingly myoglobin and hemoglobin were the first two proteins to have their 
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a 	 b 
Fig 1.16: Crystal structure of sperm whale oxymyoglobin at 1.6 A resolution (PDB entry 
1MB0 32). The heme is displayed as sticks. Residues of interest are also shown in stick 
models and coloured by element (colour code: nitrogen blue, oxygen red and carbon 
purple) 
Characteristic six helical fold of myoglobins (helixes numbered 1 to 6) 
Detail of the active site, showing oxygen bound to the heme 
1.5.4 Oxygenases 
Oxygenases are heme containing enzymes that catalyze the incorporation of one or both 
atoms of molecular oxygen (02) into their substrate. They can be distinguished as two 
types, dependent on their reaction mechanism. Monooxygenases (such as P450s and 
nitric oxide synthases) incorporate a single atom from 02 and dioxygenases (such as 
tryptophan 2,3-dioxygenase and indoleamme 2,3-dioxygenase) incorporate both atoms 
of dioxygen. 
The activation of molecular oxygen is a crucial process for every aerobic organism. 
Molecular oxygen has a low reactivity with organic substrates because it exists as a 
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triplet in its ground state. Thus, oxygenases are able to activate oxygen and catalyze 
oxygen incorporation into various substrates, and their importance has been recognized 
in the biosynthesis and transformation of steroids, prostglandins and amino acids, and 
also in the metabolism of drugs and xenobiotics. 
15.4.1 Cytochromes P450 
Cytochromes P450 (P450s) are a diverse superfamily of enzymes, so called after the 
peak at 450nm in the visible spectrum when CO is bound to the ferrous form of the 
enzyme 69  They all contain a b-type heme, axially coordinated through the thiolate side 
chain of a conserved cysteine residue, and are present in a wide range of organisms 
including mammals, insects, molluscs, plants, fungi and bacteria 70 
P450s catalyze the mono-oxygenation of a broad variety of organic molecules. Although 
it has been more than 50 years since the identification of the first cytochrome P450 71  the 
interest in this family of proteins is still increasing. This is due to their involvement in a 
number of reactions of great biological significance, including oxidation of drugs, 
steroid transformation, pro-carcinogen activation, detoxification processes and fatty acid 
metabolism 72 
Electron transfer represents a crucial step in P450 function. In fact, P450s can be 
classified into two main groups based on the redox partners that donate electrons during 
their catalytic cycle (fig 1.17): 
Class I P450s (found in the mitochondrial membrane of eukaryotes and in most 
bacteria) receive electrons from ferrodoxin (an iron-sulfur protein) which is, in 
turn, reduced by a ferrodoxin reductase (which binds NADPH and FAD). In 
bacteria these complexes are soluble (P450 cam) 73 ,while in mitochondna they 
are usually associated with membranes (e.g. P450 scc) ". 
Class II P450s (found exclusively in eukaryotes and associated with the 
endoplasmatic reticulum) require an FAD/FMN-containing P450 called NAPE!-















P450 	 FMN/FeS 
P450 II 	reductase 	- 	IV 
reductase 	VOCA, 'z 	
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Fig 1.17: Representation of the diverse classes of cytochromes P450. P450 domains are 
represented in red and redox partner components in yellow (FAD doniain), green (FMN 
domain) and blue "iron-su1/iu cluster). Class I system comprised of FAD, iron sulfi4r and 
P450 subunits. Class II system comprised of FAD FMN reductase and P450 subunits. 
Class HI system formed by fused FADFMN reductase and P450 domains. Class IV 
P450s, recently discovered such as P450 Rhf and P450 cin carring other unique 
combinations of redox cofactors. Picture from 
3) In NADPH-cytochrome P450 reductase the FAD group serves as an electron 
acceptor from NADPH, whereas the FMN moiety interacts directly with the P450 
and reduces it. When a homologue of cytochrome P450 reductase and a P450 are 
fused together in a unique enzyme they belong to a minor group, defined as class HI 
P450; this is exemplified by the bacterial flavocytochrome P450 BM3 
76 
It should be noted that in addition to these there are P450 systems with other unique 
combinations of redox cofactors, such as P450 Rhf and P450 cin 
77 which do not belong 
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Fig 1.18. Crystal structure ofJèrrous P450cam from  Pseudomonaspurida. The heme is 
displayed as sticks and coloured magenta. Relevant residues are shown in sticks and 
coloured by element (colour code: nitrogen blue, oxygen red and carbon grey). a) 
Protein folding shown in cartoon representation b) Oxygen bound complex of P450cam 
from Pseudomonasputida (PDB entry JDZ8) 
Throughout the superfamily there is conservation of the fold of the cytochromes domain 
subunit. The heme is enclosed by four helices, which also provide the important 
catalytically residues, including the cysteine which coordinates the iron atom as the fifth 
ligand. When the iron is reduced, the strong electron donating nature of the thiolate from 
the cysteine activates molecular oxygen bound to the heme (Figi .1 8b). 
The reaction catalyzed by cytochrome P450 (fig 1.19) comprises an initial phase in 
which molecular oxygen is activated, and a final phase where the substrate is attacked 
and the transients rearranged. 
RH+02+2HI+2e ° 	ROH+H20 
Fig 1.19: General reaction scheme for P450 hydroxylation 
The reaction mechanism of cytochromes P450 will be discussed in more detail in chapter 
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6 in comparison with the reaction of nitric oxide synthase. 
1.5.4.2 Nitric oxide synthases 
Nitric oxide synthases (NOSs) are flavocytochromes that have some similarities with the 
cytochromes P450. They have been found in many organisms, including vertebrates and 
invertebrates, fungi and bacteria. NOSs are oxygenases, containing a b-type heme which 
is axially coordinated via a thiolate ligand derived from a cysteine residue of the 
polypeptide chain. Bacterial NOSs consist exclusively of the heme oxygenase domain 
and therefore require an external source of electrons 78, 79• Like some P450s, the heme-
containing domain of NOSs can be covalently coupled to an NADPH-dependent domain 
which includes FAD and FMN cofactors. 
NOSs catalyze the two-steps sequential monooxygenation of the guanidino nitrogen of 
L-argrnrne (L-Arg), producing N-hydroxy-L-arginine in the first step and NO and L-
citrulline as final products (fig 1.20) 80  By controlling NO distribution and 
concentration in eukaryotes, NOSs take part in a great number of physiological 





















L-Citrulline L-Arginine 	N°-Hydroxy-L-Arginine 
Fig 1.20: Reaction catalyzed by nitric oxide synthases 
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Mammalians produce three isoforms of NOS, all encoded by different genes: inducible 
(iNOS) and neumnal (nNOS) which are soluble and mainly localized in the cytoplasm, 
and endothelial (eNOS) which is associated with endothelial cell membranes. The 
sequences of each isoform of the three NOSs are highly conserved among different 
species, but the sequence identity between any two isoenzymes is only 50-60%. 
All three NOSs are homodimers and each monomer shares a common architecture: 
The N-terminal catalytic oxygenase domain that hosts the single b-type heme 
catalytic centre, the redox cofactor (6R)-5,6,7,8-tetrahydrobiopterin (H4B) and 
the substrate (L-Arg) binding site 
The C-terminal reductase domain, containing fiavin mononucleotide (FMN), 
flavin adenine dinucleotide (FAD) and NADPH 81 . This domain is structurally 
and functionally related to the soluble portion of mammalian microsomial P450 
reductase. 
The link between the N-terminal and C-terminal domains, consisting of a 
calmodulin-binding domain that also regulates the electmn transfer from the 
reductase to the oxygenase domains ' 
Compared to P450s, NOSs are more complex from a structural point of view. The active 
form is a homodimer, complexed with two molecules of 114B and a zinc atom at the 
dimer interface. Binding to calmodulin is also required for catalytic activity. 
Furthermore, the reductase domain appears to supply electrons to the heme domain of 
the alternate subunit (fig 1.21) 86  The NOS catalytic reaction and the structural details of 








Fig 1.21: Illustration of the electron (e) flow through the NOS domains during the 
reaction. Electrons pass to the heme domain of the other subunit. The reductase domain 
is represented in green, the calmodulin binding domain in white, and the oxygenase 
domain in salmon. Cofàctors (NADPH, FAD, FMN, and H 4B) and substrate (L-Alg,) are 
all represented in yellow, while the heme is in dark red. 
1.5.43 Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase 
Indoleamine 2,3-dioxygenase (JDO) and tryptophan 2,3-dioxygenase (TDO) are 
examples of heme dioxygenases. DO and TDO have been both isolated from mammals 
87,88 Currently no functional prokaryotic DO has been identified, whilst TDO has been 
found in many bacteria 89.90 
Both enzymes catalyze the oxidative cleavage of the tiyptophan pyrrole ring, between its 
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Fig 1.22: Reaction catalyzed by IDO and TDO 
In mammals, this reaction is part of the tryptophan hepatic catabolism and kynurenine 
formation pathway. 11)0 and TDO have a fundamental importance in human physiology. 
Several neurological or psychiatric diseases have been associated with an excess of 
kynurenine metabolites 91, 92 L-tryptophan is also a precursor in the synthesis of the 
neurotransmitter serotonin and the hormone melatonin. Nevertheless the chemistry of 
TDO and 11)0 is still poorly understood, primarily due to the lack and incompleteness of 
structural information. 
Although DO and TDO catalyze the same reaction, the sequence similarity between the 
enzymes is low. Alignment of sequences across this family of enzymes is only possible 
based on their three-dimensional architecture. TDO and DO carry a b-type heme, which 
shows a positive reduction potential both in presence of tryptophan (up to +150 my) and 
when the substrate is not bound (+20 mV) 89, 90 The positive potential of the heme, 
together with a histidine as the fifth ligand of the heme iron, contribute to keep the iron 
reduced. Physiologically these enzymes are most probably always present with the iron 
in its reduced state. It is generally reported that the ferrous enzyme is the active form, 
although some catalytic activity by ferric DO and TDO has been shown, possibly due to 
trace amounts of Fe(II) 93 
DO and TDO will be described in more detail in chapters 3 and 4. 
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1.5.5 Flavocytochrome b2 
Flavocytochrome b 2 is a tetrameric enzyme (Fig 1.23) found in baker's yeast 
(Saccaromyces cerevisiae) and localized in the intermembrane space of mitochondria. 
This enzyme is involved in the oxidation of L.lactate to pyruvate during aerobic 





Fig 1.23: Crystal structure of flavocytochrome b 2 (PDB entry JFCB )27•  Each of the 
four monomers is represented with a dfferent colour. Heme domains (only defined in 
two monomers) are coloured in red. FMN and herne are represented as sticks and 
coloured in yellow. 
The enzyme catalyzes the two-electron oxidation of L-lactate to form pyruvate, with 
subsequent electron transfer to cytochrome c through the flavin and heme groups. The 
reaction proceeds in steps. First, two electrons are passed from the lactate to the flavin, 
which becomes fully reduced as the flavinohydroquinone species. Then the electrons are 
transferred to the heme moiety one at a time with the formation of a flavin semiquinone 
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intermediate and consequent reduction of the heme. The last step is the only inter-
protein electron transfer event involving flavocytochrome b 2. The electron is passed 
from the heme moiety to a molecule of cytochrome c, leaving the heme able to receive 
the second electron. The oxidised heme is then reduced again by the flavin semiquinone 
carrying the other electron. After the removal of this second electron by cytochrome c, 















Fig 1.24: The electron transfer steps in the catalytic cycle of a single subunit of 
flavocytochrome b 2. (F/a yin (F); b-herne (H); cytochrorne c (C). Electrons are 
represented by blue dots). 
The cytochrome domain is located at the N-terminus of the protein and it is oriented 
with the heme pocket facing the flavin domain. The distance from the heme iron to the 
centre of the flavin is 16 A, but only bA from the edge of the heme pyrrole ring to the 
edge of the flavin 27 
There is certainly mobility between the two domains of the enzyme 94, which suggests a 
conformational influence on inter-domain electron transfer. The flavin domain and 
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cytochrome domains are separated by a hinge region, whose integrity and length are 
important for optimal flavin hydroquinone to heme electron transfer. The 
flavocytochrome b2 structure will be treated in more detail in chapter 5. 
1.6 X-ray crystallography 
In many cases the specific role of the redox cofactors, ligands and protein matrix in 
controlling the biological functions of proteins have been elucidated thanks to our 
knowledge of high-resolution structures of redox proteins. 
Over the last 70 years three techniques have been developed to experimentally 
determine the three-dimensional structures of macromolecules: cryo-electron 
microscopy (cryo-EM), nuclear magnetic resonance (NIVIR spectroscopy) and x-ray 
crystallography. 
Through cryo-EM it is possible to work on complete macromolecular complexes 
(macromolecular weight over 150 kDa), visualize them in their physiological 
environment and in different functional states. The electron density maps obtained from 
a cryo-EM structural study are generally at low resolution and insufficient for atomic 
structure details. 
Only using NMR and macromolecular crystallography is it possible to characterize 
macromolecules at near atomic resolution and these two techniques have provided three-
dimensional structures of many important biological molecules and their complexes. 
Structure-function studies have provided important insights into the mechanisms by 
which cellular functions are regulated. 
The structure of small proteins can be solved using NMR spectroscopy. Using NMR 
spectroscopy it is possible to investigate structure and dynamics simultaneously, because 
the macromolecules are studied in aqueous solution. The main limitation of NMR 
spectroscopy is a limit on protein size of about 40 kDa, a boundary which excludes the 
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application of this method to study of a large portion of macromolecules. 
Due to this limitation x-ray crystallography is in fact the most powerful method to 
determine, the three-dimensional structure of small and large macromolecules, as well as 
macromolecular assemblies (viruses, ion channels, ribosomes and proteasomes) with 
atomic precision. The current status and future perspectives of macromolecular 
crystallography have been recently described by Dauter, 2006 95 . 
1.6.1 Diffraction conditions 
Crystals are geometrical three-dimensional objects and they often appear as beautiful 
regular solids with sharp edges and plane fces. This is the reason why crystalline solids 
have been considered since early times as the archetype of perfection and purity. 
Internally, a crystal consists of millions of molecules, atoms or ions which are stacked 
together systematically in all three spatial directions. The regularity of a crystal can be 
described with a translation lattice of a repeating unit. The basic unit of the lattice is 
defined as the unit cell. Unit cells are arranged within the crystal in sets of parallel and 
equivalent layers (fig 1.25). 
When electromagnetic radiation (i.e.: x-rays) with a wavelength of the same order of 
magnitude as the distance between atoms strikes against a collection of atoms, diffracted 
scattered waves will interfere and result in a pattern of stronger and weaker waves. 




If atoms are neatly arranged in a three-dimensional crystal lattice, then the scattering 
will occur only in specific directions. These directions are determined by the geometry 
of the crystal lattice, by the orientation of the crystal lattice, by the wavelength of the 
incident beam but not by the position of the atoms within the unit cell. To explain why 
crystals appear to reflect x-ray beams only at certain angles of incidence 8 (theta), 
physicists William Henry Bragg and his son Sir William Lawrence Bragg in 1913 
derived the equation: 
nk = 2dsinO 	(Bragg's law) 
where d is the distance between atomic planes in the crystal lattice, ?.is the wavelength 
of the incident x-ray beam and n is an integer. 
7 




Fig 1.26: Bragg law. Electromagnetic radiation scattering from objects in the crystal 
lattice. Piciure adapted from 96. (0: incidence angle A.: wavelength d: distance between 
lattice planes) 
Each lattice point represents the same arrangement of atoms, and the electrons within 
these atoms scatter the x-ray radiation (fig 1.26). Therefore all lattice points will 
generate a reflected wave at the same angle as the incident wave with the plane, and with 
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the same amplitude. 
Constmctive interference of reflected waves will occur only if the path difference of the 
reflected x-rays is a whole number. Furthermore, diffracted waves not satisf'ing Bragg's 
law will extinguish each other, resulting in a total intensity of zero 
1.6.2 Protein crystals 
A great number of substances can adopt a crystalline form: some of these crystallize 
readily (salts, sugar), some require great pressure (diamond) while others, such as 
proteins, require special physico-chemical conditions. 
Inorganic crystals can grow up to several centimetres in length, while protein crystals 









Fig 1.27: a) Salt (copper sulphate) crystal compared to a b) protein crystal 
Although protein crystals appear externally similar to crystals from inorganic material, 
from a chemical point of view there are major differences. Inorganic crystals are 
composed by rigid and small molecules, held together by strong electrostatic attractions 
of charged ions %; in a protein crystal, the nature of the interaction between molecules is 
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mainly hydrogen bonds between hydrated molecules, and only a few direct contacis 
between the molecules exist. Another important difference between protein and 
chemical crystallography is that protein crystals differ from most organic, inorganic or 
organometallic crystals because they contain large volumes of solvent, which normally 
occupy around 50% of the unit cell. The large solvent volume is not ordered and causes 
poor diffraction behaviour compared to most inorganic crystals. The presence of solvent 
in protein crystals also has the benefit of ensuring that protein molecules are in a more or 
less natural environment. The natural state of the protein in the crystal is confirmed by 
the observation that if different crystalline forms of a protein exist, the main difference 
between these crystal forms comes from the packing of the molecules; no essential 
differences are found in the conformation of the protein molecules themselves. Another 
indication of the biological relevance of protein crystal structures is that some 
crystallized proteins are still capable of binding substrates and performing their 
biological tasks 99-102 
1.6.3 Protein crystallization 
The essential prerequisite in order to determine protein structure using diffraction 
techniques is to obtain at least one single crystal of the target protein. Protein 
crystallization is a physical-chemical process in which a protein is slowly precipitated 
from its solution '° A protein remains stable in solution up to a certain limiting 
concentration. Above this limit the solution is supersaturated and the protein is no longer 
soluble. At this stage small crystal nuclei are formed and crystal growth can begin. The 
crystallization process can be illustrated using a two-dimensional phase diagram (fig 
1 .28) 104 . 
The presence of impurities in the protein sample, but also the homogeneity of the 
solution, can interfere with the crystallization process '°: purity of the preparation, both 
in terms of homogeneity and conformation of the molecules, is required for protein 
crystal growth. 
During the crystallization process the solvent is slowly displaced from the protein 
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solution using controlled conditions 106  Common additives to achieve precipitating 
conditions are salts and polyethyleneglycols (PEG). The attraction exerted by 
electrostatic forces of opposite charges upon different protein molecules causes the 
protein to precipitate: the hydrated ions of salts and PEG not only remove the water from 
the solution, but also decrease the solubility of the protein. Electrostatic attraction or 
repulsion between protein molecules can also be controlled by varying the pH of the 
solution, or through the addition of organic solvents. On the other hand, hydrophobic 
interactions can be influenced by varying the temperature 96 . 
C 

















Crystallization agent concentration 
Fig 1.28: Phase diagram of protein ciystallization. The blue area represents a non-
saturated solution. C,ystal nucleation depends directly upon protein and crystallization 
agent(s) concentrations. 
A common technique to carry out protein crystallization experiments is the vapour 
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diffusion method, through hanging drop or sitting drop approaches (fig 1.29) 106408 
A small drop (2-4 .d) of protein solution is mixed with the precipitant(s) solution. The 
drop is sealed in a small well (2-3 cm 3 ) and allowed to equilibrate with a reservoir of 
approximately 1 ml. The reservoir contains the same buffer and precipitants as the drop 
but at higher solute concentration. 
The initial concentration of precipitants in the protein drop may be not enough to 
precipitate or crystallize the protein, but in the closed system of the well, there is transfer 




Fig 1.29: Sitting drop (left) and hanging drop (right) crystallization methods 
At equilibrium the concentration of precipitants in the drop is increased and can reach 
the optimal level for precipitation and crystallization '°' 110. 
1.6.4 Intermolecular interactions 
An interesting application of x-ray crystallography is the investigation of structure-
function relationship of a target protein. X-ray crystallography has also been 
successfully applied to study protein-protein and protein-ligand interactions and to 
elucidate mechanisms of protem-ligand binding 89.102.  
Protein-ligand complex formation can be achieved during the stages of expression and 
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purification of the protein: this method is particularly useful if the protein is structurally 
unstable without the ligand. Most commonly, the target ligand can be either có-
crystallized with the protein or added by soaking to pre-grown crystals In the 
soaking method, crystals of the protein are grown in the absence of the ligand. Crystals 
are then transferred in a solution containing the appropriate concentration of the ligand, 
which has to be higher than the KjfKm values 112  The ligand can diffuse into the crystal 
through channels within the protein crystal which are filled with solvent. The soaking 
method often leads to crystal cracking or significant loss of the diffraction properties of 
the crystals: this can be due to conformational adjustments induced by ligand binding to 
the protein that result in changes of the unit-cell dimensions 111 . 
1.7 X-rays 
X-rays are electromagnetic radiations with a wavelength range of 0.02-10A, while 
covalent bonds are typically around 1.5 A in length. Therefore, x-ray diffraction 
provides an experimental method of determining the position of individual atoms in 
molecules. When x-rays meet with electrons they are quickly absorbed by the electron 
cloud, causing the electron to vibrate at the same frequency as the incoming x-ray. 
X-ray diffraction is not useful for observing the positions of light and mobile atoms with 
few electrons. Beyond x-rays lie 7-rays, with wavelengths of 0.01 A or smaller. Neutron 
diffraction technique allows the direct location of small parts of the protein structure, 
such as hydrogen atoms and bound solvent 113  Neutron diffraction would be an 
excellent method for the study of protein structure and hydration, but an important 
limitation to the success of this technology is the lack of intense, single-wavelength 
beams of neutrons in sufficient quantities. X-ray crystallography is the most widely-used 
method for macromolecular structure determination: at the moment about 83% of the 
three-dimensional molecular structures empirically determined have been solved 
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through x-ray diffraction ciystallography (PDB, 2008) 141  
1.7.1 X-ray sources 
The production of x-rays can result from two different methods. The first method is to 
accelerate electrons, using an electrical field, against a metal target (x-ray tube, rotating 
anode). The energy generated by the collision of electrons with the metal target (usually 
copper or chromium) 114  is emitted as x-rays. 
The second method is to use synchrotrons, in which the particles are accelerated in a 
ring of constant radius (fig 1.30 and fig 1.31a). 
_ -__ 
Fig 1.30: European Synchrotron Radiation 1aciliiy (ESRJ9 Grenoble, France. Picture 
from 146 
These are the most efficient and powerful sources of monochromatic x-ray beams at 
high intensity and short wavelength 115  Synchrotron radiation was originally considered 
as an undesired by-product of high energy particle accelerators 116  Electrons (or 
positrons) are injected into the synchrotron ring and accelerated at speeds approaching 
the speed of light 117  Electromagnetic radiation is emitted when the charged particles 
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travelling at near the speed of light are forced into a circular orbit by bending magnets. 
The particles are losing energy while emitting electromagnetic radiation; the energy of 
the charged particles is maintained each cycle by radio-frequency inputs. Special 
insertion device magnets called "wigglers" are made of poles of alternating polarity, 
where the electrons are forced to perform a sinusoidal type trajectory. In this way a field 
more intense than that of the bending magnets can be employed and the intensity of the 
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Fig 1.31: a) 3ynchrotron ring, where the main components making up the particles 
accelerator are illustrated: the source of particles, the linear accelerator, the storage 
ring, and the insertion devices (bending magnets and extraction magnets) b) magnetic 
wigglers, where the magnetic field between the alternate poles causes the beam to 
oscillate back and forth while it traverses the wiggler. The arrow shows the direction of 
the beam passing through the wiggler. 
Third generation synchrotrons provide high amplitude x-rays, generated by bending 
magnets and/or by wigglers. This high intensity radiation enables crystallographers to 
obtain data from very small or weakly diffracting crystals '. The spectmm of radiation 
emitted is focussed by mirror systems and monochromators to provide a sharp beam of 
intense and tuneable single-wavelength x-ray radiation 119 
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1.7.2 X-ray radiation damage 
Ciystals exposed to intense synchrotron radiation are susceptible to specific structural 
and chemical damages 120  The quality of the model resulting from structure 
determination might be compromised after an excessive radiation dose 121  Radiation 
damage can induce irreversible modifications in the crystal, including breakage of 
covalent bonds, loss of definition of the carboxyl group of acidic residues, generation of 
free radicals, charge alteration and ionization 122  Active sites of enzymes have been 
reported to be highly sensitive to radiation damage 123-125  Damage can also occur to 
metal centres within proteins 126  causing reduction. Data collection at cryogenic 
temperatures (around 100 K) can minimize some of these problems, reducing the 
diffusion of free radicals, decreasing molecular motion and disorder and increasing the 
resolution limit of the data collected 127  Furthermore, at cryogenic temperatures ligand-
protein complexes and reaction intermediates can be trapped 99b01• 
In order to expose the protein crystal to cryogenic temperatures, a suitable 
cryoprotectant agent has to be used to prevent ice formation during the data collection 
which can disrupt the internal order of the crystal and interfere with the diffraction 
pattern of the protein crystal. A complete overview of cryotechniques has been recently 
written by Garman & Owen, 2006 128 
Over the last 10 years, the use of brighter synchrotron sources (third generation 
synchrotrons) has massively increased the dose of radiation to which crystals are 
exposed during the data collection, resulting in damage to protein samples even at lOOK. 
The use of tuned x-ray sources at synchrotron radiation facilities, implemented with 
cryogenic techniques, allow crystals to tolerate x-ray without influencing the diffraction 
quality 129  Although a clear understanding of radiation damage is still in its infancy, the 
modifications induced by the x-rays to specific sites in the crystal can be now used to 
determine the crystal structures of biological macromolecules (radiation-damage-
induced phasing) 130 . 
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1.7.3 Data collection 
In a diffraction experiment the crystal is placed on a diffractometer goniostat under a 
continuous stream of nitrogen vapour at 100 K 131 
The intensities resulting from the diffracted beam are visualized using a detection 
system (usually an image plate or charged camera detector (CCD)). The detector records 
a pattern of scattered and regularly spaced spots, known as reflections, where diffracted 
waves have collided (fig 1.32). 
scattered beam  
incident beam 
protein crystal 	1T---. 
diffraction pattern 
Fig 1.32: Dffracrion pattern (on the right) generated by the incident beam passing 
through a protein crystal (represen ted in red) mounted in a ioop 
During data collection using monochromatic x-rays of fixed wavelength, the crystal is 
rotated with respect to the incident beam, in order to record a set of two dimensional 
images of reflections. Each degree of rotation causes a change in the diffraction pattern. 
The range required to be covered by rotation depends upon the crystal symmetry 132 
Data collection strategies are determined by several parameters 133:  crystal symmetry 
and quality, x-ray source, radiation damage, detector type and computer software 
available. Each dataset is composed of a series of indexed reflections and their 
associated intensities. The most important parameters to consider during data collection 
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are completeness of measured intensities of all possible reflections within the resolution 
limit 127 
Strategy software systems have been recently developed for collecting complete datasets 
in efficient and successful ways. These software systems are based on analysis (space 
group and cell parameters determination, mosaicity calculation, integration and 
refinement) of a few diffraction patterns collected at different orientations, providing the 
information necessaiy to set a data collection run (detector distance, time of exposure, 
rotation range, oscillation etc.) in order to obtain a complete dataset 134-136 
1.8 Data processing 
Two dimensional images of reflections recorded during data collection are used to 
obtain the three dimensional atomic coordinates and their corresponding electron density 
maps. Reflections have to be indexed for an initial interpretation and their individual 
intensity pixels integrated with the total pixel intensity. Same or symmetrically 
equivalent reflections from different images are then merged together. Subsequently all 
the images have to be placed on a common relative scale, in order to remove systematic 
error introduced into the data for example by a non-ordered crystal (high mosaicity) or 
variation of the incident beam. 
In particular, crystal imperfections such as mosaicity can causes difficulties in 
processing data, because the diffraction spots can appear smeared or in higher number 
than expected. In a highly mosaic crystal (fig 1 .33b), each mosaic block diffracts 






Fig 1.33: Crystal mosaicity: a) low-mosaic crystal, b,) highly mosaic crystal 
During the data collection, any rotation of the whole crystal corresponds to a different 
range of rotation angles for the single mosaic blocks. Spots from highly mosaic crystals 
are likely to be in diffraction conditions for longer and will then overlap with other 
spots. 
The most common software systems used for data processing are MOSFLM 135, 
HKL2000 137  XDS 138  and, recently, PHENIX 139. 
1.8.1 The phase problem 
A wave is characterized by the amplitude (related to the intensity) and by the phase 
(related to the frequency). 
A diffraction experiment measures the intensities and angles of diffraction of the x-rays. 
The information about the phase of the wave is systematically lost in a data collection 
experiment Together with the amplitudes, the phase information of the diffracted x-rays 
is essential for the solution of crystal structures: reflections with the same amplitude but 
different phases correspond to different structures. 
The phase can not be directly measured, but needs to be obtained in order to solve a 
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structure: this missing information is known as "the phase problem" 140 
The phase problem can be expressed by the following equation: 
I 
P (x,y,z) = 	EE IF (h,k,I) I exp (-2n i (hx + ky + Iz - a (h,k,I))] 
where p (xyz) is the electron density, V is the cell volume and cx the phase angle. From 
the position of the reflections it is possible to determine their triple indexes (h,k,l) and 
assign the appropriate intensity to them. These intensities are proportional to the 
structure factor amplitudes, IF(hkl)I and correspond to scalar values. 
Initial phase estimates can be recovered in a variety of ways: 
Direct methods (DM), which are common in small molecule crystallography ( 1000 
non-hydrogen atoms) and require high resolution data (l .4 A resolution) to derive 
the model by using known phase relationships between diverse groups of 
reflections' 4 ' 
Molecular replacement (MR) method was first developed by Rossmann 147  In MR 
the phase is calculated using as a search model a previously solved structure, 
homologous (>25%) to the target model and fitted in the experimental electron 
density obtained from data collection (fig 1.34). This procedure is based on the 
observation that proteins, homologous in sequence, share a similar folding. In order 
to place the molecule in the target unit cell two steps are required: these are rotation 
and translation. In the rotation step the spatial orientation of the known and the 
unknown molecules with respect to each other is calculated. In the translation step 
the two molecules, already correctly oriented, are superimposed. 
Molecular replacement methods are based on the properties of the Patterson function 
96, 119 The Patterson fi.mction is the Fourier transform of the intensities rather than 
the Fourier transform structure factors. Patterson function gives a map of the vectors 
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between atoms. The peaks in the Patterson function are proportional to the 
interatomic vectors distances of the peaks of the two atoms in the electron density 
map. The Patterson function is important because it can be obtained without phase 
information. The superposition of the interatomic vectors of the search and the target 
models in the rotation and translation functions gives a maximum value when the 
search model is optimally rotated onto the observed data. When the model is 
oriented correctly and placed in the correct position in the unit cell, the two 
Pattersons should be similar. Once the correct orientation and position are found, 
phases are calculated from the model and combined with the observed structure 
factor amplitudes. The electron density map is then calculated using observed 
structure factor amplitude and theoretical phases calculated from molecular 
replacement solution. 
The structure factors thus obtained and the corresponding electron density map might 
contain a bias towards the starting model, especially in low resolution structures. In 
this case, the resulting electron-density map will have the same characteristics of the 
model even if some features are not actually present in the structure 42  indeed, model 
bias can make the electron-density maps difficult to interpret. Refinement of a model, 
where incorrectly placed atoms are omitted, can reduce the bias. However, structure 
factor bias can be effectively minimized by using information contained in the first 
electron density map to bring out structure factor information. A small fraction of the 
model, (i.e. —3-5%), is systematically omitted for phasing: in this way the model bias 
is reduced by a small percentage of the atoms in the model. The recovered densities 
in the omitted region are then combined with the initial phases to form the composite 
omit map. Then, omit maps (and simulated annealing omit maps) allow to test for 
bias. The density in the omit region of such composite maps is not biased by the 
model within that omit region. The result is that the phase information obtained by 
using these maps have lowered model bias compared with that obtained directly from 
a model 148  Even when a wrong part of the structure is removed, since all of the other 
atomic coordinates have already been refined to reinforce the positions of those parts 
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that are now absent, the resultant biased phases may create electron density that again 
reinforces the wrong parts even if their atoms are not used to calculate phases. Thus, 
it is necessary to re-refine the model in the absence of the omitted part so that a new 
model can be generated without any bias. 
3) Single and multiple isomoiphous replacements (SIR and MIR), based on the effect on 
the diffraction pattern of electron-dense metal atom(s) (i.e. heavy atoms) bound to the 
protein. The changes in the scattering amplitudes in comparison to the "native" 
diffraction pattern can be interpreted to calculate the phases. Heavy atoms are 
introduced into the protein by co-crystallization or by soaking the crystal in a heavy 
atom-containing solution. The heavy atom method is the original approach by which 
protein crystal structures were solved. The mains difficulties associated with 
isomorphous replacement are in the positioning of heavy atom(s) and issues related to 
their occupancy at these positions. Collecting data at different wavelengths can 
facilitate the location of heavy atoms: this method is known as the multi-wavelength 
anomalous diffraction (MAD). At the moment the atom most commonly used for 
phase determination by MAD is selenium, because it is possible to replace the natural 
sulfur-containing methionine with selenomethionine 140 Atoms naturally present in 
proteins which are also suitable for this purpose are metal ions in metallo-proteins. 
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Fig 1.34: Representation of the molecular replacement phasing method. a) data 
collection b) experimental data c) model search >25% homology d) rotation translation 
operations of the model search in the experimental data e) and J) phasing fitting in the 
search model g) model (re)building and refinement using the target molecule 
1.8.2 Model building, refinement and structure validation 
The model building process depends directly upon the phase information and the 
resolution of the data. With phase data, an initial model can be generated using 
automated programs such as ARP'wARP 142  and RESOLVE 
143  This initial model can 
then be used to improve the phase calculations and build a more accurate model. The 
new model generated is then fitted to the new electron density map and rounds of 
refinement are performed. Refinement is the process in which the model is adjusted to 
find the closer agreement between the calculated and the observed structure factors. 
Indeed initially, calculated structure factors are generally in poor agreement with the 
observed structure factors. 
Statistical parameters are used as measure of the global quality of the refinement and 
rebuilding processes, and they express the correlation of the final model with the 
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experimental data. The most important parameter is the "residual" (R) factor, which is 
defined as: 
aII reflections I F0 - Fc  I 
aII reflections I F0  I 
where F is the structure factor and the sum extends over all the observed reflections (F 0) 
and their calculated counterparts (F e). 
In addition the free R parameter (Rfree) corresponds to a fraction of —5% of the total 
measurements not processed through refinement 1; Rfree is used to monitor the progress 
of refmement as well as reliably estimate the error in the final model. 
R factor values generally increase proportionally to the size of the molecule and directly 
correlate with the resolution of the data. Rfree  should be approximately the resolution in 
Angstroms divided by 10: a data-set with 2 A resolution should give a final R ft ,, of 
55 roughly 0.2 
Another important parameter is the B-factor (temperature factor or 'Debye-Waller 
factor). This factor describes the degree to which the electron density is smeared. B-
factor indicates the dynamic mobility of an atom, but it can also indicate where there are 
errors in model building. The B-factor is given by: 
B8U 1. 
where U1 2 is the mean square displacement of the ith atom. As U increases, B increases. 
If atoms are incorrectly built, their B-factors will tend to be higher than correctly built 
atoms. 
Each atom in a structure can be described by its position (x,y,z) and by its atomic 
displacement parameter (B-factor). During the refinement process, the adjustment of the 
model consists of changing these positional parameters and the temperature factors for 
the atoms, to obtain a better agreement with the measured data. 
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However, refinement process has generally to deal with the poor observation (number of 
independent reflections) to parameter ratio which affects macromolecular structure 
determination and is directly dependent on the resolution of the data. For example, 
considering as only parameters the position of the atoms and their temperature factors, at 
a resolution of about 2.8A, there is only one observation for each parameter. That means 
that it is easy to over fit the data to get a deceptive level of agreement between model 
and experiment. 
When the ratio of observation:parameters to be refined is poor, additional "observations" 
are incorporated in the refinement process. These are stereochemical data (bond length 
and angles), solvent information (solvent flattering) 149  and non-crystallographic 
symmetry 119  This last observation, if it exists, makes important contribution to the 
refinement of the protein structure. 
Stereochemical information (bonds length, bonds angles, etc) can be applied in two 
ways: 
• as constrained, when they are taken as rigid and only dihedral angles are varied. This 
can reduce the number of parameters to be refined 
• as restrained, when the stereochemical parameters are allowed to vary around a 
theoretical value. Typical restraints include bond lengths, bond angles and van der 
Waals contact distances. 
In high-resolution and well-refined structures the electron density might show that 
multiple conformations of certain residues exist. In this case multiple sets of coordinates 
are reported for the same atom. Alternate conformations can be observed where it looks 
that part of the structure lies in two or more different places. However, in the high-
resolution structure (1.6 A) reported in this work (Chapter 3) we did not observe any 
alternate conformation. If we had seen any they would have been refined with partial 
occupancy until the balance would had looked right. 
Many other parameters have to assets the data quality and used to validate every 
crystallographic model before deposition to the Protein Data Bank: these have been 
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Aims of the project 
In nature a large number of proteins are oxidoreductases. They participate in a wide 
spectrum of biological functions, including energy conversion (in photosynthesis and 
respiration), long-range electron transfer, drug detoxification, and catalyse a diverse 
range of biological reactions. 
Investigating electron transfer reactions is fundamental in understanding how biological 
redox reactions are linked to the events of charge exchange, protein conformational 
change, chemical catalysis and energy conversion. Structural information at atomic 
resolution on electron-transfer proteins and enzymes is essential for gaining such 
understanding. 
The redox proteins studied in this thesis are two dioxygenases (tryptophan 2,3-
dioxygenase and indoleamine 2,3-dioxygenase), and mutant forms of nitric oxide 
synthase and flavocytochrome b2 . The main goal of the project has been to elucidate the 
architecture of these enzymes using x-ray crystallography techniques. In parallel with 
the structural investigations, functional studies have been carried out with the aim of 
elucidating all aspects of catalysis in the target enzymes. 
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Materials and methods 
2.1 Growth and maintenance of bacterial strains 
2.1.1 Bacterial strain 
Escherichia coli BL21 (DE3) cells 
2.1.2 Bacterial Plasmids 
pXcRl 3-21.3: contains the X. campestris TDO coding sequences 
pSoR52-21.1: contains the S. oneidensis S04414 coding sequence 
pCRNNR: contains the G586S rat NOS heme domain coding sequence 
pKD209: contains the N42C S. cerevisiae flavocytochrome b2 coding sequence 
contains the K324C S. cerevisiae flavocytochrome b2 coding sequence 
contains the N42C:K324C S. cerevisiae flavocytochrome b2 coding sequence 
2.1.3 Site direct mutagenesis 
All TDO and IDO constructs were created at Northeast Structural Genomics Consortium 
(NY, USA). 
Neuronal NOS heme domain G586S mutant and flavocytochrome b2 constructs were 
created by Dr. Caroline S. Miles, Institute of Molecular and Structural Biology, 
University of Edinburgh, UK. 
2.1.4 Cell fransformation 
30 .tl of competent cells BL2 1 E. coli were gently defrosted on ice before 5 to 10 ng of 
plasmid DNA in a volume of 1 to 5 .tl were added and mixed. The mixture was 
incubated for 20 minutes on ice and then heat shocked at 42°C for exactly 45 seconds in 
a water bath before being quickly placed on ice again for 2 minutes. Pre-warmed SOC 
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medium (see table 2.1) (250 p1) was added before transferring the vial to 37°C for I 
hour in a shaker at 225 rpm. Susequently, different aliquots (10 to 100 p1) of the 
transformation mix were plated onto two LB plates containing the appropriate antibiotic 
concentration. A flame-sterilised loop was dragged across the surface of the culture and 
used to streak out the agar plate. The plates were incubated overnight at 37 °C in order 
to promote the growth of bacterial colonies. 
2.1.5 Growth media 
Luria-Bertani (LB) broth, Terrific Broth (TB), LB plates, SOC media (table 2.1). 
2.1.6 DMSO stocks 
From starter cultures small stocks for future use were prepared by adding 77 p1 DMSO 
to 1 ml of cells dispersion (7% DMSO by volume). DMSO stocks were then stored 
at - 80°C until required and kept on ice while in use. The DMSO stocks were replaced 
periodically using colonies from freshly prepared LB agar plates. 
2.1.7 Antibiotics 
Stock solutions of antibiotics were prepared in Millipore water, passed through a 0.22 
pm filter and stored at -20° C. 
2.1.8 Growth of bacterial cultures 
Liquid cultures of bacteria were grown in the appropriate broth by inoculating with a 
single colony using a sterile inoculating loop. Cultures of the bacterial strains were 
grown at the appropriate temperature. 
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Luria Bertani broth (LB) 	 For I litre: lOg bacto tryptone 
5 g yeast extract 
5 g NaCl 
For I litre: 20 g bacto tryptone 
10 g yeast extract 
Terrific broth (TB) 	
4 ml glycerol 
2.6 g KH 2 PO4 
4.3 g K2 HPO4 
Prepared using MilliQ ultrapure water (of resistivity 18 C2 cm') and autoclaved sterilized 
15 gl agar dissolved in LB 
Autoclaved agar was allowed to cool to room 
LB Agar plates 	 temperature. Prior to setting, agar was augmented 
with the appropriate antibiotic and poured into 
Petri dishes. 
For I litre: 5 g bacto tryptone 
5 g yeast extract 
Soc medium 058 g NaCl 
0.19 g KCI 
l.2gMgSO4 
2.0 g MgCl 2 
3.6 g glucose 
Table 2.1: Growth media and agar 
2.2 Protein purification and storage 
21.1 Cell extraction 
Cells stocks were defrosted and suspended in the appropriate resuspensionllysis buffer 
allowing approximately 40 ml buffer for 25 g of cell pellet. Lysis of the E. coli cells was 
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obtained by ultrasonication using a Sanyo Soniprep 150. Typically 8 sonication periods 
of 20 second each at 15 microns applied to a 40 ml cell suspension were required to 
distrupt cells. The cell suspension was kept on ice to prevent overheating. Eventually the 
lysate was pooled and cell debris separated by centrifugation at 20000 rpm for 1 hour at 
4°C (Sorvall RC-513 centrifuge with a SS34 head). The clear supematants containing the 
over-expressed target protein were collected and kept on ice prior to the 
chromatographic steps of purification. 
2.2.2 Concentration and storage 
Concentration of the purified proteins was obtained via centrifugation using a FALCON 
6-300 centrifuge at 2000 rpm and Amicon Centriprep concentrators with a membrane 
size of 10-50 kDa. Protein concentration was spectrophotometrically measured. Pure and 
concentrated protein was divided into aliquots, flash frozen in liquid nitrogen and stored 
at -80°C until required. 
2.23 Purity determination 
The purity of the protein was measured at several stages by both analysis of UV/vis peak 
ratios and by SDS-PAGE (Sodium Dodecyl Sulfàte-Poly Acrylamide Gel 
Electrophoresis). 
2.2.4 Gel electrophoresis 
SDS-PAGE was performed using NuPAGE ®  Novex 4-12 % Bis-Tris pre-cast 
polyacrylamide gels in combination with SeeBlue Plus 2 ® molecular weight markers. 
Assessment of the purity and integrity of the proteins was carried out through gel 
electrophoresis at various stages of the expressionlpurification. The protein samples 
were diluted using buffer as described in table 2.2 and boiled for 3 minutes to denature 
the protein and allow SDS binding. SDS bind with a constant ratio to the proteins as a 
function of their mass (1.4 g SDS: I g protein) and shields their charges, the different 
distance to which each protein migrate depending only on its mass. 
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25 111  NuPAGE® LDS 4x sample 
Sample buffer 	 preparation buffer pH 8.4 
25 ld diluted protein sample (>1 jiM) or 
50 jil dH2O 
NuPAGE MES SDS 20x running buffer 
Running buffer 	 pH 7.0 
50 ml dH2O 
40 ml methanol 
Coomassie stain 	 10 ml acetic acid 
1 ml Coomassie brilliant blue 
50 ml dH2O 
Destain 	 40 ml methanol 
10 ml acetic acid 
All prepared using MilliQ ultrapure water (of resistivity 18 Q cm') 
Table 2.2: SDS PAGE buffers and stains 
The central reservoir was filled with running buffer ensuring that the buffer level was 
beyond the sample loading wells. Aliquot of each sample (ranging from 5 to 15 jil) were 
loaded into the wells, reserving one well for SeeBlue Plus 2®  molecular weight markers 
(5 jil). A potential difference (150 V, 120 mA and 60 W) was applied to the gel for the 
time necessary for the dye front to reach the bottom of the gel (approximately 1 hour). 
The voltage was then removed and the polyacrylamide gel was stained in Coomassie 
blue (Table 2.2) approximately for 15 minutes and destained for at least 1 hour to 
remove excess of stain. Coomassie blue binds to the protein, making a band visible, and 
the comparison between the positions of the blots with the markers give an indication 
about the presence of proteins and their size. 
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2.3 Buffer preparation 
Buffer solutions were required for protein purification steps and ciystallographic 
experiments. Buffers frequently used in this work are summarized in table 2.3. 
Buffers composed of an acid and its salt were prepared by dissolving the acid form of 
the buffer in about - 60% of the water required for the final solution volume. The pH 
was adjusted using a sirong base (i.e. NaOH). Preparation of buffers composed of a 
base and its salt, started with the base form and the pH was adjusted with strong acid 
(i.e. HC1). After correction to the desired pH, the volume was adjusted by addition of 
Millipore water. Buffer solutions were typically filtered using sterilizing-grade 
membrane filters (0.22 p.m). 
23.1 Sodium phosphate buffer 
0.5 M sodium phosphate buffer was prepared by titrating 1 M NaH2PO4 with 1 M 
Na2HPO4 (both Sigma, prepared in Millipore water) to the desired pH and then the 
volume doubled by addition of Millipore water. 
23.2 TrisHCl buffer 
Ionic strength (p or 1) is a measure of the total concentration of ions in a solution, 
defined by: 
j.t (or]) = V2 1 cz12 
where z i is the charge of ionic species i and c, is its concentration. 
10 mM TrisHCl buffer was prepared by titrating 10 mM HC1 (1 N standard solution, 
Sigma) to pH 7.5 with a saturated solution of Trizma o base, Sigma). Ionic strength was 
calculated and adjusted to 10.10 by addition of NaCl (Fischer Scientific). All solutions 




Buffering system (all 	from Sigma) 	 Buffering range 
Sodium citrate 	 3.0 - 6.2 
Sodium acetate 	 3.7 - 5.6 
2-(N-morpholino)ethanesulfonic acid 
(MES) 	 5.5-6.7 
2-(bis(2-hydroxyethyl )amino)-2-(hydroxymethyl)propane- 
1,3-diol (Bis-Tris) 	 5.8-7.2 
Piperazine-1 ,4-bis(2-ethanesulfonic acid) 
(PIPES) 	 6.1-7.5 
4-(2-hydroxyethyl)piperazine- 1 -ethanesulfon ic acid 
(HEPES) 	 6.8 - 8.2 
Tnzma 	 7.0 - 9.00 
N-(2-Hydroxyethyl)piperazine-N'43-propanesulfonic Acid) 
(HEPPS) 	 7.3-8.7 
N,N-Bis(2-hydroxyethyl) Glycine 
(Bicine) 	 7.6-9.0 
(N-Cyclohexylamino)ethane Sulfonic Acid 
(CHES) 	 8.6-10.0 
3 -(Cyclohexylamino)propanesulfonic Acid 
(CAPS) 	 9.7-11.1 
Table 2.3: Commonly used buffers for protein purification and cyszallization. Buffering 
ranges are referred at 25°C 
23.3 Buffer degassing 
The buffers used in anaerobic glove boxes were prepared as required and then degassed 
by nitrogen bubbling for at least 1 hour before introducing them into the anaerobic box. 
Protein samples degassed were kept in the box at least 1 day prior to use. 
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2.4 Protein crystallization 
Crystals were growth by either hanging drops or sitting drops vapour diffusion methods 
1-3, using 24 wells Linbro ® Plate and CryschemTM plates, respectively (both from 
Hampton Research). 
Initial crystallization screenings were carried out using Hampton crystal screen Crystal 
ScreenTM, Crystal Screen 2TM  and PEG/Ion Screen. In such screens, a number of 
different conditions for crystallization were tested. 
When crystal nucleation was achieved, optimization of the condition was carried out 
varying protein concentration, pH, buffers and precipitants concentration. 
2.4.1 Crystal mounting and flash-cooling 
Mounted cryo-loop (Hampton Research or Molecular Dimensions ltd) assembly consists 
of three parts: the support, the pin and the base. The support is the interface between the 
loop to hold the crystal and the pin. The pin is attached to the base and the base is held 
on the goniometer head. 







Fig 2.1.' Mounted cryo-loop. The set involves a ?nagnetic base ('which attaches to 
goniomeler head on the x-ray beam), a thin metal pin and a thin fiber ioop of variable 
size (0.05-1.0 mm) where the crystal is mounted. 
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The choice of cryoprotectant was influenced by the mother liquor composition. In 
general the best choice of cryoprotectant was one that most closely resembles the 
composition of the mother liquor. The original mother liquor was generally 
supplemented with 23-30% glycerol. 
Crystals of different proteins were sensitive to different protectants. Some cryo-
protectants which were routinely tested are indicated in the following list: 
• glycerol 
• ethylene glycol 
• 2-methyl-2,4-pentanediol (MPD) 
• dimethyl sulfoxide (DM50) 
• polyethylene glycol (PEG) 400 
• glucose, sucrose 
• mineral oil 
Crystals were washed in a solution containing the appropriate cryoprotectant. Some 
crystals needed to go through stepwise exposure to a clyoprotectant solution in order to 
prevent damage due to solvent change. 
The freezing process was carried out rapidly in order to ensure the amorphous 
solidification of the solvent in and around the crystal and to allow isotropic freezing of 
the entire loop contents. 
Two methods of flash-cooling were used: 
Plunging the crystal into liquid nitrogen prior to transfer to the cold gaseous 
nitrogen stream or storage in liquid nitrogen. 
Plunging the crystal into liquid propane prior to transfer to the cold gaseous 





Fig 2.2: Data collection process at a synchrotron work station (pictures from Morgan, 
H. P. , with permission of the author). 
(a) Hutch view; ('b) Crystal mounting area; (c) C,ystal in a nylon loop; ('d) Dffraction 
image. Labels; (1) Sample changing robot; (2) CCD x-ray detector; (3) Synchrotron 




2.5 Data collection 
All data were collected at Brookhaven National Laboratory at the X4A beam line, at the 
European synchrotron radiation facility (ERSF) in Grenoble, France on beam line BM14 
UK MAD beam line) and BM30 and at SRS, Daresbury station 10.1. The data collection 
process is illustrated in figure 2.2. Data were typically collected as 10  (degree) 
oscillation images with the crystal maintained at 100 K in a nitrogen gas stream. 
All the data collected were mainly processed through the CCP4 suite XDS 
6  or 
DENZO . 
Diffraction images were indexed and integrated with MOSFLM 
g, 
 XDS 6  PHENIX 9 , 
MOSFLM was used to visualise the frames (fig 2.3). 
r . -7 \1 
Fig. 2.3: Snapshot of the program MOSFIM 
Reflection data were scaled with CCP4 8 or SCALEPACK 
7 and all the reflections were 
merged into an average intensity scale. 5% of the collected reflections were assigned 
with an Rft, flag 10. Resolution settings were adjusted so that the 11cr for each resolution 
shell was greater then 1. The refinement was carried out using REFMAC5 and 
PHENIX 9  was used for the rigid body refinement and the restrained refinement for the 
atomic anisotropic and positional B-factors for the models. 
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2.6 Visualization and manipulation of structures 
All the molecular graphic figures displayed in this work were made using Pyrnol 12 
chapter 3 and chapter 5 some figures were produced with Molscript 13  and rendered with 
Raster3D 14 
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Structural studies on tryptophan 2,3-dioxygenase (TDO) and 
indoleamine 2,3-dioxygenase (IDO) 
3.1 Introduction 
Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) 
catalyze the oxidative cleavage of the L-tryptophan (L-Trp) pyrrole ring to form N-
formyl-L-kynurenine (fig 3.1). In mammals, this reaction represents the first and 











Fig 3.1: The reaction catalyzed by IDO and TDO 
The kynurenine pathway accounts for the processing of over 90% of L-Trp utilised 
by humans 4 .  It is important not only as a source of metabolites, but also due to the 
effect of IDO / TDO on the local tryptophan concentration. The build up of pathway 
metabolites due to DO / TDO induction, or poor metabolism further along the 
pathway, can lead to numerous physiological conditions 5 . High levels of quinolinic 
acid and L-kynurenine in cerebrospinal fluid 6  may be involved in various 
neurological disorders (e.g. cerebral malaria, ischemic brain injury, multiple sclerosis 
and AIDS-related dementia 68)  Concentrations of these metabolites increase with 
the severity of neurological dysfunction or brain injury under a wide range of 
inflammatory conditions. For example, the kynurenine pathway metabolites 3-
hydroxyanthranillic acid and 3-hydroxykynurenine are UV filters that can bind to 
lens proteins in the eye, and they have been implicated in cataract formation when 





Fig 3.2: Kynurenilation of lens proteins is involved in age-related cataract 
10 formation. Picture from 
In addition, IDO has been implicated in a diverse range of physiological and 
pathological conditions, including suppression of T cell proliferation 11 , maternal 
tolerance to allogenic fetus 12. 13 and immune escape of cancers 
14  and is an 
attractive target for drug discovery against cancer and autoimmune and other diseases 
2. 15-17 IDO and TDO play a role in the physiological regulation of tryptophan 
distribution in the human body, also influencing serotogenic regulation 18  The local 
depletion of tryptophan by enzymatic action is mainly associated with an 
antimicrobial response involving IDO or TDO, or immune regulation by IDO j. 
Some pathogens are sensitive to tryptophan degradation including viruses (Herpes 
viruses), intracellular bacteria (Chiamydia and Rickettsia) and extracellular bacteria 
(Staphylococci), and this may be an effective mechanism for controlling their ability 
to proliferate. 
3.2 Discovery of IDO and TDO 
TDO was initially discovered in the 1930s 20  It has been reported in both eukaryotes 
(human 21  rat and rabbit 22)  and prokaryotes (Xanlhomonas campestris 
23 
Raistonia metallidurans, Pseudomonas fluorescens 24. 25) Expression of TDO in 
mammals is normally restricted to the liver, but it has been identified in the brain and 
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epididymis of some species, and in some tissues its production can be induced in 
response to stimuli. 
IDO was first isolated from rabbit intestine in 1967 26  and it has been isolated in 
many eukaryotes. In animals IDO is expressed throughout the body, except for in the 
liver 27-29  Its production can be induced in many tissues in response to various 
stimuli and this specific expression in different cellular locations suggests that IDO 
has a distinct role from TDO 13 
3.3 Bacterial IDO and TDO 
IDO and TDO are members of a family of enzymes that also includes sIDO from 
She wane/la oneidensis 23  and the second enzyme in the pyrrolnitrin biosynthetic 
pathway PrnB from Pseudomonasfluorescens 30,  although dioxygenase activity has 
not been yet demonstrated for either of these. Homology between members of this 
family is apparent from their three-dimensional structures and from the conservation 
of certain amino acids in their active sites, but sequence alignment based on their 
structures often gives an identity of approximately 10 23 
Bacteria are also believed to use members of this family for the aerobic metabolism 
of L-Trp via the kynurenine pathway, however prokaryotic IDO-like proteins bear 
little sequence similarity to eukaryotic IDO proteins and very little is yet known 
about them. 
3.4 Amino acid sequence information and substrate specificity of 
IDO and TDO 
IDOs and TDOs from a number of eukaryotic species have been sequenced and can 
be found in protein databases. 
Despite catalyzing identical biochemical reactions, the sequence similarity between 
TDO and DO is extremely low. IDO is monomeric and contains approximately 400 
amino acids, displaying high sequence similarity between eukaryotic species. TDO is 
Chapter 3 
homotetrameric, and eukaryotic TDOs contain approximately 400 amino acids per 
monomer, while prokaryotic TDOs contain approximately 300 amino acids. 
Sequence identities between prokaryotic and eukaryotic TDOs are around 20-30% 
demonstratingthe remarkable evolutionary conservation of this enzyme 23.31 
Rio 
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Fig 3.3: a) Bacterial spots on green 1ef crucifer caused by Xanthomonas 
campestris, picture from 32,  b) Xanthomonas campestris (Xc), picture from 
33 
Xanthomonas campestris (Xc) is a plant pathogen gram-negative aerobic bacterium 
(fig 3.3). It infects crucifers such as Brassica and Arabidopsis, causing lesions that 
extend toward the base of the leaf resulting in extensive wilting and necrosis as the 
infection advances 34 . Xanthomonas campestris TDO shares 34% sequence identity 
with human TDO (fig 3.4). 
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Xc TOO ----------------- M DKNLRDL-EPIHTDLEGRLTYGGYLRLDQLLSAcQPLE 
HsTDO MSGCPFLGNNFGYTFKKL1t EGSEEEKSQTVNRASKGGLIYGNYLHL-VLNA .ELQ... 
XcTDO PAH---LE-MFIiQHQTSE L LLHRAIvHLçRDEWQCR ---F.VLARSKQv--  
HsTDO TKGNKIDEHLFIiTHqAYE; F QILWE:DSVEEIF,NGH BDEPL1VSimvSV 
XcTDO - LRQLTEQWSVLETLTPSEYMGFDVLG S 	• 	YRYIEFLL11(NPQML ------- 
Hs_TDO I L.KLLVQQFSI LE TMTALDFND FPEYLS AS 3FQSLQYRLLENKI VLQNMRVPYNEBYR 
XcTDO -------QVFAYDPAGQARRiVLE - ----- ----- ------------------ - -.EFLRYL 
HsTDO DNFKGEENELLLKSEQEKTLLELVE1WLERT1 GLEPHGFNFWGKLEKNITRGLE.EFIRIQ 
Xc TOO RFGHAIpQ ---- QYARDwmAHvA:D ----------------- TPVFERIENTDi. 
HsTDO KEESEEKEEQVAEF KQKEVLLSLF EKRKEHLLSKGERRLSYRALQGALMIY REEPR 
Xc TOO YWBEYS CEDLV:VETQFQL 
HsTDO FQVPFQ LTSLMIDSLMTK YN VcMv1fGSKA3?:;: :YHY:RSTVSDRYKVFV 
XcTDO ELFDVRTSVGVDNRP-QGSADAGK ------------------ R 
Hs_TDO DLFNLSTYLIPRHWI PKPTIHKFLYTAEYCDSSYFSSDESD 
Fig 3.4: Amino acids sequence alignment of Xanthomonas canipetris (Xc) (in blue) 
and human (Hs) TDO (in black). Xc TDO shares 34% sequence identity with Hs 
TDO. In magenta are highlighted the conserved residues. 
TDO is highly specific for L-Trp and related derivatives such as 5- and 6-fluoro-Trp 
as the substrate (fig 3.5, yellow background). In comparison, IDO shows activity 
toward a larger collection of substrates, including L-Trp, D-tryptophan (D-Trp), 
serotonin, and tryptamine (fig 3.5), although the K. for D-Trp is —100-fold higher 

























Fig 3.5: TDO can use substrates coloured in green, but not those coloured in red. 
IDO can use all substrates (red and green). 
3.5 Indoleamine 2,3-dioxygenase 
The structure of human DO in the catalytically inactive ferric state in complex with 
the inhibitor 4-phenylimidazole (4-PT) has recently been reported Although this 
structure provides information about potentially important active site residues, the 
inhibitor is coordinated to the heme iron and does not provide any information 




Fig 3.6: Human indoleamine dioxygenase (IDO) crystal structure at 2.3 A resolution 
(PDB entry 2DOT). The smaller N-terminal domain is shown in blue, and the larger 
domain in cyan. The heme is shown in sticks, colored in red. 
The structure of human IDO revealed that the enzyme is folded into two distinct 
domains (fig 3.6). The larger (and C-terminal) of these is completely helical (fig 3.6 
in blue), with thirteen a-helices and two 310-helices, and belongs to the family of 
IDO-like protein folds The smaller N-terminal domain (fig 3.6 in blue) consists of 
six a-helices, two short 13-strands, and three 310-helices. The heme is bound within 
the larger domain, but is close to the domain interface. The loop region connecting 
the two domains (residues 250-267) lies above the distal face of the heme, close to 
the active site. 
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Fig 3. 7: The active site of human IDO. Potentially important active site residues are 
shown, along with the bound inhibitor 4-PI. 
The heme pocket (fig 3.7) is formed by residues from the small domain (Tyr126, 
Cys129) and from the large domain (Phe163, Phe164, Phe226, Arg231, Ser263, 
G1y261 and G1y262). Phe163 interacts with 4-PI. Ser167 is one of the closest 
residues to the inhibitor. Phe164 and Cys129 contribute to the hydrophobic wall of 
the active site pocket, but are too distant to interact with the inhibitor. Due to the 
nature of the inhibitor bound to the active site, the structure provides little 
information on the binding mode of L-Trp (or any substrate). 
To provide direct insight into substrate recognition and catalysis by DO and TDO, 
we sought to obtain the crystal structures of the oxidised and reduced forms of TDO 
from X campestris in binary complex with the substrate L-Trp or 6-fluoro-D/L-
tryptophan (6-F-Trp). Furthermore, we obtained the structure of the active reduced 
form of a putative DO from Shewanella oneidensis. The description of the above 




3.6.1 Expression of Xanthomonas campestris TDO 
Full-length X campestris TDO construct was created at the centre for Advanced 
Biotechnology and Medicine (Northeast Structural Genomics Consortium), Rutgers 
University, Piscataway, NJ 08854.The expression plasmid was produced by cloning 
the the full-length Xanthomonas campestris TDO (Q8PDA8_XANCP, NESG ID 
XcR13) into a pET21d (Novagen) derivative, generating the plasmid pXcR13-21.3, 
with a C-terminal hexa-histidine tag, as described in Acton, et al. (2004)38.  The 
resulting XcR13 contains 8 (LEHHHHHH) nonnative residues at its C terminus. The 
construct sequence was verified by standard DNA sequence analysis. Escherichia 
co/i BL2 1 (DE3) pMGK cells, a rare codon-enhanced strain, were transformed with 
pXcRl3-21.3. Two single isolates were cultured individually in either LB containing 
hemin (7 p.M final concentration) for the holoenzyme or MJ9 minimal media 40, 
containing selenomethionine, lysine, phenylalanine, threonine, isoleucine, leucine, 
and valine for selenomethionyl XcR 13 Initial growth was carried out at 37 °C 
until the 0D600 of the culture reached 1.0 units. The incubation temperature was then 
decreased to 17°C, and protein expression was induced by the addition of IPTG at a 
final concentration of 1 mM. After overnight incubation at 17 °C, the cells were 
harvested by centnfugation. 
3.6.2 Purification of Xanthomonas campestris TDO 
Native heme-containing and selenomethionyl XcR13 protein was purified by 
standard methods. The cell pellet was resuspended in lysis buffer (Tris / HC1 pH 7.5, 
500 mM NaCl, 40 mM imida.zole, and 1 mM TCEP) and disrupted by sonication. 
Cell debris was removed by centrifugation at 26,000 x g for 45 min at 4 °C. The 
XcR1 3 protein, in its separate supernatant, was then purified using an AKTA-
Express (GE Heathcare) two-step purification strategy. Briefly, the His-tagged 
protein in the supematant was loaded onto a HisTrap HP column (GE Heathcare), 
washed with lysis buffer, and eluted with the same buffer, containing 250 mM 
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imidazole, into a 10-mi sample loop. The loop content was then injected onto a gel-
filtration column (Sephadex G75; GE Heathcare), and eluted in buffer 2 (10 mM Tris 
/ HCl (pH 7.5), 5 mM DTT, 100 mM NaCl, 0.2% (w/v) NaN3). The purified XcR13 
protein resulting from gel filtration was concentrated to 5-10 mg/mi, while sample 
purity (-- 97 %) and molecular weight were verified by SDS-PAGE (fig 3.8) and 
MALDI-TOF mass spectrometry (data not shown). All steps in the preparation of 
heme-containing proteins used buffers without the DTT reducing agent. 
F 
mw 
62 kDa 	Monomeric TDO 
28 kDa - (36 KDa) 
40 
Fig 3.8: Purified Xc TDO. Samples are analyzed by 4-12% SDS-PAGE and 
visualized by Coomassie staining. 
Protein and heme concentrations were determined by the Bradford 
42  and pyridine 
hemochrome methods , respectively. An extinction coefficient of 9404= 180500 Nf' 
cm' per protomer was calculated for ferric of X. campestris TDO. 
3.6.3 Protein crystallization 
Crystals of TDO were produced by the hanging-drop vapor-diffusion method at 
18°C, for the apoenzyme the reservoir solution comprised 50 mM Tris I HCI pH 7.0, 
13% (w/v) PEG 3350, 100 mM magnesium chloride, and 5 mM DTT. In the case of 
the holoenzyme the well solution was 50 mM MES pH 6.15, 12% (w/v) PEG 1000, 




Fig 3.9: Crystals of the holoenzyme TDO grown using a reservoir comprising 50 mM 
MES pH 6.15, 12% (wt/vol) PEG 1000, and 60 mlvi manganese chloride 
The enzyme was at 20 mg/mI concentration. Crystals of the apoenzyme (without 
heme) were cryoprotected in paratone, and those of the holoenzyme (fig 3.9) in 
mother liquor supplemented with 25% (v/v) glycerol, before being flash-cooled for 
data collection at 100 K. 
In order to obtain the structure of TDO in the ferrous state, the crystallization process 
was conducted in a Belle Technology (Belle Technology, Dorset, U.K.) anaerobic 
glove box (fig 3.10) with the 02 concentration maintained < 2 ppm. 
Prior to crystallization, the protein was chemically reduced by the addition of sodium 
dithionite. Excess sodium dithionite was removed by gel filtration (Sephadex G25 
column) before crystallization (fig 3.11). The gel filtration buffer contained 50 mM 
Tris / HC1 pH 8.0, 1 mM EDTA., and 2 mM L-tryptophan or 8 mM 6-fluoro-D/L-
tryptophan (6-F-Trp). 
Crystals of TDO were grown by the sitting-drop vapour-diffusion method with a 
well solution comprising 100 mM pH 6.3 MIES, 10-12% (w/v) PEG 4000, 60 mM 
MnC12, 10 mM sodium dithionite and 2 mM L-tryptophan or 8 mM 6-F-Trp. All 
crystallization solutions were prepared outside the anaerobic box and degassed to 
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materials and methods in the section 2.3.3. Furthermore, all solutions were allowed 
to equilibrate inside the anaerobic box for at least 1 day to make sure they were 
oxygen-free. 
Crystals appeared after 4 days and slowly reached maximum size in four weeks 
Before mounting in cryo-loops (Molecular Dimensions ltd) and flash-cooling in 
liquid nitrogen, crystals were immersed in a cryoprotectant solution composed of 
mother liquor (with L-Trp concentration increased to 50 mM) supplemented with 
23% (v/v) glycerol. 
- 	'IC 
J- --_ 
'?' '  
Fig 3.10: Belle technology anaerobic glove box. One side of the anaerobic box is 
adapted for the setting up of the crystallization experiments, while the other is fitted 
with a microscope for the observation and the manipulation of crystals 
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ANAEROBIC BOX (02 concentration - 2.0 ppm) 
sodium dithionite 	gel filtration 





Fig 3.11: Oxidised pure protein was chemically reduced inside the glove box with 
sodium dithionite. Be/öre ctystallization, sodium dithionite was removed using a gel 
filtration column (Sephadex G-25) and eluted with a buffer containing L-Trp or 6-F-
Trp. 
3.6.4 Data collection and processing 
X-ray diffraction data were collected on an ADSC CCD at the X4A beam line of the 
NSLC at Brookhaven National Laboratory (NY) for the holoenzyme of TDO, on a 
Mar225 detector at the 2IBM beam line at the Advanced Photon Source (Argonne, 
IL) for the apo enzyme of TDO, and on a Mar225 detector at the BM14 beamline at 
ESRF (Grenoble, France) for the binary complexes. The diffraction images were 
processed and scaled with the I-IKL package The data processing statistics are 
summarized in Table 3.1. 
3.6.5 Structure determination and refinement 
Crystals of the apoenzyme of TDO belong to space group P2 1 212 1 , with cell 
dimensions a = 89.7 A, b = 110.2 A, and c = 149.4 A. There is a single tetramer of 
TDO in the asymmetric unit. 
Crystals of the holoen.zyme of TDO (fig 3.9) belong to space group P21212 1 , with cell 
dimensions a = 88.9 A, b = 109.4 A, and c = 125.5 A. Again there is a single 
tetramer of TDO in the asymmetric unit. 
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Crystals of the binary complex of TDO (with L-Trp or 6-F-Trp) belong to space 
group P3 1 21, with cell dimensions a = b = 114.1 A, and c = 96.2 A. In this case, the 
asymmetric unit contains two TDO monomers. 
The structure of the apoenzyme of TDO was determined by the selenomethionyl 
single-wavelength anomalous dispersion method (SAD) (PDB entry 1YWO) 46  The 
selenium sites were located with SnB ', and the reflection phases were calculated 
with Solve/Resolve 48  The structures of the holoenzymes and the binary complexes 
were determined by the molecular replacement method, with the programs COMO ' 
and AMoRe 50  . The atomic models were built with the programs 0 51 and TURBO-





Fig 3.12: Active site: F0 -Fe prior to ligand fitting (a) and 2 F0 -F TDO L-Trp 
55 complex (b) Figure produced with Mo/script and rendered with Raster3D . 
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T 	Protein 	 TDO 	 TDO 	[ TDO 	 TDO 
(holoenzyme) 	(holoenzyme) 	(holoenzyme) 	(apoenzyme) 
Beam line ESRF BMI4 ESRF BM14 NSLS X4A APS 2IBM 
Ligand L-Trp [6FTrP J 	None None 
PDB entry 2NW8 2NW9 2NW7 1 YWO 
Space group P321 P3121 	IL F212121 
ab114.1 ab114.1 a88.9, a=89.7, 
Cell dimensions (A) 	c = 96.2 A 	c = 96.2 A 	b = 109.4, 	b= 110.2, 
c= 125.5 c= 149.4 
Resolution 24.5-1.6 26.3-1.8 (1.86- 46.4-2.6 30.0-2.7 
(A) (1.66_1.60)* 1.80)* (2.692.60)* L (2.82.7)* 
no. of unique 
reflections 	94048 	67279 	37833 	 71669 
completeness (%) 	87 (65)*1 	87 (61)* 	72 (54)* 	82 (68)* 
I/[c(I)] 	23.8 (2.93)* 	19.97 (2.5)* 	10.4 (2.74)* 	n/a 
8.6 (60 9)* 	13 0 (32 3)*  
Rwork (%)b 
	 17.1 (18.9)* 	16.6 (17.9)* 	25.7 (25.7)* 	25.0 (32.l)* - 
Rfr 	(%)C 	II 18.9 (22.0! 18.4 (21.1)* 26.3 (26.2)* 29.4 (35.1)* 
rmsd from ideal values 
bond lenths(AT[ 0.005 0.005 0.008J1 0.011 
bond angles (deg) 1.0 1.0 1.2 1.6 
Ramachandran analysis 
most favoured (%) 92.4 91.2 88.9 86.9 
additionallyallowed 	7.6 	 8.8 	 11.1 	 13.1 
(%) 	 L 
no. of waters 
included in 	 708 	 596 	 142 	 105 
refinement 
Table 3.1: Summary of crystallographic information; * Values in parentheses represent 
statistics for the highest resolution shell ° R,,, = EhLII(12) - L(h) ! Ei/.(h), where I,(h) and 
1(h) are the ith and mean measurement of reflection h, respectively. b R rk = EhIFo - FI/ 
E,,F.,, where F. and Fc  are the observed and calculated structure factor amplitudes of 
reflection h, respectively. C Rj is the test reflection data set, 5 % selected randomly for 
cross validation during crystallographic refinement. 
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3.7 Structure of TDO 
The structure of X campestris TDO monomer contains 12 helices (named (XA 
through aL) and no 13-strands (fig 3.13). 
TDO is an intimately associated tetramer and 4500 A 2 of the surface area of each 
monomer is buried in the tetramer. Helices aB and ctC are located in the extensive, 





Fig 3.13: The structure of TDO. (a) Schematic representation of the structure of the 
monomer of X campestris TDO. The ct-helices are labelled. Hei-ne and L-Trp are 
represented with sticks and shown in magenta. Gradient colour scheme: N-tenninus 
to C-terminus, blue to red 
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The N-terminal segments (residues 21-40, including helix (XA) of the two monomers 
are intimately associated with the adjacent monomer, which is important for catalysis 
by TDO because several residues in this segment are part of the binding site for the 
tryptophan substrate in the active site. 
90 0 * 
Fig 3.14: Representation c'f the tetramer of X campestris TDO. The four monomers 
are coloured in yellow, cyan, red, and green) (PDB entry 2NW7). 
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Fig 3.15: The structure of ferric X campestris TDO. The 'dimer of dimers' 
arrangement can be seen, with one monomer coloured green and the other cyan. 
Residues 7-40 of the ad helix from one monomer interact intimately with the other 
monomer. Heme groups are shown in grey. This is the substrate free structure (PDB 
entry 2NW7). 
3.7.1 Binding Mode of the L-Trp Substrate to TDO 
The structure of the binary complex defines the molecular mechanism for the 
recognition of the L-Trp substrate by TDO. Clear electron density was observed for 
heme and L-Trp in the active site based on the crystallographic analysis at 1.6 A 
resolution (fig 3.12 and fig 3.16). 
The L-Trp substrate is located in a pocket over the distal face of the heme and has 
interactions with residues in helices ctB and ctD, and the ci.D—aE and cti-aK loops. 
The carboxylate group of L-Trp is recognized by bidentate ion-pair interactions with 




Fig 3.16: In cyan is the final 2FFc electron density at 1.6 A resolution for heme, L-
Trp, and water in the active site contoured at 1 a. In purple is the F0—F omit map 
contoured at 3o-. Figure produced with Mo/script 54 and rendered with Raster3D 55 .  
The carboxylate group is also hydrogen-bonded to the side chain hydroxyl of Tyrl 13 
(helix (xD) and the main-chain amide of Thr254 (cd-aK loop). The ammonium 
moiety of L-Trp is recognized by the 7-propionate side chain of the heme group, and 
is also hydrogen-bonded to the side chain hydroxyl of Thr254. The indole ring is 
located -3.5 A above and perpendicular to the heme and is held in place by van der 
Waals interactions with the side chains of Phe5 I (helix aB) and several other 
hydrophobic residues, including Tyr24, Tyr27, and Leu28 from the N-terminal 
segment of another monomer of the tetramer (fig 3.17, Leu28, Tyr24, and Tyr27, all 
in blue). In addition, the Ni nitrogen of the indole ring is hydrogen-bonded to the 
side chain of His55 (helix aB). The hydrophobic characteristics of the active site 
pocket surrounding the indole ring of L-Trp in comparison with the hydrophilic 
residues forming the hydrogen bond network around carboxylate group and 
ammonium moiety of the substrate are highlighted in fig 3.18 and fig 3.19, with the 





Fig 3.17: The active site of X campestris TDO. Some of the residues involved in 
interactions between the bound L-Trp and the active site residues are shown. 
L 
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kT e electrostatic surfiice potential of fIX) in PvAIOL 
Fig 3.18: Interactions of L-Trp in the active site are shown a) Hydrogen bond 
network between the carboxylate group of L-Trp and Tyrl 13, ArgI 17, Thr254, heme 
7-propionate side chain and water molecule in the active site b) The electrostatic 
suijace of the L-Trp pocket. In this /Igure the darker the blue colour indicates a more 






a 	 b 
kT e electrostatic surface potential (?f TD() in Pi\IOL 
Fig 3.19: Interactions of L-Trp in the active site are shown; a) van der Waals interactions of 
the indole ring of L-Trp with Try24. Leu28. Tyr27 and Phe5l: hydrogen bond between 
Ni nitrogen of the indole ring with H1s55 b) Hydrophobic wall of the L-Trp pocket. In this 
figure the darker the blue colour indicates a more positive charge, whilst the darker the red 
means that the charge in that area is more negative. 
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A water molecule is present in the active site of this binary complex, hydrogen-
bonded to the ammonium ion of L-Trp and the main-chain amide of residue Gly 125 
(see fig 3.17). The water is 3.5 A from the ferrous atom in the heme, too far for 
ligating interactions. The iron atom is still 0.3 A out of the plane of the heme, on the 
side of the proximal His240ligand (fig 3.17). 
3.8 6-F-Trp binary complex 
The structure of the 6-fluoro-Trp binary complex is essentially identical to that of the 
L-Trp binary complex, apart from the presence of 6-F-Trp bound in the active site. 
The electron density surrounding the 6-F-Trp is shown in fig 3.20. The atomic 








Fig 3.20: In cyan is represented the final 2F,,-Fc electron density at 1.8 A resolution 
for 6-F-Trp in the active site, while in purple is the FFc omit density. 2F0-FC map 
contoured at la, 2FFc map at 3o. Figure produced with Mo/script 54  and rendered 
55 with Raster3D 
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3.9 Induced-fit behaviour of TDO 
The structural information described here suggests that TDO is an induced-fit 
enzyme. Although the active site pocket is well defined in the binary complex, the 
aJ—aK loop, which helps to form the walls of this pocket, is disordered in the free 
enzyme, and the aD-aE loop has a somewhat different conformation. Moreover, the 
Arg 117 side chain assumes a different conformation in the free enzyme (fig 3.21a 
and 3.21b). Upon recognition of the L-Trp substrate, a complex and extensive 
network of interactions is established, thus stabilizing the active site region. Although 
this region is exposed to solvent in the free enzyme (fig 3.21c), it is almost 
completely shielded from the solvent in the binary complex, and only the carboxylate 
group of the 6-propionate of heme is visible on the surface (fig 3.21d). 
Additional evidence for the induced-fit behaviour is observed in the active site of the 
second TDO monomer in the asymmetric unit. The binding mode of the L-Trp 
substrate is very different in this monomer. The L-Trp side chain is not positioned as 
deeply into the pocket, and the hydrogen bond between the ring nitrogen and the side 
chain of His55 is lost (distance of 3.8 A, fig 3.22b). Both nitrogen atoms are instead 
hydrogen-bonded to a water molecule, located 3.5 A from the heme iron but at a 
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Fig 3.21: TDO is an induced-fit enzyme with significant structural changes on 
binding of substrate. The active site here is shown in the open and closed 
conformations; a) detailed view of the open( substrate free) active site (top view); b) 
comparison of the features of the closed active site when the substrate is bound (top 
view), the dotted line marks the hydrogen bonds interactions in the open and the 
closed structures, c) and d) comparison of the surface features of the closed and 
open conformation structures. Blue areas are positively charged, and red areas are 
negatively charged. 
This conformation may also be stabilized by crystal packing interactions, as the 7-
propionate of heme is ion-paired with an Arg residue from another TDO tetramer in 
the crystal. The main chain atoms of the Trp substrate appear to be disordered, 
because no clear electron density was observed for them. 
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a 	 b 
Fig 3.22: Representation of the active site in the two subunits: in monomer a L-Trp is 
productively bound to the active site in a stable con/ormation: the monomer in b has 
fewer interactions (in particular the H-bond with His55, represented by a dotted 
line) and has assumed a transient binding geometry. 
Consistent with this finding, the aJ—aK loop is disordered in this molecule, similar to 
that in the substrate free enzyme. 
This complex may represent an initial stage in the formation of the Michaelis 
complex of TDO. Proper positioning of the L-Trp substrate for catalysis would lead 
to the recognition of its main chain atoms and the ordering of the aJ—aK loop. 
3.10 Comparison of IDO and TDO 
With the exception of the smaller N-terminal domain of IDO, the structures of IDO 
and TDO are very similar. Indeed, in comparing 201 structurally equivalent Ca 
atoms between TDO and the large domain of IDO the rmsd (root mean square 
difference) is only 3.1 A. A comparison between IDO and TDO structure is shown in 
figures 3.23a and 3.23b. An overlay of the structures is shown in Figure 3.23c. 
The "dimeric" arrangement in TDO, which involves the N-terminal region of one 
monomer comprising part of the substrate-binding site in the adjacent monomer, is 
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not possible in monomeric [DO. However, the two tyrosine residues in TDO that are 
proposed to be important in this arrangement, Tyr24 and Tyr27, are in equivalent 
positions to Tyr126 and Cys129 in IDO. In TOO the side chain of Tyr27 occupies a 
space that is taken by the side chain ofPhel64 in IDO. 
I Pir 
b 
Fig 3.23: A comparison between a) human IDO and b) one monomer of X 
campestris TDO; also shown is the N-terminal region of TDO (in green, residues 
21-40) of the adjacent monomer which fornis part of the active site. The heme groups 
are shown in sticks c) an overlay of human IDO (same coloring as and b) with one 
monomer ofX campestris TDO 
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3.10.1 The Active Site 
The active sites of IDO and TDO have several similarities. The substrate binding site 
of TDO is well characterised due to the presence of L-Trp in the crystal structure and 
it has been already described in section 3.12. 
Phe 164 I Tyr27 
Tyr126/Tyr24 . 
Phe163 I E 
A: 	I 
The226 I Tyrl 





His346 I H1s240 
Fig 3.24: An overlay qf the active sites of IDO (cyan) and TDO (magenta and green). 
In contrast to TDO, the structure of DO is not available with any substrate bound, 
but has been solved with the inhibitor 4-PI 52  at the active site (fig. 3.7 and fig 3.24)). 
This model shows that 4-PI binds to the heme iron as expected, but does not yield 
any information regarding the mode of substrate binding in IDO. Given the similarity 
between the active sites of both dioxygenases it is perhaps reasonable to assume a 
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similar substrate-binding mode in IDO. This is supported by comparison of the active 
sites of IDO and TDO (fig 3.24). 
For example, it can be seen that Argi 17 in TDO is equivalent to Arg231 in IDO, 
while Phe5l in TDO is in the same position as Phe163 in DO and Tyr24 in TDO is 
equivalent to Tyr126 in IDO. Similarly, the position occupied by Tyrll3 in TDO is 
taken by Phe226 in IDO. However, in addition to these similarities it should be noted 
that the equivalent region in IDO of the loop comprising residues 250-260 of TDO is 
disordered in the IDO structure. This region is particularly important in TDO because 
it includes Thr254 that, as mentioned above, is involved in binding the ammonium 
and carboxylate moieties of L-Trp. It is interesting to note that in the absence of L-
Trp this loop region is also disordered in the TDO structure, and that substrate 
binding is required to induce its ordering. This may also be the case for IDO, but the 
possibility exists that there is no equivalent interaction between IDO and L-Trp. 
Perhaps the most obvious difference between the active sites of the two enzymes is 
the presence of His55 in TDO and its equivalent Ser167 in IDO. In TDO the 
histidine side chain is hydrogen-bonded to the indole nitrogen atom of L-Trp, and the 
role of His55 would appear to be in regulating substrate binding (paper in 
preparation). The role of Ser 167 in IDO is less clear in the absence of a substrate-
bound crystal structure, but it is unlikely that this residue plays, any crucial role in 
1D0 56 
3.11 An allosteric binding site in the tetramer interface? 
In the TDO-L-Trp structure was observed the binding of four L-Trp residues at the 
interface of the tetramer, with well defined electron density. The L-Trp molecule 
appears to be recognized specifically by the enzyme in this pocket. There have been 
reports of allostenc activation by the substrate L-Trp 58,  and our observations offer 
a possibility for this effector site. Kinetic studies so far have not shown any allosteric 
effects with X. campestris TDO. This site is not occupied in the 6-F-Trp complex, 
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possibly because of the lower concentration of the substrate in the crystallization 
solution. 
01 
Fig 3.25: The L-Trp binding site in the tetramer interface. Each L-Trp molecule 




Fig 3.26: Final 2F0 Fc electron density map at 1.6 A resolution for L-Trp and the 
hydrogen bonding residues in the putative allosteric binding site. 
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3.12 Biochemical studies confirm the structural observations 
X campestris TDO has robust catalytic activity toward L-Trp and 6-F-Trp but is 
inactive toward D-Trp, tryptamine or indolepropionic acid (Table 3.2), confirming its 
designation as a TDO. In fact, D-Trp is a weak, competitive inhibitor of the enzyme 
at high concentrations. Binding data show that D-Trp has much lower affinity for the 
enzyme than L-Trp, consistent with our structural information, and explaining why D-
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Table 3.2: Summaiy of kinetic data on X campestris TDO; NC, No spectral change 
detected; *hl/zjbjto,y  constant, Kg.; 'Although a spectral change was evident, 
substrate solubility prevented accurate measurement of Kd.  Values were estimated 
based on the maximum substrate concentration attainable. 
Binding was too tight to be measured. Values quoted represent the minimum Kd that 
can be measured under standard assay conditions. Indol acid: indolepropionic acid 
The biochemical studies also provide direct evidence for the induced-fit behaviour of 
TDO. Indeed, there is a large increase in the affinity of the enzyme for L-Trp when 
the heme iron is reduced (K (Fe (III) heme) = 3.8 mM, whereas Kj (Fe (II) heme) 
4.1 l.LM). These parameters were converted to free energy changes (i.e. 
AG=—ln(1IK), expressed as RT units (where R, gas constant, T, absolute 
temperature). In fact, the shift in reduction potential almost perfectly correlates with 
the increase in affinity for L-Trp on reduction, from which the variation of free 
energy due to heme reduction (AAG) was computed as the difference in binding 
energy between femc and ferrous forms of the enzyme 
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(AAG=AG(fenic)—AG(ferrous)) in the presence and absence of substrate: both gave 
an estimated L\AG of 15 kJ/mol. The electrical potential of the reaction (AE) can be 
then derived from the Nernst equation shown below, where n is the number of 
electrons involved in the reaction and F is the Faraday constant (23.06 kcal/volt/mol 
or 94.4 kJ/volt/mol): 
AG = -nFAE 
The electrochemistry data show a large, positive shift in reduction potential (+136 
mV) in the presence of 15 mM L-Trp 23  These data show that there is a significant 
stabilization of the ferrous form when substrate is bound. This stabilization could 
also play a physiological role in keeping the protein reduced, and therefore active, 
when L-Trp is present. 
Our structural studies have defined the binding mode of the substrate L-Trp to TDO, 
revealing the structural basis for the stereospecificity of this important enzyme. The 
induced-fit behaviour of TDO, confirmed by biophysical studies 23,  appears crucial 
for the exclusion of water from the active site and for stabilizing the enzyme in the 
presence of the substrates. Finally, structural comparisons among these enzymes 
reveal the striking evolutionary conservation of the heme-dependent dioxygenases. 
3.13 Ternary complexes with dioxygen analogs in crystals 
The Fe (II) atom of the heme prosthetic group of TDO has high affinity for 02,  NO, 
and CO, and the binding of diatomic molecules is of critical importance for TDO 
catalysis. Kinetic study of diatomic ligands binding behaviour to TDO has been 
investigated by Miss Sarah J. Thackray (unpublished results) only on the ferrous, 
active form of the enzyme. Indeed, the affmity of NO for ferrous heme is too high to 
be determined with spectrophotometry techniques. CO reveals a high affinity for 
TDO ferrous heme, with a Kd of 90 tM. Furthermore, both NO and CO can bind to 
TDO ferrous heme. In order to obtain the ternary complex of the ferrous active form 
of the enzyme, the preparation of stable TDO ternary complexes with gaseous 
diatomic ligands required anaerobic conditions. 
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We have invested significant effort into obtaining the crystal structure of TDO—CO 
and TDO-NO complexes in the presence of L-Trp. This is because these data would 
provide important insights into the structure of the Michaelis complex. 
In a first attempt to obtain the ternary complex of TDO with L-Trp and an inactive 
diatomic ligand in the active site, we used the following procedure. Before mounting 
in nylon ioops and flash-freezing in liquid nitrogen, crystals were immersed in a 
cryoprotectant solution composed of mother liquor (with L-Trp concentration 
increased to 50 mM) supplemented with 23% (v/w) glycerol and bubbled initially 
with N2 for 15 minutes and then with nitric oxide (NO) or carbon monoxide (CO) for 
15 minutes before use. The crystals were exposed to the solution saturated with NO 
or CO before being flash-frozen in liquid nitrogen. 
We did not observe the binding of this dioxygen analogue in the structure. This was 
confirmed by our structure of the binary complex with 6-F-Trp, which was not 
exposed to NO but contained the same density for the water molecule. NO probably 
diffused rapidly from solution during the pre-flash-cooling manipulations in the 
anaerobic box. 
3.13.1 Pressure cells for preparing gas/protein complexes in crystals 
In a second attempt to obtain the ternary complex of TDO, we used a Cajon ® Ultra-
Ton fitting cell 59,60  as described in Vernède, X. & Fontecilla-Camps, J. C., 199961.  
These experiments were performed in Grenoble at the Laboratoire de 
Cristallographie et Cristallogenese des Protéines (LCCP), Institut de Biologie 
Structurale, under the guidance of Dr Juan-Carlos Fontecilla-Camps and Mr Xavier 
Vernède. In this cell, it is possible to pressurize a crystal already mounted on a 
cryoloop (fig 3.27). 
Such a procedure shows some advantages compared to the technique used 
previously. In particular, gases can more easily access the crystal interior due to the 
smaller volume of solvent surrounding it. 
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Crystal mounted on cryo-loop 
3cm 
go 
Loop mounting pin 	 A 
1/8 teflon 	\ vai 	th swagelok fittings AML 
Loop-containing 
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71v Plexiglass p 
Cell (CAJON® Ulrra-Torr fitting) 
	
Adapted groove 
Fig 3.27. Schematic representation of the cell (Cajon® Ultra- Torr fitting) and 
photograph of the pressure-cell setup. From 61 . The crystal monted in the cryoloop is 
held by a lead pencil support. The pressure chamber is connected (A) to a 
manometer equipped with a three-way valve to allow for pressurization and 
depressurization. 
Under these conditions the maximum applied pressure was 1.5 bar for both NO (1% 
v/w) and CO (100% v/w). Pressure chamber crystal soaking experiments were 
carried out for 5, 10 and 15 minutes for each diatomic gas. 
In this setup crystal freezing through rapid flash-cooling in liquid propane was 
performed. This approach for crystal freezing avoids the use of liquid nitrogen, 
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Fig 3.28: The ctystal transferring device from '. 
Propane was solidified in a liquid nitrogen bath and introduced to the anaerobic 
glove box. When the propane was liquefied (-3 minutes) (about 100 K), the loop 
with the crystal mounted was dipped in the propane container (fig 3.29). The boiling 
point of propane is 231 K, while its melting point is 83 K. This avoids the formation 
of the insulating film that occurs during flash-cooling with liquid nitrogen due to its 
boiling. Liquid propane appears then to be a better freezing agent than liquid 
nitrogen for protein crystals. 
Using this method, the crystals were flash-cooled less than 10 seconds after pressure 
chamber treatment, decreasing the chances of gas/protein complex dissociation. The 
device (fig 3.28) containing the crystal mounted on the loop and immersed in liquid 
propane was then immediately removed from the glove box and the crystal stored 
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Fig 3.29: Description of the flash-cooling (1-5), transferring (6-7) and storing (8-10) 
procedure for protein crystals. From 61 
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Few data sets of crystals soaked with diatomic ligands were collected, but due to the 
low quality of the crystals we could not verify the presence of dioxygen analogs in 
the active site. These experiments are still in progress at lBS Grenoble. 
3.14 S04414: a putative IDO from Shewanella oneidensis 
To date, more than 50 bacterial TDO sequences have been reported 62  The large 
distribution of TDO between different life-forms suggests that the origin of this 
enzyme is quite ancient. 
Bacteria are also believed to use IDO family members for the aerobic metabolism of 
L-Trp via the kynurenine pathway, although prokaryotic IDO-like proteins bear little 
sequence similarity to eukaryotic IDO proteins and very little is yet known about 
them. However it appears that for bacterial IDO, L-Trp is not a true substrate and 
their actual function is still unknown. 
We investigated the structure of the S04414 protein (sIDO) from Shewanella 
oneidensis, which (fig 3.30) shares a 12% sequence homology with human IDO. 
S. oneidensis 63'64  is a gram-negative bacterium which is used as model organism for 
electron transfer studies. It can utilize a great variety of electron acceptors for its 
respiratory process (nitrite, nitrate, thiosulfate, iron (Ill), manganese (IV), uranium 
(IV)) and it can grow both aerobically and anaerobically. 
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IDO_ (Hg) 	-----)HAM ENSWTISKEY HIDEEVG--F ALPNPQE,,LP DFNDW'LA1U1PDLIE SG 
sIDO 	XKPATYNTEA FDEWIRSRPV ELNSQLEQLY YQQTDRANVQ E ------- VGTETJ(HTL - 
IDO_ (Hg) QLPVEKLN HLSIDHLTDH KSQBLABLV GCIThAYVWG KG GDVRKVL PNIAVYCQ 
sIDO 	EGRELVKAL- ---LDETD EGFDSJWDL NVGLYXAAC BREEITEPT- -RETiSPLLE 
IDO_ (Hg) LS-------K 1U.ELPPILVY ADCVLAN41( GPNKPLTYE NVLFSFRD GDCSFGFFLV 
sIDO 	ASALAXHIGA SIGVTPRPAT AIILTflINBAU NGIYBFDL PDEK VDYN --- T: I--- 
IDO (Hs) S:LVEI.AAAS AXYVI; TV1( AMQMQERDTL LKALLEIASC EKALQVFH IHDHVNPKA 
sIDO 	- AYKRASDA LLIQLGIS HPISMDLLRV Th------QA iQDVIESNQc LFNRIDTDR.F 
IDO_ (Hs) £ SVLRIYLSG WKPQLSDG LVYEGFWEDP KEFAGGSAGQ SSVFQCFDVL :•IQQTAGGG 
sIDO 	 yCVRpyy -- --- KPYRVGS VV -------- -- YRGANAGD FAGINVIuLT ;L-CFA.A 
IDO_(Hs) HAAQFLQDMR R1P AHRNF LCSLESNPSV R-EFVLSKGD AG-------L REAYDAIVKA 
s IDO SYSQXLVDKF LYEDQQI LRECICRRPNL WDFIAKGC IHQDWYQL KLFIEWELH 
IDO_ (Hs) LVSLRSY}ILQ IVTKY I LI PA SQQP1ThcTS EDP&YIEAKG TGGTDL1P 	KTVkSTTEKS 
s IDO GQTAIQHHNE LVTKYIAEPS VSXEQQH--- --IJIU--VT__kSG PPLIWLLA.Si EBLPDEBAAV 
IDO_(Hs) L --------- ---- LKEG -- -----  
s IDO LRDDIRTRYY DLKKLKDSLR LEAAA 
Fig 3. 30. Amino acids sequence alignment of Shewanella oneidensis putative IDO 
(sIDO) (in blue) and human (I-Is) IDO (in black). The conserved residues are 
highlighted in magenla. 
3.14.1 Expression and purification of S04414 
Cloning and purification of the S04414 was performed as described in section 3.7 
for TDO. Shewanella oneidensis S04414 (Q8E972_SHEON, NESG ID SoR52) was 
cloned into a pET2 I d (Novagen) derivative, generating plasmid pSoR52-2 11. The 
resulting SoR52 ORFs contain 11 (AAALEHHIHHHIH) nonnative residues at their C 
termini. Escherichia co/i BL2I (DE3) pMGK cells were transformed with pSoR52-
21.1. Expression either in LB media and MJ9 media containing selenomethionine, 
were performed as described in section 3.7 
39.40 
Purification of sIDO was carried out by using an AKTA-Express (GE Heathcare) 
two-step purification strategy. The His-tagged protein in the supernatant was loaded 
onto a HisTrap 1-JP column (GE Heathcare), washed, and eluted with lysis buffer 
containing 250 mM imidazole into a 10-mi sample loop. The loop content was then 
injected onto a gel-filtration column (Sephadex 75; GE Heathcare), and eluted in 
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Buffer 2 (10 mM Tris (pH 7.5)15 mM DTT/100 mM NaCII0.2% NaN3) (fig 3.31a). 
The purified protein resulting from gel-filtration purification was concentrated to 5-
10 mg/ml and sample purity (> 95%), and molecular weight were verified by SDS-
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Fig 3.31: (a) Elution profile of 6His-tagged sIDO as monitored by UV adsorption 
from a 26160 Superdex-200 column. Elution peak qfsJDO  is indicated by the arrow 
and reported on the SDS-PAGE on the right. (b) SDS-PAGE analysis of elution peak. 
3.14.2 Protein crystallization 
Crystals of the apoenzyme of S04414 were produced by the hanging-drop vapour-
diffusion method at 18°C, and the reservoir solution contained 20 mM Tris (pH 7.5), 
18% (wtivol) PEG 3350, 150 mM lithium sulfate, and 5 mM DTT. Crystals of the 
holoenzyme of S04414 were grown anaerobically as described in section 3.8. 
Briefly, pure protein was introduced to the anaerobic glove box and chemically 
reduced with sodium dithionite. The excess of sodium dithionite was then removed 
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using a gel filtration column (Sephadex G-25) and eluted with a buffer containing 
10-50 mM L-Trp. The crystals were produced by the sitting-drop vapour-diffusion 
method, with a reservoir solution of 100 mM Tris (pH 7), 20% (w/v) PEG 3350, and 
50 mM magnesium formate and 10-50 mM L-Trp. The enzyme was at 10 mg/mI 
concentration. Crystals of the apoenzyme were cryoprotected in paratone, while 
crystals of the holoenzyme were protected in mother liquor supplemented with 25% 
(v/v) glycerol. 
3.14.3 Data collection and processing 
X-ray diffraction data were collected on an ADSC CCD at the X4A beam line of 
Brookhaven National Laboratory for both the apo- and holoenzymes of S04414. The 
diffraction images were processed and scaled with the HKL package The data 
processing statistics are summarized in Table 3.3. 
Crystals of the apo- and holoenzymes of S04414 belong to space group P2 1 2 1 2, with 
cell dimensions a = 138.1 A, b = 68.0 A, and c = 91.0 A, and a = 138.8 A, b = 68.7 
A, and c = 87.8 A, respectively. In both, there were two monomers in the asymmetric 
unit. 
3.14.4 Structure determination and refinement 
The S04414 apoenzyme structure was determined by the selenomethionyl single-
wavelength anomalous diffraction method 46  . The reflection phases were calculated 
with Solve/Resolve 48  The structure of the holoerizyme was determined by the 
molecular-replacement method, with the programs COMO 49 and AMoRe The 
atomic models were built with the program XtalView 65  and TURBO-FRODO 52  and 
the structure refinement was carried out with CNS 53 
The structure of the S04414 holoenzyme from Shewanella oneidensis 66  was 
determined at 2.4 A resolution by molecular replacement based on the structure of 
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Table 3.3: Data collection and refinement statistics * Values in parentheses represent 
statistics for the highest resolution shell a Rrnerge = EhEII(h) - 1(h)! Eh2L,IJ(h), where 
Ij(h) and 1(h) are the ith and mean measurement of reflection h, respectively. b Rrk 
= IhIF,, - FI/ hFo, where F0 and Fc are the observed and calculated structure 
factor amplitudes of reflection h, respectively. C Rfree is the test reflection data set. 5 
% selected randomly for cross validation during cmystallographic refinement. 
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3.14.5 The structure of sIDO 
Structural similarity is observed between human [DO and the S04414 protein from 
S. oneidensis, with an rms distance of 4.4 A for 206 equivalent carbon-a atoms, 
suggesting that S04414 may also be a dioxygenase. The structure contains an extra 
domain that is formed by residues at the N terminus, similar to the small domain in 
human [DO (fig 3.35). Both the active sites are located on the larger subunit scaffold. 
3.14.6 The putative active site of sIDO 
Although S04414 crystals were grown in the presence of 10-50 mM L-Trp, we did 
not observe the binding of L-Trp in its putative active site. Our biochemical efforts so 
far have not been able to demonstrate [DO (or TDO) activity for this protein, 
suggesting that S04414 may prefer a different substrate for oxygenation. 
rg218 
a 	 b 
Fig 3.32: a) The location of the putative active site in sJDO; b) a detailed side view 
of active site residues Asn156, Phe 152, Phe213, Arg218 and the fifth herne ligand 
His324. The water molecule in the active site is hydrogen bonded to Asn156 
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The mode of substrate binding in human IIDO is not well characterised due to the 
absence of any substrate in the crystal structure (see section 3.5). However, it is clear 
(fig 3.33) that human IDO and S04414 share structurally similar active sites. In 
particular comparison of the active sites indicates the presence of the same residues 
around the heme. Arg23 1, Phe226, and Phe163 in human DO corresponds 
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Fig 3.33: Comparison of the active sites of the human IDO (a) (in blue) and S04414 
(b) (in yellow). The two sites are structurally similar and some residues (Arg2311 
Arg218, Phe2261 Phe213, Phe163 Phe152) are identical and in similar orientations 
The core of the active site around the heme consists of seven a-helices that are 
arranged the same in both enzymes (fig 3.35). Furthermore, the key residues possibly 





Fig 3.34: a) human IDO b) S04414, both coloured as chainbow. The two enzymes 
show limited primary sequence similarity. Nevertheless they have nearly identical 
folds and their 3D structures are conserved. In the red circles: Phe226 and Arg231 
from (a) and Phe231 and Arg218 from (b) all belonging to the a-H chains of the two 
enzymes. Phel 63 and Serl 67 from (a) and Phe152 and Asn 156 from (b) belong to a-




The crystal structures of X. campestris TDO presented here show the exact 
positioning of the substrate in the active site. The role of the heme propionate group 
and the surrounding residues in ligand binding is fundamental in dictating the strict 
substrate specificity of TDO. These findings, in conjunction with the high level of 
overall structural similarity with human IDO, contribute to the understanding of the 
structure-activity relationships in this important family of dioxygenases. The 
structural information provided is complemented by biochemical studies and 
altogether offer significant molecular insight into tryptophan dioxygenation by TDO 
and IDO. 
As yet, very little is known about substrate binding in S04414. Despite differing 
sequence, human IDO and S04414 show to have converged upon a very similar 
active site design and are therefore likely to share a common mechanism. 
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Chapter 4 
Crystallographic studies on histidine 55 mutant of 
tryptophan 2,3-dioxygenase from Xanthomonas campestris 
4.1 Introduction 
As described in chapter 3, the crystal structures of bacterial TDO 1,2  and human DO 
reveal similarities between the two enzymes and allow the identification of potentially 
important active-site residues. 
The catalytic mechanisms of TDO and DO have, so far, not been fully elucidated. It has 
been proposed that their catalytic mechanism involves the base-catalyzed deprotonation 
of the mdole nitrogen of the substrate . However, the structures of TDO and DO show 
that while TDO contains a histidine residue in its active site, DO does not contain any 
residues in its active site capable of performing base-catalyzed deprotonation. In the 
TDO active site the histidine 55 hydrogen bonded to L-Trp could be implicated as the 
active site base. This chapter reports the crystallographic study of a X campestris TDO 
mutant, where the active-site residue histidine 55 has been substituted by alanine 
(H55A). The structural data, in conjunction with potentiometric and kinetic studies on 
the mutant, attempt to resolve the question of whether an active site base is necessary for 
catalytic activity in TDO and provide information on the molecular mechanism used by 
TDO to control substrate binding. 
4.2 Reaction mechanism of TDO: a model for the Michaelis complex 
A model for the Michaelis complex can help to provide insight into the catalytic 
mechanism of TDO (fig 4.1). The model was built by placing one oxygen atom (01) of 
the dioxygen substrate directly over the heme iron, at a distance of 2.1 A. The distal 
oxygen atom (02) is placed such that the 01-02 bond is parallel to the C2—C3 bond of 
indole ring, giving a Fe-01-02 angle of 135° (Fig 4.1b). This conformation places the 
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02 atom within 0.5 A of the water molecule observed in the crystal structure (PDB entry 
2NW8) (Fig 4.1 a), suggesting that this water should be ejected from the active site upon 
dioxygen binding. The active site is therefore completely devoid of solvent molecules in 
this Michaelis complex. The modeled dioxygen-binding mode reveals the activation 
mechanism of this substrate for the reaction. 
1 r 	 1hr254 
	 L-TF. 	 Thr254 











Fig 4.1: Molecular insights into the catalysis by TDO. a) Crystallographic model 
showing the water in the active site as a small sphere in cyan. b) Model of the Michaelis 
complex where the oxygen atoms are represented in green. 
It has been established that TDO has an ordered catalytic cycle 4 . The protein (with heme 
in its ferrous form) first binds L-Trp near the sixth coordination position of the heme 
iron. This event is followed by the binding of dioxygen to the distal coordination of the 
heme iron. The model for the Michaelis complex (fig 4.1b) of TDO shows that the 01 
atom is 2.6 A from the Ni atom of L-Trp and therefore might act as a base to extract the 
proton from the NI atom 6  In the model, the distal oxygen atom (02) interacts with the 
L-Trp ammonium moiety and the backbone amide nitrogen of Glyl 25 (not shown in the 
figure). The Lewis acidity of the hydrogen-bonding donors, coupled with the electron-
withdrawing nature of the heme, would increase the electrophilicity of the bound 





















Fig 4.2: Schematic representation of the reaction mechanism of TDO. The figure 
displays an ionic, base catalyzed mechanism of L-Trp dioxygenation. Firstly substrate 
binds to the protein (1), followed by dioxygen binding to form the ternary complex (2). 
The mechanism proceeds by the formation of a hydroperoxide intermediate (3 and 6), 
which can undergo two dfferent rearrangements to form the product, N-
formylkynurenine (8), a Criegee rearrangement (4 and 5) or a dioxetane rearrangement 
(7). The product (N-formylkynurenine) is then released leaving the protein in the active 
ferrous state. The reaction scheme is proposed on the basis of the active site architecture 




After the initial attack by the C3 atom, the reaction may proceed via a Criegee 
rearrangement or a dioxetane intermediate (Fig. 4.2 indicated respectively as 3 and 6 
intermediates). However, the Criegee pathway seems to be favoured, based on chemical, 
thermodynamic, and quantum mechanical considerations 6 
In TDO the Ni atom of L-Trp is hydrogen-bonded to His55. In order to investigate the 
role of the histidine side chain involved in substrate binding this residue was replaced, 
alternately, by alanine (H55A) and by serine (}155S) . The mutant enzymes showed 
slightly higher Michaelis constants (K m) and lower k 1 values for L-Trp oxidation. The 
values for both the H55A and H55S enzymes were about 10-fold lower than the 
value for the wild-type enzyme (Table 4.1). 
In the wild-type enzyme there is a large increase in the affinity of the enzyme for L-Trp 
for ferrous vs. ferric enzyme (Kd Fe (III) = 3.8 mM, Kd Fe(H) = 4.2 .tM) (table 4.1, data 
from Miss Sarah J. Thackray, 7)•  For both the H55A and the H55S mutants this effect is 
essentially destroyed, with only a small increase in the affinity of ferrous enzyme for L-
Ti-p relative to ferric (Table 4.1). This trend in K4 is repeated for other substrates (tables 
4.2 and 4.3). The presence of His55 decreases the affmity of the oxidised protein for 
substrate, and its removal increases binding affinity by a factor of >300. 
KdL-Trp(M) 
Enzyme Substrate k2 (s5 K. (jiM) Ferric heme 	Ferrous heme 
TDOwt L-Trp 19.5± 1.2 114±1 3840± 140 	4.12± 0.24 
TDO H55A i.-Trp 2.860.10 133±7 11.8 ±0.2 	3.7± 1.3 
TDOH55S L-Trp 2.60±0.01 197±2 18.4±3.0 	5.25± 1.0 
Table 4.1: Summary of kinetic data on X campestris TDO wild-type (WI) and TDO 
H55A and H55S with L-Trp. Experiments were performed at 25 °C, in 100mM phosphate 
buffer, pH 7.5 as described in 
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K1 L-Trp (IIM) 
Enzyme Substrate kcat (s) K. (1iM) Ferric heme Ferrous heme 
TDOwt 6F-D/L-Trp 37.3±0.6 186±12 2450±420 <1.00 
TDO H55A 6F- DIL -Trp 3.78 ± 0.10 195 	1 165 = 44 73 = 3 
TDOH55S 6F-o/L-Trp 3.8±0.04 546±36 86.0±12 6.16±0.9 
Table 4.2: Summary of kinetic data on X campestris TDO wild-type (wt) and TDO 
H55A and H55S with 6F-D/L-Trp. Experiments were performed at 25 °C, in 100mM 
phosphate buffer, pH 7.5 as described in 
IQ L-Trp (SM) 
Enzyme Substrate k2 (sd) K. (p.11) Ferric herne Ferrous heme 
TDOwt 5F-D/L-Trp 2.4±0.1 100±6 1510±80 <1.00 
TDO H55A 5F- uk. -Trp 0.86 ± 0.14 194 ± 25 66.8 ± 20 9.0 ± 1.2 
TDO H55S 5F- U/L -Trp 0.80 ± 0.01 183 ± 12 73.4 ± 5.0 <5.0 
Table 4.3: Summary of kinetic data on X campestris TDO wild-type (wt) and TDO 
H55A and H55S with 5F-D/L-Trp. Experiments were performed at 25 °C, in 100mM 
phosphate buffer, pH 7.5 as described in '. 
Furthermore, the kcat of TDO is relatively insensitive to pH over the range p11 6.0 to pH 
8.0 and the H55A mutant show only a 10-fold decrease in the value Of kat, suggesting 
that this residue is not essential for catalysis, consistent with the presence of a serine 
residue in IDO in the equivalent position. On the other hand, the value of Km shows a 
marked increase at lower pH, possibly because of the protonation of this residue. 
All these data 2, 7 enhance the view that His55 is not acting as a base in the catalytic 
cycle since its substitution might have been expected to render the enzyme inactive. It 
must therefore play a different role in catalysis. Effects similar to these are seen in IDO 
where the equivalent residue to His55 is Ser167 . A possible role of His55 in TDO 
could be to control the binding affinity of the active site for L-Trp, gating the binding of 




43.1 Genetic manipulation, protein expression and purification 
Full-length X campestris TDO (NESG (Northeast Structural Genomics Consortium) ID 
XcR13) was cloned into a pET-21d (Novagen, San Diego, CA) derivative with a C-
terminal 6-histidine tag, and overexpressed at 17 °C in Escherichia coli BL21 (DE3) 
pMGK cells. Point mutation 1155A was created with the QuikChange II site directed 
mutagenesis kit (Stratagene, La Jolla, CA). Oligonucleotide primers directing the 
mutation were designed in an automated fashion by using the Primer Prim'er program, 
accessible at www-nmr.cabm.nitgers.edulbioinformaticsfPrimer Primer. The mutation 
and its associated ORF were verified by DNA sequence analysis. 
Protein was purified by using nickel-affinity and gel-filtration chromatography as 
described in section 3.6.2 for the wild-type protein. 
Protein and heme concentrations were determined by the Bradford and pyridine 
hemochrome methods respectively 8,9  For wild-type TDO extinction coefficients C4flm 
and 6431nm of 180.5 (± 0.1) mM'cm' and 113.0 (± 0.1) mM 1cm' per protomer were 
calculated for the femc and ferrous enzymes respectively 2  For the H55A mutant 43Inm 
of 120.0 (± 0.1) mM'cm'and 6431 , of 130.4 (± 0.3) mM 1cm per protomer were 
calculated for the ferric and ferrous enzyme respectively. 
43.2 Protein crystallization and data collection 
Crystallisation of H55A TDO was camed out by hanging drop vapour diffusion at 18 °C 
in Linbro plates. Crystals were obtained with well solutions comprising 9-10% (w/v) 
PEG 1000, 80 mM MES buffer pH 6.3, 20 mM bicine buffer pH 9.0,40 mM MnCl 2, 400 
mM MgCl2, 8 mM NaCN and 20 mM L-Trp. Hanging drops (4 il volume) were 
prepared by adding 2 j.il of 8 mg mr' protein (in 50 mM TrisHC1 buffer pH 8.0, 5 mM in 
EDTA) to 2 p.1 of well solution. Red tetragonal shaped crystals appeared after 









Fig 4.3: Crystals of TDO H55A mutant grown in 10% (w/v) PEG 1000, 80 mM MES 
buffer pH 6.3, 20 mM bicine bifferpH 9.0, 40 mMMnC1 2, 400 mMMgC1 2, 8 mMNaC'N 
and 20 mML-Trp 
Crystals were immersed in mineral oil prior to being mounted in nylon loops and flash 
cooled in liquid nitrogen. A data set was collected to 2.15 A at station 10.1 (X = 1.381 
A) at SRS Daresbury using a Mar Research MAR225 CCD detector. Crystals belonged 
to space group P2 1 with unit cell parameters a = 78.2 A, b = 117.6 A, c = 139.3 A andfl 
95.70 . All data processing was carried out using the CCP4 package The wild-type 
TDO apo-enzyme structure (PDB ID I YWO), stripped of water was used as the initial 
model. Electron density fitting was carried out using the program Turbofrodo 11 and 
structure refinement was carried out using Refmac 12 
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most favoured (%) 
additionally allowed (%) 








total no. of reflections 




D 	0/ C 
1 trec 	0 
rmsd from ideal values 
bond lengths (A) 







a = 78.2, b = 117.6, c = 139.3 (A) 
and,8 = 95 .7° 
59.66-2.15 (2,27 _2.15)* 
312593 
131764 










Table 4.4: Data collection and refinement statistics Values in parentheses represent 
statistics for the highest resolution shell a Rm erge = 1,,Z111('h) - Ij(h)I/EhE,1('h,), where I1 ('h) 
and I(h,) are the it/i and mean measurement of reflection h, respectively. b Rwork = EhJF0 - 
FI/I,,F0,  where F0 and F are the observed and calculated structure factor amplitudes 
of reflection h, respectively. C Rfree is the test reflection data set, 5 % selected randomly 
for cross validation during crystallographic refinement. 
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4.4 Crystal structure of H55A TDO 
It was possible to obtain crystals of the ferric H55A mutant enzyme in a binary complex 
with the substrate due to the much greater affinity of L-Trp for the oxidised mutant 








Fig 4.4: Stereoview of electron density around the heme, A1a55,Argi1 7 and the 
substrate at the active site of H55A TDO (monomer B) in complex with L-Trp. The 
electron density map was calculated using Fourier coefficients 2 F0 - Fe., where F0 and 
Fc  are the observed and calculated structure factors, respectively, the latter based on the 
final model. The contour level is Ia, where a is the rms electron density. 
A data set to 2.15 A resolution was used to refine the structure to a final R-fàctor of 
20.1% (Rfrve = 28.5 %), and the data collection and refinement statistics are summarised 
in table 4.4. The structure of TDO is an intimately associated tetramer and this is shown 
in figure 4.5. As already described for wild-type TDO (section 3.7), the N-terminus of 
each monomer (up to residue Leu40) penetrates into the active site of an adjacent 
subunit, and is involved in substrate binding. The final model of the TDO HSSA mutant 
enzyme consists of two TDO tetramers (1 and 2), one of which (tetramer 1) is better 





Fig 4.5: Tetramer structure of H55A mutant TDO. The heme groups are shown in red 
and L-Trp in cyan. One dier'is shown in magenta and green and the other in grey 
and blue. The interfacial L-Trp molecules can be seen in the centre of the tetramer. 
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Fig 4.6: Two teframers making up the asymmetric unit of TDO H55A crystal. Monomers 
of tetramer 1 are shown in magenta, green blue and gray. Tetramer 2 is more weakly 
defined in the model and ills shown entirely in light pink. Hemes are represented in 
sticks and colored in gray. L-tryptophan bound in the active site and in the interface of 
the monomers are represented in sticks and colored in cyan. 
Each of the eight monomers in the model is slightly different in terms of which N- and 
C-terminal residues are ordered. In this respect the most complete monomer is chain B 
which consists of residues Leu7-Asn286, while the least well-defined monomer is chain 
F, consisting of residues Thr23-G1y283 (with a gap of 11 residues between Tyrl 87 and 
Asp199). As in the structure of wild-type TDO, approximately 15 residues at the C-




omitted from the model. However, the N-terminal region of the H55A mutant enzyme is 
better defined than in wild-type TDO and is distinguishable in the electron density for 
tetramer I from Leu7 upwards (12 residues more than wild-type TDO), in chains A, B 





Fig 4.7: Dimers of TDO wild-type and H55A mutant. In yellow is shown the model of 
monomer A of TDO wild-type (PDB entry 2NW8) overlaid with the model of the 
corresponding monomer of TDO H55A mutant (in green) (PDB entry 3BK9). The hemes 
and the substrate are represented as sticks and colored respectively red and cyan. 
Residues 7-21 are visible only in the TDO H55A model. 
Each monomer also binds one heme group and one substrate molecule. Further to this, a 
second L-Trp molecule is observed at the inter-subunit interface close to each of chains 
A, B, C, D and E. In addition the model contains 1026 water molecules. The atomic 
coordinates have been deposited in the Protein Data Bank, accession code 3BK9. 
The increased definition of the N-terminal region in some monomers of the H55A 
mutant enzyme structure is of interest given that these residues (7-21) interact with the 
loop region which is involved in substrate binding (residues 250-260). It is notable that 
in the wild-type TDO model the active site tryptophan has temperature factors slightly 
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above the average for the whole protein (23.6 A2 vs 21.7 A2). 
,y 
I 	'•\ tr- 
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Fig 4.8: Monomers A and B of TDO wild-type (a) and TDO H55A (b) where 
respectively monomer A and monomer B have been colored as a rainbow gradient 
according to temperature factor or B-factor on relative scale -- highest B-factors red, 
lowest blue. The B-factor is measure of how much an atom oscillates around the position 
specified in the model. TDO H55A model (b) appears to have less motion than wild-type 
TDO (a). 
In addition, the ioop region has an average B-factor of 28.4 A2 . In the model of the 
H55A enzyme there is a correlation between the substrate temperature fctors, those of 
the substrate binding loop region, and the level of disorder at the N-terminus of each 
monomer. In this way, when the substrate B-factors are low, then so are those of the 
loop region and the N-terminus is more ordered. 
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Fig 4.9: TDO H55A active sites of monomer B (a) and monomer F (b) coloured 
according to their temperature factor. Monomer B is more defined in the electron 
density and appears to have less motion than to monomer F. 
The average rmsd fit of all backbone atoms between all monomers of the H55A TDO 
model and the structure of the wild-type enzyme (PDB entry 2NW8, in 2)  is 0.6-0.8 A, 
indicating no major differences between the two protein structures, except the 
substitution ofHis55 by alanine. The quality of the final electron density map around the 
active site of chain A of tetramer 1 is shown in Figure 4.4. 
4.5 Binding mode of L-Trp to H55A TDO 
The binding orientation of L-Trp at active site of the H55A mutant enzyme is slightly 
different from that observed in the wild-type TDO structure. Overlays of the active sites 
of wild-type TDO and the H55A enzyme are shown in Figures 4.10 and 4.11. 
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Fig 4.10: Stereoview of an overlay of the active site region of wild-type TDO (yellow) 
and H55A TDO (green) viewed from the side. The L-Trp from the H55A enzyme (in 
green) is rotated toward alanine 55 and the heme, relative to the position of the 
substrate in wild-type TDO (yellow). The H-bond between histidine 55 and the substrate 
is lost as a result of the substitution by alanine. The position of the water molecule in 
H55A TDO (wat552) is slightly different than in wild-type enzyme (wail) due to the 
altered substrate binding. 
The bound L-Trp belonging to the H55A mutant (in green) is rotated by approximately 
15 0  towards alanine 55 relative to the position of L-Trp in the wild-type enzyme (in 
yellow). Due to the substitution of histidine 55 by alanine, the hydrogen bonding 
interaction between residue 55 and the substrate indole nitrogen atom is lost. The 
positions of the side chains of other active-site residues are unperturbed by both the 
substitution and the change in substrate orientation. In particular, substrate carboxylate 








Fig 4.11: Stereoview of an overlay of the active site region of wild-type TDO (yellow) 
and H55A TDO (green) viewed from above. 
Furthermore, the van der Waals interactions between the substrate indole ring and 
residues Phe5 1, Tyr24 and Tyr27 and Leu28 (these latter three belonging to the N-









Fig 4.12: The active site of X campestris TDO H55A mutant. Here the interactions 
between the bound L-Trp and the active site residues are shown. 
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A water molecule is found in the active site of both wild-type TDO and the H55A 
mutant enzyme. This water is H-bonded to the ammonium group of L-Trp (3.0 A in 
H55A) and the main-chain amide of glycine 125 (2.8 A). As a result of the alteration in 
the position of L-Trp this water is found to be 2.7 A from the heme Fe in the H55A 
mutant, compared to a distance of 3.3 A in wild-type TDO. This is shown in figure 4.12. 
In wild-type TDO His55 hydrogen bonds to a water molecule in the substrate free 
ferrous state (C.G. Mowat, unpublished results) which is displaced upon binding of 
substrate. In the substrate free active site of the H55A crystal structure there is no 
equivalent water molecule, thus allowing greater access to the binding cavity compared 
to wild-type TDO. 
An interesting finding in the structure of the substrate-bound ferrous wild-type TDO was 
the existence of a second L-Trp binding site in the tetrameric interface, and it is possible 
that this represents an allosteric site (section 3.11). In the structure of the H55A mutant 
enzyme tetramer 1 this site contains four L-Trp molecules (per tetramer) interacting with 
Arg85, Lys92 and Asp228 from one monomer and Lys86 from another (fig 4.5). 
However, in tetramer 2 there is only interpretable L-Trp density in one of the four 
interfacial binding sites. 
The decrease in the value of 	for L-Trp oxidation in the H55A mutant (see table 4.1) 
may be explained by the orientation of L-Trp in the active site. The new position of L-
Tip in the active site of TDO H55A (figures 4.10 and 4.11) is accompanied by a slight 
increase in the substrate Km value, implying a small decrease in the stability of the 
enzyme ternary complex. The rotation has resulted in the tryptophan indole ring being 
further from the dioxygen binding site, thus decreasing the overlap of the molecular 
orbitals involved in catalysis. The transition state for the reaction will therefore be less 
stable, resulting in greater activation energy for catalysis. This will decrease the rate of 
turnover for the H55A mutant compared to wild-type TDO. 
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4.6 Electrochemical studies (Miss Sarah J. Thackray) 
Electrochemical data for wild-type TDO 2  and the H55A mutant
7  show that there is a 
much smaller shift in the reduction potential upon binding of substrate (LE,d 1­155A= 23 
mV) for the H55A enzyme compared to wild-type TDO (Eja wr = 136 mV). The shift 
in reduction potential of 23 mV almost perfectly correlates with the increase in affinity 
for L-Trp for ferrous H55A enzyme vs the ferric form (Kd (Fe (H)) = 3.7 jiM vs. Kd (Fe 
(ifi)) = 11.8 jiM), both giving an estimated L\AG of 3.5 kJ moF'. In fact, the difference 
in these AAG values calculated for wild-type TDO and the H55A mutant enzyme is 
approximately 11.5 Id moF', within the range of energies for a single hydrogen bond. It 
is possible that the lower affinity of oxidised wild-type TDO for substrate may be 
attributed to subtle changes in the structure of the active site (in terms of the hydrogen-








a 	 b 	 c 
Fig 4.13: Top views ofX campestris TDO. a) Femc substrate free wild-type, b)ferrous 
substrate bound wild-type, and c)ferric substrate bound H55A mutant. 
In the substrate bound structures, the hydrogen-bonding network is disrupted by the 
entrance of the L-Trp. A water molecule is still visible in the active site (b and c), but in 
a different  position, and out of range of hydrogen bonding interaction with the nitrogen 
atom of the histidine (b). A new water molecule appears in the H55A active site, 
hydrogen bonding with the main chain of Phe5I (c). 
Binding of L-Trp accompanies expulsion of solvent from the active site and results in the 
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formation of a hydrogen-bond between histidine 55 and the pyrrole nitrogen of the 
indole ring. 
In ferric wild-type TDO there is a tightly bound water molecule occupying the vacant 
heme iron coordination site (fig 4.13a). This water would be held in place by a 
combination of interactions with active site residues (including His55) and other solvent 
molecules. Upon reduction of the enzyme there is likely to be a restructuring of the 
active site solvent content. The implication of this rearrangement is that L-Trp is unable 
to effectively displace the waters when the enzyme is in the femc form (hence the high 
L-Trp K41 (mM)) but is able to do so in the ferrous form as reflected in the low L-Trp Lj 
value (.tM) (see table 4.1). The substitution of histidine 55 by alanine is therefore 
proposed to destabilise the bound waters and make the ferric active site more like that of 
the ferrous enzyme. In the H55A mutant enzyme the carbon atom of alanine side chain 
is unable to form the same hydrogen-bonds that histidine 55 can in wild-type TDO. 
Consequently there may be less rearrangement of the active site hydrogen-bonding 
interactions necessary to allow L-Trp binding, and the 1(43 for substrate binding to ferric 
enzyme is correspondingly small. All other interactions binding L-Trp in the active site 
are analogous to wild-type TDO. Consequently, the absence of significant oxidation-
state-dependent changes in the active site in H55A TDO results in decreased specificity 
of binding to the oxidised or reduced enzyme. 
4.7 Conclusions 
Kinetic and electrochemical data, together with the crystal structure, indicate that His55 
does not assume the role of active site base, but reveal a role for His55 in controlling 
substrate binding at the active site, greatly decreasing the affinity of the oxidised enzyme 
for substrate and regulating the binding of dioxygen, thus allowing precise control of the 
mechanism of turnover. This prevenis unproductive coupling to the ferrous enzyme that 
would lead to the production of superoxide and the dead-end femc complex. Substrate 




Zhang, Y. Ct al. Crystal Structure and Mechanism of Tiyptophan 2,3-
Dioxygenase, a Heme Enzyme Involved in Tryptophan Catabolism and in 
Quinolinate Biosynthesis. Biochemistry 46, 145-155 (2007). 
Fomuhar, F. et al. Molecular insights into substrate recognition and catalysis by 
tryptophan 2,3-dioxygenase. Proc. Nati. Acad. Sci. USA 104,473-8 (2007). 
Sugimoto, H. et al. Crystal structure of human indoleamine 2,3-dioxygenase: 
Catalytic mechanism of 02 incorporation by a heme-containing dioxygenase Proc. 
Nati Acad. Sci. USA 103, 2611-2616 (2006). 
Terentis, A. C. et al. The Heme Environment of Recombinant Human 
Indoleamine 2,3-Dioxygenase. J Biol Chem 277, 15788-15794 (2002). 
Littlejolm, T., Takikawa, 0., Truscott, R. & Walker, M. Production of Truncated 
Enzymically-Active Human Indoleamme 2,3 -Dioxygenase (IDO) Using Site-Directed 
Mutagenesis. J. Biol. Chem. 278, 29525-2953 1 (2003). 
Sono, M., Roach, M. P., Coulter, E. D. & Dawson, J. H. Heme-containing 
oxygenases. Chem. Rev. 96, 2841-2887 (1996). 
Thackray, S. J. et al. Histidine 55 of tryptophan 2,3-dioxygenase is not an active 
site base but regulates catalysis by controlling substrate binding. Submitted (2008). 
Bradford, M. A Rapid and Sensitive Method for the Quantitation of Microgram 
Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 
72, 248-254 (1976). 
Berry, E. & Tmmpower, B. Simultaneous Determination of Hemes a, b, and c 
from Pyndine. Hemochrome Spectra. Anal. Biochem. 161, 1-15 (1987). 
CCP4. The CCP4 suite: programs for protein crystallography. Acta Ciystallogr. 
D50, 760-763 (1994). 
Roussel, A. & Cambillau, C. (eds.) In Silicon Graphics Geometry Partners 
Directory 86 (Mountain View, CA, USA: Silicon Graphics, 1991). 
Murshudov, G., Vagin, A. A. & Dodson, E. Refinement of macromolecular 
structures by the maximum-likelihood method. Acta Cryst. D53, 240-255 (1997). 
155 
Chapter 5 
Structural characterisation of 
the N42C:K324C mutant 
offlavocytochrome b2 
Chapter 5 
Structural characterisation of 
the N42C:K324C mutant of flavocytochrome b 2 
5.1 Introduction 
Flavocytochrome b2 from Saccharomyces cerevisiae is a flavohemoprotein localized 
in the yeast mitochondrial intermembrane space, and catalyzes the oxidation of L-
lactate to pyruvate. This reaction is coupled to cytochrome c reduction (fig 5.1). 
Outer Membrane 
Oo 
k0A x 2 
00*] 0 0 
) x4 o. 
muo - - - - 	- 
Ice 
2 H 2 0 
Fig 5.1. Schematic illustration of the biological role of .flavocytochrome b2 
(represented in green as a tetramer). Flavocytochrome b2 is localized in the 
intermembrane space. The oxidation of L-lactate results in the reduction of 
cytochrome c (represented in red). Electrons involved in the reaction are shown in 
blue and are passed .from flavocyrochrome b2, via cytochrome c and cytochrome c 
oxidase (in dark magenta),) to finally reduce water. 
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The crystal structure of the native enzyme has been solved to 2.4 A resolution in 
1990 1,2 
The enzyme is a homotetramer (fig 1.23). Each subunit of the tetrameramer is 
formed by two functionally distinct domains, each one carrying a prosthetic group. 
The N-terminal moiety of the protein (residues 1-88) (Fig 5.2 in purple) carries the 
heme. The C-terminus (residues 106486) (fig 5.2 in yellow) binds the flavin (FMN) 
and contains the L-lactate binding site. The two domains are connected by a flexible 
loop (residues 89-105) (fig 5.2 in blue). 
10 
/ 
Fig 5.2: An individual subunit of flavocytochrome b 2. 2. The heme domain is 
represented in dark magenta, the hinge domain is shown in blue, and the flavin 
domain is shown in yellow. The heme and the FAIN are represented as sticks and 
coloured respectively in dark red and orange. 
5.2 The inter-domain hinge region of flavocytochrome b2 
The catalytic cycle of flavocytochrome b2 has been extensively studied 	and 
consists of five steps as described in section 1.5.5. 
Although the enzyme is tetrameric (fig 1.23), each subunit acts independently 
8 
After the oxidation of L-lactate to pyruvate, the two electrons gained from the 
reaction are transferred from the flavin to the heme domain, through sequential 
158 
Chapter 5 
electron-transfer reactions. Then the electrons are transferred to the acceptor, 
cytochrome c (fig 5.1). 
The mechanism of such electron transfer is deeply connected with the folding of 
flavocytochrome b2 into two distinct domains. 
Domain mobility plays a crucial role in catalysis by many enzymes 9 . An example of 
protein flexibility is the so called "hinge mechanism". The hinge mechanism allows 
rigid body movements in proteins which do not display extensive inter-domain 
contacts. Indeed, hinge bending is a very common motion in proteins and an 
important mechanism at the basis of functional changes in enzyme conformations 10 
14 Hinge motions have been reported to contribute to ligand binding 15, 16 mediate 
allosteric effects 17  and modulate the function of enzymes 18 
Hinge regions are generally characterized by a high percentage of short-side chain 
and uncharged residues, such as glycine, alanine and proline. The characteristics of 
these residues seem to contribute to the hinge bending 
In flavocytochrome b2, the folding of the flavin and heme domains is globular and 
quite rigid, allowing only a limited internal motion 2  The flavin and heme domains 
are linked together through a flexible loop (fig 5.2, in blue) that constitutes the hinge 
region. The hinge region has been proposed to confer domain mobility, allowing 
movement of the heme domain with respect to the flavin domain 20 
Inter-domain mobility of flavocytochrome b2 has been confirmed both by 
crystallographic 2  and NMR spectroscopic 21  observations. The crystal structure 2 
showed two distinct monomeric subunits in the tetramer. In one of these, no pyruvate 
is bound at the active site, and the cytochrome domain is well-resolved. In contrast, 
in the second subunit pyruvate is present, but the electron density for the heme 
domain is not visible. The reason why the heme domain is not defined when pyruvate 
is bound at the active site is probably the mobility of the heme domain with respect 
to the flavin domain. This flexibility was even more clear in solution, where NIMR 
spectroscopic data 2 1 revealed that the heme domain is more mobile than expected 
for a large tetrameric protein such a flavocytochrome b2. 
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5.3 The role of domain mobility in flavocytochrome b 2 
In order to investigate the domain mobility of flavocytochrome b2, White et al. 20 
constructed a hybrid enzyme, where the hinge region of the Saccharomyces 
cerevisiae enzyme was replaced with the shorter and more acidic hinge region of 
flavocytochrome b2 from Hansenula anomala (hinge-swap-b2). Inter-domain 
electron transfer was shown to be severely affected in the hybrid enzyme. Kinetic 
experiments have shown that the major effect in hinge-swap-b2 was a significant 
decrease in the rate of flavin to heme reduction 20 
Further experiments demonstrate the importance of maintaining the structural 
integrity of the hinge for optimal inter-domain electron transfer. Three mutant 
enzymes with truncated hinge regions (named HA3, HA6 and HA9 respectively with 
three, six and nine amino acids deleted) were constructed and characterized 
22  In 
addition, two other mutants with elongated hinge domains (named H13 and 1 ­116, with 
insertion between residues 100 and 101 of respectively three and six residues) were 
engineered 23  All the altered hinge regions are illustrated in fig 5.3, in comparison 
with the wild-type hinge region. 
Wild-type PPELVCPPYAPGETK' °3 
H13 P P E L V C P P YA PGA P G E T K 
H16 PPELVCPPYAPGAPGAPGETK 
HA3 PPELVCPPY- - 	- ETK 
HA6 PPELVC ------ ETK 
HA9 P P E --------- ETK 
Figure 5.3: The amino acid sequence for the inter-domain hinge is shown, from 
Pro89 to LysI03 of the wild-type flavocytochrome b 2. The H13 and H16 enzymes 
have the typical tripeptide motif Ala-Pro-Gly inserted in the primary structure 
(insertions are indicated in magenta). The gaps in the sequence represent the amino 
acid residues deleted from the hinge sequence in the H43, H46 and HA9 enzymes. 
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Kinetic characterization of all the mutants shown in fig 5.3 was conducted using both 
ferricyanide and the natural reaction partner cytochrome c as electron acceptors. 
With ferricyanide, the steady-state kcat values for L-lactate oxidation were decreased 
only with the HA3 and HA6 mutant enzymes 22  In contrast, with cytochrome c as the 
electron acceptor, the steady-state k u, values were dramatically decreased for all the 
mutants (table 5.1). Such a difference in the kcat values can be explained since it is 
known that cytochrome c can only accept electrons from the heme of 
flavocytochrome b2 24,  while ferricyanide receives the electrons both from the FMN 
and the heme-domains 25 
Enzyme = 	k 	(1) L-lactate K. (mM) 
Wild-type 207 ± 10 0.24 + 0.04 
1{13 b 28.3 ± 0.7 >0.10 
H16b 12.7±0.3 >0.10 
C 39 ± 1 0.25 ± 0.03 
HA6 d 33.5 ± 1.4 0.09 ± 0.01 
HA9d 7.9±0.4 0.02±0.01 
Table 5.1. Steady-state kinetic parameters using cytochrome c as electron acceptor 
for wild-type flavocytochrorne b 2 and hinge-modified mutants. All the measurements 
were carried out at 25 °C, in 10 mM TrisHCl, pH 7.5, 1 0.10. More details about the 
conditions are described in the quoted references: a 26 b 22 c 27 d 23 
Pre-steady-state kinetic analysis 22, 23, 26.27 demonstrates that by altering the length of 
the hinge domain there is a little effect on L-lactate oxidation, while the inter-domain 
electron transfer is severely affected. The integrity of the hinge was proved to be 
important for controlling the mobility of the flavin and the heme domain with respect 
to each other, maybe helping to position the FMN and the heme at the optimal 
distance for efficient electron transfer. The rate limitation at the inter-domain 
electron transfer step in the hinge mutants, was confirmed by the pre-steady-state 










5.4 An inter-domain disulfide bridge in flavocytochrome 1)2 
To investigate the heme domain mobility relative to the FMN-domain in 
flavocytochrome b2 a more recent approach (Bell, PhD thesis, 1997, 
37)  involved the 
restriction of inter-domain movement by the introduction of a covalent bond between 
the FMN-binding and heme domains. 
5.4.1 Disulfide bond engineering as a tool to study conformational changes 
The amino acid cysteine can oxidatively pair up with another and produce a disulfide 
bond. Disulfide bonds play important roles in the folding of many proteins 28. 29 and 
they can represent a structural motif for increasing stability in many proteins. 
Disruption of S-S bonds leads to lowering the thermal stability of the tertiary 
structure The geometry of a disulfide bond is shown in fig 5.4. 
a 
Fig 5.4: a) Cysieines pair up ('colour code: carbon in green, oxygen in red, nitrogen 
in blue, sulfur in yellow) b) disu/fide bond geometry: the optimal sulfur-sulfur 
distance is about 2.0.4, with the angle between the carbon and the sul/lir of about 
103°. The dihedral angle between the C-S-S-C - atoms, is usually close to 90°. 
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Disulfide bonds form between the thiol groups (-SH) of two cysteme residues 
through an oxidation reaction that involves two electrons (fig 5.5). 
R-SH + R'-SH ' R-S-S-R' + 2H + 2& 
Fig 5.5: The general redox scheme describes the overall reactions that create 
(oxidize) or destroy (reduce) disulfide bonds 
Disulfide bonds occur naturally in vivo. Under oxidative conditions a bond between 
the two sulfur atoms of cysteines positioned at a suitable distance will form 
spontaneously. The ultimate electron acceptor for thiol oxidation is normally 02, 
while in the case of anaerobic conditions an electron acceptor such as fumarate or 
nitrate reductase can be used 31 
In vitro, development of site-direct mutagenesis allows the replacement of naturally 
occurring cysteine residues by other amino acids preventing the formation of an S-S 
bond. It is also possible to engineer strategically placed non-native disulfide bonds 
within a given protein. This has been a powerful tool for analyzing protein 
conformational changes 32-34  In the past, many attempts at disulfide bond 
engineering yielded low success rates, mainly due to a lack of methods for 
determining the optimal site for introduction of a disulfide bond within a protein. 
Lately, computational approaches to predict protein folding and protein folding 
studies have increased the chance of success of these strategies . 
5.4.2 Disulfide link between the two domains of flavocytochrome b 2 
In flavocytochrome b2, by creating a disulfide bond the two domains can be locked 
together and their mobility decreased. Consequently the electron transfer rate may 
be affected. Such a method has been previously applied in the case of fumarate 
reductase from Shewanella frigidimarina 36,  where the introduction of an inter-
domain cross-link between the FAD- and clamp-domains of the enzyme, 
successfully restricted the relative mobility of the two domains. 
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In a previous attempt, site direct mutagenesis was used to introduce a disulfide link 
37 
between the two domains of Saccharomyces cerevisiae flavocytochrome b2 
Alanine 67, located in b2-heme domain, was substituted by a cysteine (A67C) (fig 
5.6). This engineered cysteine was expected to form a disulfide bridge with the 
naturally occurring Cys233 of the flavin-binding domain. Although Ellman assays 
37 and kinetic assays suggested the formation of such a disulfide bridge between the 
two domains, this was never proven because no crystal structure for this mutant 
enzyme was available. 
Fig 5.6: A single monomer of flavocytochrome b 2. The domains are coloured as for 
.fig 5.2. The target residue for cysteine modification (A1a67) is indicated in green, as 
is the naturalyl occurring Cys2333  , while the distance between their a-carbon atoms 
is shown as a dotted line (insert). 
Subsequentially, site-directed mutagenesis has been used to construct the 
38 
N42C :K324C double mutant Saccharomyces cerevisiae flavocytochrome b2 The 
a-carbon atoms of the residues at position 42 of the heme-binding domain and 
position 324 of the flavin-binding domain are 5.9 A from one another. From the 
three-dimensional model of the native enzyme 
2  was clear that the introduced 
cysteine residues can readly adopt a S-S distance of 2.0 A, an ideal distance to form a 
disulfide bridge. Figure 5.7 highlights the location of residues 42 and 324 at the 









Fig 5.7: A single monomer qffiavocytochrome b2. The domains are coloured as for 
fig 5.2. The target residues for cysteine modification (Asn42 and Lys324) are 
indicated in green 
37  and the distance between their a-carbon atom as a dotted line in 
the insert on the right. 
5.5 Kinetic characterization of the flavocytochrome b2 N42C:K324C 
mutant 
The kinetic behaviour of the fiavocytochrome b2 N42C:K324C mutant has been 
reported by Drewette (2006) . Steady-state kinetic experiments were conducted 
both using the physiological electron acceptor cytochrome c and the artificial 
electron acceptor ferricyanide [Fe (CN)6] -3 . Assays were carried out in both the 
closed (disulfide bridge formed) and open (disulfide bridge reduced by the addition 
of DTT) conformations of the enzyme. The resulting kcat and K. values were 
compared with those for the wild-type enzyme 39 and are summarised in table 5.2. 
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Electron acceptor: [Fe(CN) 6 3 
Enzyme 	 (s') 	Km (mM) 	10 x kcat/Kri, (M' s) 
Wild-type * 400 ± 10 	0.49 ± 0.05 	 8.2 
Open 	 76 ± 4 	 1.8 ± 0.3 	 0.43 
Closed 	5.1 ± 1.6 	0.72 ± 0.24 	 0.07 
Electron acceptor: cytochrome c 
Enzyme 	kcat (s') 	Km (mM) 	10 X kcatIKm (M' s') 
Wild-type * 207± 10 	0.24± 0.04 	 8.6 
Open 	 13±1 	 1.2±0.2 	 0.11 
Closed 	0.84 ± 0.14 	0.33 ± 0.09 	 0.03 
Table 5.2: Steady-state kinetics results for Saccharomyces cerevisiae 
flavocytochrome b 2 N42C:K324C mutant with L-lact ate as substrate. All 
measurements were carried out at 25 °C, in 10 mM TrisHCl, pH 7.5, 1 0.10. Electron 
acceptor concentrations were 5 mM for [Fe(CN) 6j3  and 100 pJt'Ifor cytochrome c 
38 
* Wild-type values were reported in Miles et al. (1992) . 
From the steady-state kinetic analysis shown in table 5.2, it appears that although the 
mutant enzyme retains activity, the rate of FMN reduction by L-lactate is affected by 
the disulfide bridge formation. 
In the open form (where the disulfide bond is not formed) the kca t value with 
[Fe(CN)6] 3 as electron acceptor shows only a 5-fold decrease compared to the wild-
type enzyme. However, with cytochrome c as the electron acceptor a more 
pronounced decrease in kcat (some 16-fold) is observed. A decreased kca t value with 
cytochrome c as electron acceptor has been previously reported for flavocytochrome 
b2 with other point mutations (1739A and P44A) 40•  Interestingly, both these 
mutations lie in close proximity to the substituted asparagine residue in the 
N42C:K324C mutant enzyme. This may indicate a disruption of one of the electron-
transfer steps, either FMN to heme or heme to cytochrome c. 
The closed form of the enzyme (where the disulfide bridge is formed) reveals a 15- 
fold decrease in k 1 compared to the open mutant enzyme, with both the electron 
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acceptors. In addition, the catalytic efficiency (indicated by the "cat/Km ratio) of the 
closed form is lower than the open form. With [Fe(CN') 6] 3 as electron acceptor the 
kcatlKm ratio is approximately 16 % of that of the open form of the mutant enzyme, 
while when cytochrome c is used as the electron acceptor, the catalytic efficiency is 
27 % of that of the open form. 
This result is important for the understanding of electron flow through 
flavocytochrome b2. As mentioned in section 5.3, ferricyanide can receive electrons 
from both the FMN and heme of flavocytochrome b2, while cytochrome c accepts 
electrons only from the heme. The fact that in the closed form of the enzyme both 
electron acceptors show a 15-fold decrease in kcat indicates that is the rate of FMN 
reduction by L-lactate that is primarily affected by disulfide bridge formation. 
Pre-steady-state kinetic analyses were consistent with the steady-state data. FMN 
reduction was confirmed to be rate limited by the formation of the disulfide bridge 38 
In this chapter the crystal structure of the double mutant flavocytochrome b2 
N42C:K324C, obtained at 3.0 A resolution is described. This confirms the formation 
of the disulfite bond and validates the kinetic assays. In addition, steady-state kinetic 
control experiments, conducted on single mutants N42C and K324C are reported. 
5.6 Results 
5.6.1 Mutagenesis and expression 
Flavocytochrome b2 mutants (N42C, K324C, and N42C:K324C) were created by Dr. 
Katy J. Drewette and by Dr. Caroline S. Miles, at the Institute of Structural and 
Molecular Biology, University of Edinburgh, as described in Drewefte (2006) 38 
Site-directed mutagenesis was performed by the Kunkel method of nonphenotypic 
selection 41  E. co/i stain AR120 was used for production of cultures containing the 
expression vector pKD209 for N42C, pKD212 for K324C and pKD213 for 
N42C:K324C flavocytochrome b2 mutants. Cultures were grown aerobically in LB 
media containing SOjtg/ml carbenicillin to mid-exponential phase (O.D. 0.6) at 37 
°C for 24 hours and then cells were harvested. 
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Mutant enzyme 	 Code 
asparagine 42 - cysteine 	 \42C 
lysine 324 -* cysteine 	 K324C 
asparagine 42 , lysine 324 - cysteine , cysteine 	42C:K324C 
Table 5.3:Summary of the mutants studied in sections 5.7, 5.8, and 5.9 
5.6.2 Purification 
N24C, K324C and N42C:K324C mutant flavocytochromes b2 expressed in E. coli 
were isolated from cells using a previously reported procedure 38,42 
Flavocytochrome b2 single mutants (N42C, K324C) were purified according to the 
following procedure. 
The cell pellet was resuspended in buffer 1 (100 mM phosphate buffer pH 7.0, 1 mM 
EDTA, and 10 mM L-lactate) and then sonicated on ice. Cell debris was removed by 
centrifugation. The proteins contained in the soluble fraction were precipitated by 
addition of ammonium sulfate, (70% saturation). Precipitated proteins (including 
flavocytochrome b2 ) were resuspended in 100 mM phosphate buffer pH 7.0, 10 mM 
L-lactate and dialyzed overnight against the same buffer. 
The suspension was loaded into a DE-52 colunm (Amersham) previously 
equilibrated with buffer 1. The flow through from DE-52 was then applied to a 
hydroxapatite column equilibrated with buffer 1. The bound flavocytochrome b2 was 
extensively washed with the equilibration buffer until A 280 was found to be zero. The 
protein was then eluted with a step gradient of (NH 4)2 SO4 added (up to 10% 
saturation in 2% increments). Flavocytochrome b2 eluted between 8% and 10% 
saturation (NR4)2 SO4 . The purity of each 5 ml fraction was determined by UV/vis 
spectrophotometry. Only the fractions whose spectral ratio (A423/A2 69) had a 
value? 2 were pooled together and precipitated with 70% saturation (NH 4) 2 SO4 . 
The red pellet containing flavocytochrome b2 was resuspended in TrisHCl 10 mM 
pH 7.5 10.10. 
The buffer was then exchanged using a Sephadex G-25 desalting column (Sigma) 
which was equilibrated in 10mM TrisHClpH 7.5 10.10. 
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For the flavocytochrome b2 double mutant (N42C:K324C) the same purification 
procedure was followed, with the difference that all the buffers were supplemented 
with 5 mM DTT. Furthermore, in the last step of purification the N42C:K324C 
mutant enzyme was purified through a Superdex 200 column equilibrated with 
TnsHCI 10 mM pH 7.5 I 0.10. The double mutant N42C:K324C eluted at a volume 
corresponding to -240 kDa molecular weight. 
Purified enzyme samples were stored either as precipitates from a 70% saturated 
(N}142SO4 solution (short-term storage), as concentrated solutions at -80 °C, or as 
flash-frozen enzyme aliquots in liquid nitrogen (long-term storage). 
5.6.3 Aggregation of the N42C:K324C mutant enzyme 
Previous attempts to purify N42C:K324C flavocytochrome b2 enzym, did not take in 
account the tendency of this double cysteine mutant to form intermolecular disulfide 
bridges and aggregate in the absence of DTT (fig 5.8). This happened during the last 
chromatographic step of gel filtration when the DTT was removed from the buffer. 




Fig 5.8: SDS PAGE showing the purification results for the flavocytochrome b2 
N42C.K324C mutant. Samples were prepared by adding SDS-PAGE buffer and 
heating at 100 °C. Sample in lane 1 was augmented with 10 mM DTT. The 58 kDa 
bands indicated the presence of the monomers (mw -- 58 kDa). DTT chemically 
reduces covalent bonds and allows the protein in lane 1 to run as a monomer. 
However, close examination shows at least other 3 visible bands at higher molecular 
weigh in lane 2, where DTT is not present. The bands at higher molecular weight in 
lane 2 are protein aggregates, formed due to inter-subunit covalent bonds, and also 
appear in the pun/I cation profile from gelfiltration (see fig 5.8). 
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It was demonstrated using an analytical gel filtration column that there were different 
profiles of elution from the Superdex 200 purification step between the wild-type 
flavocytochrome b2, the N42C:K324C mutant in the presence of 10 mM DTT and 
the N42C:K324C mutant in the absence of DTT. 
As is shown in fig 5.9a, wild-type flavocytochrome b2 (molecular weight 58 kDa) 
elutes with a main peak corresponding to the molecular weight of a tetramer, around 
240 kDa. 
In contrast, the elution profile of the N42C:K324C mutant show that the engineered 
cysteine residues can form inter-subunit disulfide-bridges, together with the desired 
bond between the cytochrome and fiavin-binding domains (fig5.9b). In fact, the 
peaks eluting at higher molecular weight than 240 kDa are likely to be caused by the 
tetramers aggregating together. Due to the localization of the engineered cysteines at 
the surface, they may possibly have formed inter-subunit covalent bonds rather than 
just only the intended inter-domain disulfide bridge. Aggregation of surface cysteine 
mutants has been previously reported (e.g. 43) 
When DTF was added to the equilibration and elution buffer of the analytic gel 
filtration, the N42C:K324C mutant displayed an elution profile similar to that of the 
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Figure 5.9: Elution profiles (shown in blue) from Superdex 200 gel filtration column 
of flavocytochrome b2 samples (a) wild-type enzyme,running buffer TrisHCl 10 mM 
pH 7.5 10.10 (b) N42C:K324C, running buffer TrisHCl 10 mMpH 7.510.10, and 10 
mM DTT. (c) N42C:K324C mutant enzyme DTT, (d) previously gel filtrated 
tetrameric N42C:K324C mutant. For both the running buffer was TrisHCl 10 mM 
pH 7.5 I 0.10. The elution profile of the molecular weight standards (in green) is also 
shown. 
In order to exclude the possibility that the gel-filtered mutant enzyme re-aggregate 
over time in oxidising conditions, the tetrameric protein was isolated and then 
incubated for 30 minutes at 4 °C before being run again through the Superdex 200 
column. The resulting elution profile (fig5.9d) is similar to that of the wild-type 
enzyme, indicating that once in the tetrameric state the N42C:K324C mutant will not 
re-aggregate as a multimer. 
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Appropriate molecular weight standards were passed through the column to calibrate 
it. Extrapolation from a plot of Log Mr VS Vv/Ve (fig 5.10) allowed the determination 
of the molecular weight of the sample peaks. 




bovine y-globulin (158 kDa) • 
5.0 	 flavocytochrome b 7 
N42C:K324C 
4.5 	 chicken ovalbuttlin (44 kDa) 
CM 
.3 U 
4.0 	 horse myoglobin (17 kD) 
3.5 
3.0 	
U Vitamin 812(1  .35 kDa) 
0.3 	0.4 	0.5 	0.6 	0.7 	0.8 	0.9 
VN 
v 	e 
Figure 5.10: Molecular mass determination of flavocytochrome b2 N42C:K324C by 
ge/filtration. Plot of Log Mr vs void volume (V)/eIution volume (Ve) of the standard 
molecular weights. The points were fitted to a linear gradient, (y=mx + c, where m 
= 5.5 ± 0.8, c = 1.4 ± 0.5). The corresponding V/Ve for the N42C:K324C tetramer 
is highlighted by the green-grey circle. 
Only fractions eluting from the gel filtration at the molecular weight of 240 kDa 
were pooled together and concentrated to 20 mg mr' (fig 5.11). 
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F 5.11. SDS-PA GE of the flavocytochrome b 2 N42C.K324C gel filtered sample 
used for crystallographic experiments. 
5.6.4 Protein concentration determination 
Protein concentration was determined spectrophotometrically. The extinction 
coefficients for flavocytochrome b2 in both its oxidised and reduced forms are shown 
in table 5.4. 
Oxidation State 	Soret Maximum / nm 	F. (M' cm') 
Oxidised 	 413 	 129500 
Reduced 	
Aimm 
I 	 423 	 183000 
Table 5.4: Extinction coeffi dents for oxidased and reduced flavocytochrome b 2 
5.6.5 Crystallization of flavocytochrome b2 N42C:K324C mutant 
Crystals of b2  N42C:K324C were grown by the hanging-drop vapour diffusion 
method. 2.tl of protein (at 20 mg/mI in 10 mM TrisHCl pH 7.5 1 0.10) were mixed 
with 2i.tl  of well solution (0.1 M sodium citrate pH 5.0, 10% PEG 4000, 0.2 M 
sodium bromide, 5% glycerol, and 50 mM sodium pyruvate) at 18°C in the dark. 
Red crystals appear after 3 days (fig 5.12). 
Before flash-cooling in liquid nitrogen, crystals were cryoprotected in 0.1 M sodium 




5.6.6 Data collection and processing 
The best dataset was collected to 3.0 A resolution at ESRF (Grenoble, France) on 
beamline BM14 using a Mar research CCD detector (wavelength X = 0.9537 A). 
Crystals were found to belong to space group P2 1 with cell dimensions a = 64.226 A, 
b = 179.895 A, c = 96.369 A and fi = 90.68°. Data processing was carried out using 
MOSFLM . The structure was solved by molecular replacement using MOLREP 
and the wild-type flavocytochrome b2 structure (PDB entry IFCB) stripped of water, 
was used as a starting model. Electron density fitting was carried out using the 





Fig 5.12: Crystals of flavocytochrome b2 N42C:K324C mutant grown in 0.1 M 
sodium citrate pH 5.0, PEG 4000 10%, 0.2 M sodium bromide, 5% glycerol and 50 
mM sodium pyruvate 
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5.7 The crystal structure of N42C:K324C flavocytochrome b2 
A dataset to 3.0 A resolution was used to refine the structure of N42C:K324C 
flavocytochrome b2 to a final R-factor of 18.03 % (R& ee = 25.62 %; table 5.5). 
additionally allowed (%) 
no. of waters included in refinement 
Space group 
cell dimensions (A) 
resolution (A) 
total no. of reflections 










rmsd from ideal values 
bond lengths (A) 
bond angles (deg) 
Rarnachandran analysis 
most favoured (%) 
P2 1 















Table 5.5: Data collection and refinement statistics. 
Values in parentheses represent statistics for the highest resolution shell, 3.16 - 
3.00 A. bRmerge = h2I1(h) - 11(h) J/ E,,X1I(h), where 11(h) and 1(h) are the ith and mean 
measurement of reflection h, respectively. CR,,st = Eh IF0 - FI/ EhF0, where F 0 and F 
are the observed and calculated structure factor amplitudes of reflection h, 
respectively. Rjr ee is the test reflection data set, 5 % selected randomly for cross 
validation during crystallographic refinement. dMediu,n  NCS restraints were used 
during refinement, with each subunit (A - D) being defined as a group. 
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Initial refinement was done without waters, but adding these improved the R-factors 
and the quality of the map in certain areas. Each added water was checked and 
ejected if unreasonable. 
The final model consists of four protein molecules (subunits A-D) each including 
residues Glul to A1a51 1, one b 2-heme and one FMN. In addition the model contains 
213 water molecules. The arrangement of the subunits to form the tetramenc enzyme 
in the asymmetric unit is shown in fig 5.13. In all subunits residues 300-3 17 are not 
visible in the electron density because of disorder, similar to that found in other 
structures of this enzyme 2 
: 
Figure 5.13: The asymmetric unit content of N42C:K324C flavocytochrome b2. 
Subunit A is shown with the cytochrome domain in green and the flavin domain in 
purple. Subunit C is shown in cyan. Subunits B and D are shown in grey. In all 




The presence of the amino-acid substitutions (N42C and K324C) is evident from the 
electron density map (fig 5. 14a). From the electron density it is also confirmed that 
in each subunit a disulfide bond has been formed between Cys42 and Cys324 (fig 
5. 14a and 5. 14b). The major effect of this inter-domain disulfide bond formation is 
the presence of an ordered heme domain in each of the four subunits. There are 
several other structures of holo-flavocytochrome b2 deposited in the PDB, all from 
crystals which belong to space group P3221 
2, 5. 50 In all cases the model consists of 
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Figure 5.14. (a) Stereo view of the 2F 0 - F, electron density map surrounding the 
heme ('in red) and residues 41-43 and 323-325 of subunit A of N42C:K324C 
flavocytochrome b2. The disulfide bond is clearly visible in the electron density map. 
The contour level is Ia, where a is the mis electron density. (b) Stereo view of the 
same region overlaid with that in subunit A of the wild-type envme  (in green, PDB 
entry IFCB). Figure produced with Mo/script 48 d Raster3D . 
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Although the conditions used to grow crystals of flavocytochrome b2 N42C :K324C 
were almost identical to those used to grow crystals of other forms of the protein 2.5, 
50,  ulavocytochrome b2 N42C:K324C, crystallized in the P2 1 space group. This 
represents evidence of the structural changes imposed by the formation of the four 
disulfide bonds in the tetrameric enzyme. However, the presence of the disulfide 
bond has little effect on the overall structure of the protein, with the average rmsd fit 
for a-carbon atoms of each subunit with those of subunit A of the wild-type enzyme 




Figure 5.15: The overlay of subunit A of the N42C:K324C double mutant enzyme 
(green and purple) with subunit A of the wild-type enzyme (in grey). Jr can be 
observed that there is only a little change in the position of the cytochrome domain 
as the result of the disuifide bridge .formation. Heme and FMN are shown as sticks 
and coloured respectively in red and yellow. The disulfide bridge is highlighted in 
the red circle. Figure produced with Molscript 48  and Raster3D . 
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The formation of a disulflde bond results in the locking of the cytochrome domain to 
the flavin domain, and the major effect of 'fixing' the two domains is the presence of 
an ordered heme domain in each of the four subunits of the tetramer. However, the 
disulfide bridge does not prevent mobility within the heme domain itself. B-factors 
of the cytochrome domain are considerably higher than the average over the whole 
protein (70-100 A 2 compared to a mean B-value of-49 A 2 over the whole model). 
As already described in section 5.2, in the structure of wild-type enzyme 2  pyruvate 
is visible at the active site of only one of the two subunits (where the heme domain is 
disordered). In the structure of N42C:K324C flavocytochrome b2, although the 
crystallization condition contains 50 mM pyruvate, electron density for the substrate 
is absent in the model. This suggests that cross-linking the heme and flavin domains 
could restrict the access of the substrate to the active site. 
In the N42C:K324C flavocytochrome b2 there are water molecules present at the 
active site. The number of water molecules varies from 1 to 3 between the four 
subunits. In subunit A (fig 5.16) there are three water molecules (wat25, wat 146 and 
watl94). Wat25 is hydrogen bonded to the flavin (3.1 A from N5 of the FMN) and 
also toHis373 and to Tyrl43 (respectively 3.2 A and 3.7 A apart). Wat146 is 3.3 A 
from Wat25, and is also hydrogen bonding to one of the heme propionate groups at a 
distance of 2.7 A. The third water, watl94, is 3.1 A from watl46. The heme 
propionate double hydrogen bond Tyr143 (being 2.5 A and 3.9 A apart), and around 
4.2 A from where pyruvate would be bound if it was present in the same position as 
observed in the wild-type enzyme structure. 
The 3.0 A resolution of the flavocytochrome b2 N42C:K324C model is limiting for 
any further speculation. However this structure has certainly confirmed the presence 
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Figure 5.16: (a) Stereoview of the overlaid active sites of N42C:K324C ('subunit A) 
and wild-type (subunit A, green) flavocytochromes b2. (b) Stereoview of the same 
region in the N42C:K324C enzyme overlaid (carbon alpha of the protein chain) with 
that in subunit B of the wild-type enzyme (green). The positions of the water 
molecules in the double mutant enzyme are indicated by the arrows, as is the 
pyruvate in subunit B of the wild-type enzyme. The propionate of the heme groups is 
near to the substrate binding site. Figure produced with Molscript 




5.8 Steady-state kinetic analysis of single mutants N42C and K324C 
Steady-state kinetic analysis is a technique that allows observation of enzyme under 
turnover conditions, in terms of its consumption of substrate or generation of 
products. 
Steady-state kinetic analysis was conducted on the single mutants N42C and K324C 
as control experiments, in order to verify the effect on catalysis of the individual 
single mutations and validate the kinetic results of the double mutant 
flavocytochrome b2 N42C:K324C 38 
Steady-state kinetic analyses were carried out in 10 mM TrisHCl, pH 7.5, 10.10 at 
25°C. The flavocytochrome b2 mutants (N42C, K324C) used were thawed on ice 
directly prior to use, and incubated on ice throughout the whole experiment. 
The concentration of the enzyme was determined before use (see section 5.7.4) and a 
suitable concentration of enzyme to obtain a good trace was added to each assay. 
Assays were carried out using both ferricyanide (K3[Fe(CN)61, Fisons) and 
cytochrome c (horse heart, type VI, Sigma) as electron acceptors. The data obtained 
for steady-state kinetic analysis with L-lactate as substrate are shown in table 5.6, in 
comparison with the wild-type and the double-mutant N42C:K324C (both in the 
open and closed conformation). L-lactate solution was made as a standard by the 
addition of buffer (10 mM TrisHCl, pH 7.5, I 0.10) to the calculated amount of 
lithium salt of L-lactic acid. 
Ferricyanide reduction (Fe(III) to Fe(II)) was followed by monitoring the decrease in 
absorbance at 420 Mn ( ox-red = 1010 M'cm). Saturating concentrations of between 
1 and 5 mM ferricyanide were satisfactory depending on the mutant form, however, 
this resulted in the need to use 2 mm or 5 mm path length cuvettes and either smaller 
or larger assay volumes depending on the cuvette path length. 
Cytochrome c was used freshly prepared in 10 mM TrisHCl, pH 7.5, 1 0.10 and 
diluted to a suitable concentration. A saturating cytochrome c concentration of 100 
jiM was used. Cytochrome c reduction by flavocytochrome b2 mutants was 




All steady-state kinetic data were fitted to a normal Michaelis—Menten model using 
non-linear least squares analysis in the program Microcal Origin to obtain values for 
kcat and Km. 
N42C 
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Fig 5.17: Michaelis plots for L-lactate dependence offlavocytochrome b2 a,) N42C, b) 
K324C, both obtained using ferricyanide as the electron acceptor. K0b is the first 
order rate constants, which has units of 1'time (s'). Conditions were 100 mM 
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Fig 5.18: Michaelis plots for L-lactate dependence of flavocytochrome b2 a,) N42C, b) 
K324C, both obtained using cytochrome c as the electron acceptor. . K is the first 
order rate constants, which has units of 1/time (s'). Conditions were 100 mM 
TrisHC'l buffer pH 7.0, 25 °(", 10.10 
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Electron acceptor: [Fe(CN)61 3 - 	- 
Enzyme kcat(S) Km (mM) 103 X kcatlK m (M's') 
Wild-type 400± 10 0.49± 0.05 8.20 
N42C;K324C open 76 ± 4 1.8 ± 0.3 0.43 
N42C:K324C closed 5.1 ± 1.6 0.72 ± 0.24 0.07 
N42C 151.1 ± 6.7 0.72 ± 0.11 0.20 
K324C 92.5 ± 8.7 1.38 ± 0.38 0.67 
Electron acceptor: cytochrome c 
Enzyme kcat(S) Km (mM) 103 X kcatlKm M 1 s') 
Wi1d-tpe 207 	10 0.24 ± 0.04 8.60 
N42C:K324C open 13±1 1.2± 0.2 0.11 
N42C:K324C closed 0.84 ± 0.14 0.33 ± 0.09 0.03 
N42C 18.1 ± 0.39 0.25 ± 0.01 0.72 
K324C 27.6± 1.3 0.57± 0.09 0.48 
Table 5.6: Steady-state kinetic parameters for flavocytochrome b 2 wild-type (from 39 , 
N42C:K324C mutant (open and closed conformations) (from ) , and N42C and 
K324C mutants 
With both ferricyanide and cytochrome c as electron acceptors the single mutants 
behave in a similar way to the N42C:K324C open form of the enzyme. These results 
confirm that is only the cross-linked formation that deeply affects the enzyme's 
activity. When the disulfide bridge is formed, there is a decrease of 15-fold or more 
in the 	values and a significant decrease of the catalytic efficiency (k cat/Km), 
compared to the N42C:K324C open form and to the two single mutants. 
From these data it is possible to conclude that the disulfide bridge, preventing the 




Steady-state and pre-steady-state kinetic analyses from Drewette (2006) 38  indicate that 
the rate of flavin reduction by L-lactate is influenced by the formation of the disulfide-
bridge. Inter-domain mobility does not seem to play a direct role in cytochrome c 
reduction. However, cross-linking the b2-heme and flavin-binding domains clearly 
effects the efficiency of this reaction. 
The crystal structure of the flavocytochrome b2 N42C:K324C mutant, solved at 10A 
resolution, confirms the presence of the disulfide bridge. From a crystallographic point 
of view, the major effect of locking these two domains together was the observation of 
clear electron density for the cytochrome domain in each of the four subunits. Notably, 
although the crystals were grown in the presence of 50 mM pyruvate, in the final 
structure the substrate electron density was not distinguishable at the active site. 
From the above data, including the crystallographic observations, it appears that in the 
wild-type enzyme the b 2-heme domain must move away from the flavin-domain in order 
to allow the substrate to access the active site. The engineered disulfide-bridge between 
the b2-heme and flavin-binding domains prevents mobility of the cytochrome domain 
and blocks the pathway taken by the substrate to the active site. 
When the disulfide bond is cleaved by DTT addition, or in the single N42C and K324C 
mutations, the enzyme behaves again in its native manner, confirming that flexibility in 
the hinge region is required for efficient substrate access. 
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Crystallographic studies on rat neuronal nitric oxide synthase 
heme domain mutant G586S 
6.1 Introduction 
As was already mentioned in section 1.5.4.1, the cytochrome P450 superfamily 
includes a wide variety of different enzymes. 
In a broad sense nitric oxide synthases (NOSs) could be considered as part of the 
cytochromes P450 family. Both cytochromes P450s and NOSs are mono-oxygenases, 
they share the same spectroscopic properties, they both have a b-type heme in the 
active site (which is cysteine thiolate-ligated), they exhibit similar catalytic 
intermediates, and, notably, mammalian NOS oxygenase domain (NOS0) and P450s 
receive electrons from the same redox partner . 
The reason why NOSs are not included in the P450s group is that apart from the 
above mentioned general characteristics, NOSs and P450s have little in common. 
NOSs are obligatory dimers while most of the P450s are monomers. 
The polypeptide chain of mammalian NOSs includes both a P450-like 
oxygenase domain and a cytochrome P450-like reductase domain. 
The activity of NOS depends on the presence of a cofactor 
(tetrahydrobiopterin (1-1413)) that acts both as a dimerization factor and as an 
auxiliary proton donor 2  Interestingly, H4B is not required in cytochrome 
P450 catalysis 3. 
Furthermore, substrate specificity is very different, because NOS catalysis is only 
limited to arginine, N°-hydroxy-L-arginine (NOHA) and few other substrate 




6.2 Nitric oxide synthase 
NOS catalyzes the hydroxylation of L-arginine (L-Arg) producing NO and citrulline 
in two reaction cycles 6  In both cycles a molecule of oxygen is consumed . Both 
steps require electrons (two electrons in the first and one electron in the second step) 
that are provided by the reductase domain via the two flavin cofactors (FAD that 
accepts two electrons directly from NADPH, and transfers one electron at a time to 
the heme via the FMN). 
The enzyme consists of a C-terminal flavin-binding domain, containing binding sites 
for the redox cofactors NADPI-I, FMN, and FAD (fig 6.1a), and an N-terminal b-
heme domain, that contains the active site (fig 6. ib). The two domains are connected 
by a 20-25 amino acid functional loop that binds calmodulin (CaM) . In mammalian 
neuronal NOS (nNOS) there is an additional N-terminal domain, located upstream 
from the heme domain that is the PDZ domain . 
Fig 6.1: Crystal structure models of nNOS. a) Reductase domain (PDB entry 1F20) 
101  b) oxygenase domain (PDB entry 10M4) He/ices are represented in red, loops 
in green and /3-sheets in yellow. NADPH, FMN, FAD, heme, H 4B and L-Arg are 
represented as stick (colour code: grey, carbon, blue, nitrogen, orange, oxygen). 
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Details of the structure of the reductase domain can be found in Zhang, J., et al. 
The x-ray crystal structure of substrate-bound NOS shows that both the substrate and 





Fig 62: The active site of rat nNOS. Here are shown some of the residues involved 
in interactions between the bound L-Arg, the cofactor H4B, the heme (color code: 
carbon in grey, nitrogen in blue, oxygen in red), and the active site residues (color 
code: carbon in green, nitrogen in blue, oxygen in red, and sulfur in yellow) (PDB 
ently 10M4) 
6.2 P450 and NOS reactions 
The catalytic mechanism of NOS has been proposed based on the better-known 
mechanism of cytochrome P450 
1345  In this section the P450 and NOS catalytic 
cycles are described in parallel,highlighting similarities and differences. However, it 
should be noted that the NOS reaction consists of two reaction cycles, while the P450 
reaction involves only one. 
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Substrate binding and first electron delivery 
• The initial step in P450 catalysis is the binding of substrate at the 
active site. This event corresponds to the expulsion of a water 
molecule bound to the heme and as a consequence induces a positive 
shift in the heme reduction potential. P450 is at this point more easily 
reduced to its ferrous form by electrons derived from its redox partner 
NAD(P)H. Such a mechanism prevents P450s from entering into an 
uncoupled cycle when substrate-free. Only the ferrous forms are 
capable of binding molecular oxygen, forming the oxy-ferrous 
compound (Fe2 -O2). 
• NOS does not depend entirely on substrate binding for the shift in the 
reduction potential of the heme, which is already partially high spin, in 
particular in the presence of H4B 16  Nevertheless, the reduction 
potential of the heme increases when the substrate binds to the active 
site. As already mentioned in section 6.1, NOS does not require an 
external redox partner, but it receives the electron from its reductase 
domain via the flavin cofactors. 
Oxygen binding 
• Both P450 and NOS bind 02 after heme reduction. 
Second electron delivery 
• At this stage, the oxy-ferrous complex is reduced by a second electron. 
In P450s reaction, the second electron is delivered by NAD(P)H-
bound protein, producing the peroxy-ferric species (Fe 3tOO2). 
• In contrast, the reaction of NOS at this stage involves the donation of 
one electron from H4B 17,18  The involvement of H4B in NOS reflects 
the most important difference in its catalytic cycle compared to P450. 
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Protonation and oxy-ferryl species formation 
• The reaction in P450 continues with two protonations, the first of 
which produces a hydroperoxy-ferric intermediate (Fe 3 -OOH), that 
accepts the second proton and, by losing a water molecule, produces 
the highly reactive cationic oxy-ferryl species (Fe 4 =O). 
• At this stage, 114B in NOS has been suggested to be involved in the 
proton transfer, together with a heme propionate and a conserved 
glutamic acid side chain (G1u363) 19  Although in NOS there is no 
evidence for the production of the hydroperoxy-ferric intermediate 
(Fe3tOOH) after the second electron delivery, a similar superoxy-
ferrous species has been observed 20  This putative hydroperoxy-ferric 
intermediate is thought to be the reactive species in NOS, but it has 
never been directly observed. Indeed, the peroxy-ferric complex could 
be the active species. 
Product form ation 
• As the P450 reaction proceeds, the oxy-ferryl (Fe 4 =O) compound 
creates a substrate radical by abstraction of a hydrogen atom. The 
heme (at this point in a hydroxy-ferric form) and the substrate radical 
rebind through the central oxygen, forming a hydroxylated product 
that dissociates successively from the heme, which remains in its ferric 
form 21-23 
• In NOS the putative double protonation of the peroxy-ferric complex 
weakens its oxygen-oxygen bond, and this eventually breaks to 
broduce a water molecule. The process lead to the formation of the 
oxy-ferryl (Fe4 =O) compound, which can attack the arginine nitrogen 
(or the hydroxylated nitrogen of N-hydroxy-L-arginine in the second 
cycle) to form NOHA in the first cycle and NO and citrulline in the 
second cycle. The heme is oxidised prior to the release ofNO, because 
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Fig 6.3: Overall of NOS reaction scheme (from 
24)  The reaction of NOS described in 
the text is here divided by colour code. In yellow are illustrated steps 1 (substrate 
binding and first electron delivery) and step 2 (oxygen binding). In orange is shown 
step 3 (second electron deiive,y), and in red, steps 4 and 5 rotonation, oxy.-ferryl 
species formation and product productions). The electron transfers are shown in 
green, reductions being light green and oxidation darker green. 
The structures of three transient intermediates in the hydroxylation reaction of 
camphor (cam) by P450cam have been recently solved by crystallographic 
techniques, in combination with data collection using sequentially short and long 
wavelength x-rays 25 
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tTyr96 Asp251 Tyr96 	
Asp251 Tyr96 	Asp251 
Owl 	
cam am cam(prod) ' 
I 
2Trir252 
Thr1O '-* timr252 Thr1O1, 
Cys357 G1u366 ' Cys357 Cys357 G1u366 
a b c 
Fig 6.4: (',:''sea/ 1,licFiire.s u/three I1'UILS1CI!l inierniediates in the reactiuii u/J'450cam 
from Pseudomonas putida (a, b, and C). The 02 complex was obtained by exposure to 
a high pressure 0/02/usi be/bre flash cooling. The first dataset (ci) was collected with 
shoil -wavelength x-rays to minimize reduction of the heme. The result is the structure 
of the oxygen bound complex of P450cam (PDB entry JDZ8). The second data set (b) 
was collected cl/icr illuminating the same crsial used/br (a) /br 3 hoiwc with long-
wavelength x-ravs to produce hydrated electrons, and consequently driving the 
reaction toward the reduced, activated oxygen intermediate. The result is OXO-
complex of P45Ocani (PDB entry JDZ9). The third dataset (c) was collected a/icr 
thawing and refree:ing the sanie crystal. Thi.c final data correspond to the product 
complex (PDB entry IDZ6). 
Cam represents the substrate, while cam (prod) is the final product of the reaction 
25 
The process of redox partner recognition and the reaction mechanism of P45 Os have 
been crucial and interesting problems for P450 investigations. Although the 
structures of several members of the P450 family have been solved 
21, 26. 27 the 
question of how P450s interact with their redox partners and the precise nature of the 
reaction mechanism still remains to be answered 
28 
Conclusions about the reaction mechanism of NOS are even more difficult to draw. 
The intermediate species formed in the catalytic site have been identified only up to 
the formation of the oxy-ferrous species 
20  The events taking place after that are not 
clear, and this is due in particular to the lack of accumulation of the intermediates 











6.3 Neuronal NOS OXV G586S mutant 
More information on the nature of the transient species formed during the NOS 
reaction could contribute to a better understanding of the mechanism. In the past, 
several approaches have been used in order to identify the intermediates generated 
upon oxygen activation in the NOS catalytic site. The catalytic reaction has been 
analysed at very low temperature in an attempt to trap and isolate the intermediates 
20, 29 Furthermore, H4B analogues have been used to characterize the reaction 
activated by the second electron transfer 30, 31 
Fig 6.4: The active site of rat nNOS. All the interactions between the active site 
residues and the substrate L-Arg are shown (PDB entry 10M4). 
As already described in section 6.3, NOS and P450 reactions are similar. However, 
from analysis of the active site residues of NOS u  it is clear that the amino acid 
residues localized at the distal side of the heme reveal a hydrophobic character fig 
6.4b). This observation is in contrast with the cytochrome P450 active site, where 
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hydrophilic residues are predominant, and play a key role during the activation of 
oxygen. 
In NOS, the introduction by site-direct mutagenesis of a hydrophilic amino acid 
residue, close to the substrate binding site, could stabilize the transient species of the 
reaction, by forming hydrogen-bonding interactions with them. 
Indeed, the mutant of rat neuronal NOS OXY where glycine 586 was replaced by a 
serine residue (nNOS0 G586S) showed the capability to stabilize an intermediate of 
the reaction that is formed after the oxyferrous compound 24 
In Papale D., 2008 24  it was observed that the G586S mutation has altered the UV-
Vis spectroscopic spectrophotometric characteristics of the mutant in comparison 
with the wild type enzyme. The spectroscopic, electrochemical and catalytic 
behaviour of the mutant was tested thoroughly under a variety of conditions and 
analyzed in comparison with the wild type 24  As part of this project structural studies 
were conducted on the nNOS 0,, G586S mutant. 
In this chapter the crystal structure of the nNOS 0 , G586S mutant is described, 
solved in complex with L-Arg to 2.6 A resolution. The crystal structure confirms the 
presence of the serine mutation and reveals the interactions between the Ser586 and 
the substrate. 
6.4 Results 
6.4.1 Genetic manipulation 
The neuronal NOS heme domain G586S construct was created by Dr. Caroline S. 
Miles, at the Institute of Structural and Molecular Biology, University of Edinburgh. 
The NOS G586S heme domain mutant was generated by site-directed mutagenesis 
using the Kunkel method 32  The E.coli strain BL21 was used for the expression of 
G586S mutant construct using plasmid pCRNNR An N-terminal 6-His tag was 



















The G586S mutant of the nNOS heme domain was expressed and purified as 
descnbed in Ost, T. and S. Daff, 2005 
30 
For crystallographic studies the purification protocol was modified, following the 
procedure described in H  in order to obtain a higher degree of purity of the 
preparation. 
Cell lysate containing nNOS 0 G586S mutant was loaded into a HisTrap 1-IP column 
(GE Healthcare), equilibrated with 50 mM sodium phosphate buffer at pH 7.8 
containing 10% glycerol, 1 mM dithiothreitol (DTT), 20 l.LM H4B, 0.1 mM L-
arginine, 0.3 M NaCl, and 20 mM imidazole. The protein was eluted from the 
HisTrap HP column using a 100-150 mM imidazole step gradient using 5 bed 
volumes of 50 mM sodium phosphate buffer at pH 7.8 containing 10% glycerol, I 
mM DTT, 20 pM H4B, 0.1 mM L-Arg, 0.3 M NaCl, and 500 mM imidazole. 
mw (kDa) 
a 	 Volume (ml) 
Fig 65: a) A280 trace (blue) from HisTrap HP purification and elution gradient trace 
(green). The corresponding fractions of the peak were analysed by SDS-PAGE (b). 
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The colored elution peak fractions were pooled together and dialyzed overnight at 
4°C against buffer 1 (HIEPES 50 mM pH 7.5, 10% glycerol, 1 mM DTT, 20 M 
H4B, 0.1 mM L-Arg and 0.25 mM PMSF). 
A HITrapQ FF anion-exchange column was equilibrated with five bed-column 
volumes of the buffer 1. Post-dialysis fractions from HisTrap 1-IP were loaded onto 
the HTTrapQ FF column. The column was washed with 2 bed-column volumes of 
buffer 1 containing 100 mM NaCl. The protein was then eluted with a 100— 300 mM 
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Fig 66: a) The elution profile from ion exchange chromatography using a HITrapQ 
FF column. A280 trace is represented in blue and elulion gradient trace in green. The 
target enzyme peak can be seen on the elution profile and the corresponding 
fractions were analysed by SDS-PAGE (b) 
The G586S mutant nNOS heme domain used for crystallographic studies was 
produced by a limited trypsin digestion of the protein after the Ni- and Q-Trap 
column steps. 
Neuronal NOS PDZ domain is composed of a 6-stranded anti-parallel 3-barrel and 2 
34 a-helices (fig 6.7a). Due to its high mobility, no structure of nNOS has been solved 













The trypsin digestion was carried out by incubating the partially purified protein on 
ice for 8 h with a nNOS:trypsin (weight) ratio of 100:1 under continuous stirring. 
The results of partial trypsin proteolysis were analyzed by SDS-PAGE and 
undigested enzyme was used as a comparison (fig 6.7b). As expected, the difference 
in molecular weight between the digested and undigested enzyme was 15 kDa. Such 
a molecular weight corresponds to the removed PDZ domain. 
Heme domain 
417 residues 
mw- 50 kDa 
Fig 6.7: a) Illustration of the Irypsin digestion of nNOS0.,, where the PDZ domain is 
cleaved from the heme domain, b) comparative analysis by SDS-PA GE of the Irypsin 
digestion product (2) with the undigested protein (1). 
The digested protein was then further purified through a Superdex 200 column 
equilibrated with 50 mM TrisHCl, pH 78, containing 10% glycerol, 10 mM DTT, 20 
ptM H4B, 0.1 mM L-Arg, and 200 mM NaCl (fig 6.8). The protein eluted at a volume 
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Fig 6.8: The elution pro/lie from gel-filtration chromatography using a Superdex-
200 10/30 column for nNOS0- G586S mutant (blue) overlaid with the elution profile 
of the molecular weight markers (cyan). The elution peak appears to be broad and 
asymmetric, due to the heterogeneity of the sample after Irypsin digestion. However, 
only the fraction of the elution peak in between the two red arrows were pooled 
together and concentrated. 
The nNOS heme domain produced from trypsin digestion retains the 6-1-lis tag. 
Protein concentration was determined spectrophotometn cally exploiting the 
absorbance difference between the ferrous and the ferrous CO-bound forms 
(extinction coefficient Ac 444..467= 55, 000 M'cm') 
30, 
6.4.3 Crystallization 
A critical reason that finally increased the crystallization rate of nNOS0, compared 
to the initial attempts, has been the improvement of the purification protocol and the 
exclusive use highly homogenous sample for crystallization experiments. 
Furthermore, the crystallization experiments were entirely performed in the 
anaerobic box (although the protein was not reduced) including the flash-cooling 
step. Finally, it was noted that all the crystals flash-cooled using liquid propane as a 
freezing agent instead of liquid nitrogen yielded a higher quality of the diffraction. 
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Crystals of G586S mutant of nNOS heme domain were produced by the hanging-
drop or sitting-drop vapour diffusion methods at 18°C, by mixing 2 .tl of 7-9 mg/mI 
protein (in 50 mM TrisHCl, pH 7.8, 10% glycerol, 10 mM DTT, 20 l.IM I-LB, 0.1 
mM L-Arg, and 200 mM NaCI) with 2 tl of reservoir solution (0.1 M pH 5.8/6.0 
MIES, 22-24% PEG 3350, 0.2 M ammonium acetate, 25 mM L-Arg, 35 .iM sodium 
dodecyl sulfate (SDS), 5 mM glutathione (GSH), 2% isopropanol). 





Fig 6.9: ('rystals of the G586S NOSOXJ, grown in a 4 p1 volume sitting drop 
6.4.4 Freezing procedure 
Crystals of the His-tagged G586S nNOS heme domain were washed with reservoir 
solution and then exposed to increasing amounts of cryoprotectant in a step-wise 
fashion. The final cryoprotectant solution consisted of 25% (w/v) PEG 3350, 0.1 M 








trehalose, 5% (w/v) sucrose, 5% (w/v) mannitol and I niM L-Arg . Crystals were 
flash-cooled in liquid propane as described in section 3.20 for TDO crystals 
36• 
6.4.5 Data collection 
The best dataset was collected to 2.59 A resolution at 100 K at the ERSF (Grenoble, 
France) on beam line BMI4 (wavelength A. = 0.9737 A) using a Mar Research CCD 
detector. 
b 
Fig 6.10: a) Crystal snapshots on beam line BMJ 4, ESRF. b) Diffraction pattern qf 
NOS G586S mutant crystal. Oscillation range 1.00,  Exposure time 30.0 s; detector 
distance 269.4 mm; resolution at corner 2.5 A; resolution at edge 3.54.4. 
Crystal were found to belong to space group P2 1 2 1 2 1 with cell dimensions a = 
51.9630 b = 110.8470 c = 164.6270 a=/3= 90. 
Data processing was carried out using MOSFLM and SCALA . The structure 
was solved by molecular replacement using PHASER and the wild-type nNOS0 
structure (PDB entry I 0M4), stripped of water, was used as a starting model. 
Electron density fitting was carried out using the programs TtJRBO-FRODO ° and 




6.5 The crystal structure of G586S nNOS 
A dataset to 2.59 A resolution was used to refine the structure of G586S nNOS heme 
domain to a final R-factor of 19.8% (R&ee = 25.3 %, table 6.1). 
The fmal model consists of two protein molecules each comprising residues 299-716 
and one b-heme. In addition each subunit contains one H4B molecule bound in the 
cofactor binding pocket (fig 6.111) and one L-Arg bound in the active site. 
Fig 6.11: the 2F0 —Fc electron density map around the H4B. The map is contoured at 
I a. In this figure are also shown some relevant residues binding the cofactor. 
Residues in green belong to the same monomer, while residues in blue belong to the 
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Table 6.1: Data collection and refinement statistics Values in parentheses represent 
statistics for the highest resolution shell a Rm erge = 1(h) - Ij(h) 1 EjXj,(h), where 
11(h) and 1(h) are the ith and nean measurement of reflection h, respectively. b Rw0rk 
= EhIFQ - FI/ EhF0, where F0 and Fc are the observed and calculated structure 
factor amplitudes of reflection h, respectively. C Rfree is the test reflection data set, 5 
% selected randomly for cross validation during crystallographic refinement. 
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The presence of the amino acid substitution (G586S) is apparent from the electron 
density around residue 586 (fig 6.12). 
Fig 612: Stereoview of electron density around the heme, serine 586, and L-Arg at 
the active site of G586S nNOS (monomer A). The electron density map was 
calculated using Fourier coefficients 2 F0 - F, where F0 and Fc are the obseri'ed 
and calculated structure factors, respectively, the latter based on the final model. 
The contour level is 1.0 o where a is the rms electron density 
The substitution in the active site has little effect on the overall structure of the 
protein. The rms (root-mean-square) deviation of the backbone a-carbon the atoms 
of each monomer with those of each monomer of the wild-type enzyme structure 
(PDB entry 10M4) is only 0.3 A. An overlay of the monomer of G586S mutant with 
the wild-type is shown in fig 6.13. 
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Fig 6.13: Overlay of nNOS0 3. wild-type (orange, PDB entry 10M4) and G586S 
mutant (blue). The hemes and the H 4B are represented as sticks and coloured 
respectively dark red and yellow. The Zn atom at the dimer interface is represented 
as a sphere. The substrates bound at the active site are coloured according to the 
chain colour. 
The binding orientation of L-Arg at the active site of the G586S mutant enzyme is 
very similar to that observed in the wild-type nNOS0, model. Figures 6.14 and 6.15 
show the active sites of the wild-type and the G586S mutant structures with L-Arg 
bound. The occupancy of L-Arg in the mutant is 100% with an average B-factor of 
34 A2 . B-factors are consistent with 100 % L-Arg occupancy because the contacting 
atoms between L-Arg and the protein have similar B-factor values. No restraints on 
B-factors were applied. 
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Fig 6.14: Stereoview of an overlay of the active site region of wild-type nNOS 
(orange) and G586S mutant (blue) viewed from the top. L-Arg from the G586S 
enzyme (in blue) and L-Arg from the wild-type display the same position in the active 
site. 
Fig 6.15: Stereoview of an overlay of the active site region of wild-type nNOS 
(orange) and G586S nNOS TDO (blue) viewed from the side. 
From the kinetic characterization of the nNOS0 G586S mutant it was possible to 
observe the formation of a novel reaction intermediate in the presence of H413 and 
substrate, subsequent to the formation of the oxy-ferrous compound 24  If this 
observation is due to the introduction of a new interaction in the active site, it is 
likely that this would be a hydrogen bond between Ser586 and the substrate. 
As shown in fig 6.16, L-Arg maintains the same interactions with the G586S enzyme 
that it has with the wild-type enzyme. However, the distance between the 
guanidinium nitrogen of L-Arg and the side chain oxygen of Ser586 is 2.9 A, in line 




Fig 6.18: The active site of the nNOS 0. G586S mutant, showing some of the 
interactions between the bound L-Arg and the active site residues, that are the same 
as observed in the wild-type enzyme structure. The new hydrogen bond between L-
Arg and Ser586 is represented in cyan as a dotted line. 
The affinities of NOSOXJ  wild-type for L-Arg and NOHA are very similar (table 6.2), 
while the G586S mutant displays increased affinities for both substrates. 
NOS G586S NOS wild-type 
Kd4NI) Kd(M) 
L-Arg 	 010=005 1.0±0.1 
NOHA 	 0.5±0.1 0.9±0.1 




Interestingly, in the G586S enzyme the affmity for L-Arg is a factor of 10 greater 
then in wild-type, while the affmity for NOHA is only doubled in the G586S enzyme 
(data from Papale D., 2008 24) 
This comparison suggests a new capability for L-Arg of forming a supplementary 
hydrogen bond induced by the presence of Ser586. 
NOHA, on the other hand, has a slightly greater volume due to the additional 
hydroxyl group, which can clash with the oxygen of Ser586. This may negatively 
affect its binding in the catalytic site. 
A model of the active site, built by overlaying NOHA with the L-Arg in the crystal 
structure, can help to visualize and explain substrate specificities and affinities. 
Such a model has been built only for only illustrative purposes, and is obviously not 
taking into account the residue motion that can occur upon NOHA binding. The 
crystal structure of nNOS0 G586S in complex with NOHA would certainly provide 






Fig 6.19. Model of nNOS0x in complex with NOHA created by placing the NOHA 
over the bound L-Arg. It is possible to observe that in this model the additional 
hydroxyl group of NOHA clashes with the oxygen of Ser586 
6.6 Ternary complexes with dioxygen analogs in crystals 
Diatomic molecules such as NO and CO bind to the nNOS heme ". Structural 
characterization of their binding has been important as a source of information about the 
binding manner of oxygen in the very unstable oxy-heme complexes In addition, NO 
binding to the heme is important, as part of the catalytic cycle Although not 
physiologically relevant, the CO binding mode to the heme provides information on the 
normal functioning of NOS, because its binding mode at the heme is more similar to that 
assumed by oxygen 
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Affmities of both NO and CO in the wild type and G586S mutant enzyme have been 
measured under different conditions 24  NO binding to wild-type enzyme has been 
reported only with ferric heme, because the affinity of NO for ferrous heme is too high 
to be determined using standard techniques 24  CO shows a high affinity only for ferrous 
heme, while the binding affinity for ferric heme is too low to be interesting. 
No substrate L—Arg 	NOHA 
G586S Kd (j.t1) 	1.8 ± 0.1 	3.2 ± 0.2 	2.2 ± 0.2 
wt Kd (p.M) 	2.5 ± 0.2 	6.9 ± 0.4 20.3 ± 1.8 
Table 6.3: Dissociation constants offerric wild type and G586S nNOS for nitric oxide in 
the absence and presence of substrates (L-Arg and NOHA). From Papale D., 2008 24 
No substrate 	L-Arg 	NOHA 
G586S Kd(.LM) 	11.5 	1.5 	2.9 0.3 	2.6±0.2 
wt K (tiM) 	10.4 ± 1.0 	21.4 ± 2.3 30.8 ± 1.9 
Table 6.4: Dissociation constants of ferrous wild type and G586S nNOS for carbon 
monoxide in the absence and presence of substrates (L-Arg and NOH4). From Papale 
D., 200824. 
The G586S mutation does not cause a significant change in the values of the binding 
constants for each diatomic molecule in the absence of substrate, but there are 
differences between the wild-type and mutant enzymes concerning their binding 
affinities when the enzyme is complexed with the substrates (table 6.3 and 6.4). 
Indeed, the substitution increases the affinity for the diatomic ligand by a factor ranging 
from 2-fold (difference for NO binding to L-Arg-bound enzymes), to 12-fold (CO 
binding to NOHA-bound enzymes). 
Such a difference is probably due to the newly formed hydrogen-bond in the active site 
of the enzyme. The different values can be explained by the slightly different positions 
of the substrates in the ternary complex. In the G586S mutant, substrates can possibly 
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assume a position closer to the heme and form a tighter hydrogen bond with the heme 
sixth ligand. 
In an attempt to obtain the structure of the ternary complex of nNOS 01 G586S with 
substrate and a diatomic ligand (nNOS0-L-Arg-NO or nNOS0-L-Arg-CO), crystals 
were brought inside an anaerobic glove box. Crystals were reduced during the 
cryoprotection procedure, using a cryoprotectant solution because was used a freezing 
solution (see section 6.4.4) containing 10 mM DIT After reduction, crystals were 
mounted in a pressure chamber (see fig 3.27) and exposed to high pressures of each 
diatomic gas. Soaking proceeded for 5, 10 or 15 minutes, as described in section 3.13 for 
TDO, before flash-cooling in liquid propane 36 
Although several datasets for crystals soaked with diatomic ligands were collected, we 
did not observe the binding of these dioxygen analogs in the structures. This was mainly 
due to the poor diffraction quality of the crystals exposed to the high-pressure chamber. 
6.7 Conclusions 
The detection of a novel reaction intermediate during the G586S nNOS0,, catalytic 
reaction, subsequent to the generation of the oxy-ferrous compound, has been previously 
reported (Papale D., 2008) 24  The 2.6 A resolution crystal structure of G586S nNOS0 
confirms the presence of the mutation and reveals new active site geometries due to the 
formation of a hydrogen bond between the side chain of the introduced serine 586 and 
the bound L-Arg. 
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• The crystal structure of TDO from X campestris in complex with its natural 
substrate has been solved to 1.6 A resolution, showing the exact positioning of 
the substrate in the active site and explaining the substrate specificity of TDO. 
The structural information, integrated with biochemical studies, allow the 
identification of potentially important active-site residues. 
• Significant effort has been invested in order to obtain the crystal structure of 
the ternary complexes of TDO with L-Trp and or NO. This data would have 
provided important insights into the structure of the Michaelis complex. As 
such, it would be interesting to continue the structural work in this direction, 
to investigate the effects of diatomic ligands binding into the active site. 
• Another important point that still remains obscure is the presence of the 
allosteric binding site of tryptophan. Again, the combination of kinetic and 
structural information on mutant forms of the enzyme, where the residues 
interacting with the second tryptophan are mutated, will clarif' if there is any 
functional role of such putative allosteric binding site. 
• We have also determined at 2.4 A resolution the structure of the S04414 
protein (sIDO) from Shewanella oneidensis. Anyway, very little is yet known 
about substrate binding in S04414. Future work will be addressed on attempts 
to crystallize S04414 in complex with a substrate or an inhibitor. 
• The question behind chapter 3- why is there such a strict substrate specificity 
in TDO compared with IDO and which is the mechanism of catalysis? was 
then only partially answered. Although we have sufficient elements to explain 
the substrate specificity of TDO, on the other side the catalytic mechanisms of 
TDO and IDO have, so fur, not been completely understood. For TDO it has 
been proposed that its reaction mechanism involves the base-catalyzed 
deprotonation of the indole nitrogen of the substrate. 
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• Indeed, compared with DO structure, the most obvious difference between 
the active sites of the two enzymes is the presence of His55 in TDO and its 
equivalent Serl 67 in [DO. In order to answer the question - is the active site 
histidine 55 hydrogen bonded to L-Trp implicated as the active site base in 
TDO?- a crystallographic study of a X campestris TDO mutant, where the 
active-site residue histidine 55 has been substituted by alanine has been 
conducted. The structural data, in conjunction with potentiometric and kinetic 
studies on the mutant have provided information on the mechanism used by 
TDO to control substrate binding. Our data indicate that His55 does not 
assume the role of active site base, but instead reveal a role for His55 in 
controlling substrate binding at the active site, significantly decreasing the 
affinity of the oxidised enzyme for substrate and regulating the binding of 
dioxygen. 
• The crystal structure of the flavocytochrome b2 N42C:K324C mutant, solved 
at 3.OA resolution, confirms the presence of the disulfide bridge. The major 
effect of locking these two domains together was the observation of an ordered 
cytochrome domain in each of the four monomers of the enzyme. 
Interestingly, despite the crystallising conditions containing 50 mM pyruvate, 
the presence of the substrate was not observed at the active site in our crystal 
structure. 
• The question posed on chapter 5 was - why is there inter-domain mobility in 
flavocytochrome b2 and is it important for catalysis? From our data it appears 
that the role of inter-domain mobility is to allow the b2-heme domain to move 
away from the flavin-binding domain in order for substrate to effectively 
access the active site. Cross-linking the b2-heme and flavin-binding domains 
prevents mobility about the cytochrome domain and essentially disrupts the 
usual pathway taken by the substrate to the active site. On reduction of the 
disulfide bond by DTT, or in the single N42C and K324C mutations the 
enzyme is again able to behave in its native manner, indicating its requirement 
for dynamic flexibility about the hinge region. 
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• The 2.6 A resolution crystal structure of G586S nNOS0,, confirms the 
presence of the mutation and reveals the formation of a new hydrogen bond 
between the side chain of the introduced serine 586 and the bound L-Arg. 
Future efforts should be certainly addressed to obtain the crystal structure of 
nNOS0,, G586S in complex with N-hydroxy-L-Arg in order to understand 
the reason of the different binding affinity for the two substrates. 
Another future goal will be the structural characterization of nNOS 0, in 
ternary complex with a substrate and diatomic ligands, such as NO or CO. 
This has already represented an important source of information about the 
binding manner of oxygen in the very unstable oxy-heme complexes. In 
particular, the CO binding mode to the heme will provide information on the 
normal functioning of NOS, because its binding mode at the heme is more 
similar to that assumed by oxygen. 
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Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxyge-
nase (IDO) constitute an important, yet relatively poorly under-
stood, family of heme-containing enzymes. Here, we report ex-
tensive structural and biochemical studies of the Xanthomonas 
campestris TDO and a related protein S04414 from Shewanei!a 
oneidensis, including the structure at 1.6-A resolution of the 
catalytically active, ferrous form of TDO in a binary complex with 
the substrate L-Trp. The carboxylate and ammonium moieties of 
tryptophan are recognized by electrostatic and hydrogen-bonding 
interactions with the enzyme and a propionate group of the heme, 
thus defining the i-stereospecificity. A second, possibly allosteric, 
i-Trp-binding site is present at the tetramer interface. The sixth 
coordination site of the heme-iron is vacant, providing a dioxygen-
binding site that would also involve interactions with the ammo-
nium moiety of L-Trp and the amide nitrogen of a glycine residue. 
The indole ring is positioned correctly for oxygenation at the C2 
and C3 atoms. The active site is fully formed only in the binary 
complex, and biochemical experiments confirm this induced-fit 
behavior of the enzyme. The active site is completely devoid of 
water during catalysis, which is supported by our electrochemical 
studies showing significant stabilization of the enzyme upon 
substrate binding. 
cancer I heme enzymes I immunomodulation I indoleamine 
2,3-dioxygenase 
T ryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3- dioxygenase (IDO) catalyze the oxidative cleavage of the 
L-tryptophan (L-Trp) pyrrole ring, the first and rate-limiting step 
in L-Trp catabolism through the kynurenine pathway (1-3). In 
addition, IDO has been implicated in a diverse range of physi-
ological and pathological conditions, including suppression of T 
cell proliferation, maternal tolerance to allogenic fetus, and 
immune escape of cancers (4-8), and is an attractive target for 
drug discovery against cancer and autoimmune and other dis-
eases (2, 9-12). 
Despite catalyzing identical biochemical reactions (Fig. la), 
the sequence similarity between TDO and IDO is extremely low. 
An alignment of their sequences is only possible based on their 
structures, which suggests a sequence identity of 10% between 
them (Fig. lb). In comparison, Xanthomonas campestris TDO 
shares 34% sequence identity with human TDO (Fig. lb), 
demonstrating the remarkable evolutionary conservation of this 
enzyme. TDO is a homotetrameric enzyme and is highly specific 
for L-Trp and related derivatives such as 6-fluoro-Trp as the 
substrate. In comparison, DO is monomeric, and shows activity 
toward a larger collection of substrates, including L-Trp, D-
tryptophan (D-Trp), serotonin, and tryptamine (3), although the 
Km for D-Trp is "100-fold higher than that for L-Trp (13). The 
structure of human IDO in the catalytically inactive, ferric 
[Fe(ffl)]-heme state in complex with the 4-phenylimidazole 
inhibitor has recently been reported (14). Although this struc-
ture gave information about important active site residues, the  
inhibitor is coordinated to the heme iron and does not provide 
any information regarding Trp or oxygen binding. 
To provide direct insight into substrate recognition and ca-
talysis by these enzymes, we report here the crystal structures at 
up to 1.6-A resolution of the active, reduced (Fe(II))TDO from 
X campestris in a binary complex with the substrate L-Trp or 
6-fluoro-Trp. Our structures reveal for the first time the struc-
tural basis for the stereospecificity of this important enzyme. Our 
structural information is confirmed by biochemical studies and 
offers significant molecular insight into tryptophan dioxygen-
ation by TDO and 11)0. 
Results 
Structure Determination. Crystals of the reduced (Fe(II)) TDO 
from X cam pestris in a binary complex with the substrate L-Trp 
or 6-fluoro-Trp were obtained after extensive efforts and by 
using anaerobic conditions, because the oxidized (Fe(III)) en-
zyme has much lower affinity for L-Trp (see below). The 
structures at up to 1.6-A resolution of these binary complexes 
[Table 1; and see supporting information (SI) Table 3] as well as 
that of the free enzyme were determined by molecular replace-
ment based on the structure of the apo enzyme, in the absence 
of heme, which we had determined by the selenomethionyl 
single-wavelength anomalous diffraction method (PDB entry 
1YWO) (15). 
The structure of the S04414 protein from Shewanella onei-
densis (16) was determined at 2.4-A resolution by molecular 
replacement based on our structure of the apo enzyme (PDB 
entry 1ZEE). 
Structure of TDO. The structure of X campestris TDO monomer 
contains 12 helices (named aA through aL) and no 0-strands 
(Figs. lb and 2a). TDO is an intimately associated tetrainer (Fig. 
2b), and "4,500 A2  of the surface area of each monomer is 
buried in the tetramer. Helices aB and crC are located in the 
extensive, mostly hydrophobic interface between two of the 
monomers. The N-terminal segments (residues 21-40, including 
helix aA) of the two monomers are swapped in this dimer (Fig. 
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Fig. 1. Primary structures of TOO and IDO. (a) The biochemical reaction 
catalyzed by TDO and IDO. (b) Amino acid sequence alignment of K campes-
ti-is TOO (XcTDO), human TDO (HsTDO), S. oneidensis 504414 (504414), and 
human 100 (HslDO). The filled circles indicate residues involved in binding 
L-Trp, and the diamonds indicate residues involved in binding heme. The 
symbols for residues before helix iA are given different colors, to indicate that 
they are from another monomer of the tetramer. 
2b), which is important for the catalysis by TDO because several 
residues in this segment are part of the binding site for the Trp 
residue in the active site (Sc C below). 
Bklding Mode of the L-Trp Substrate to TDO. Our structure of the 
binary complex defines the molecular mechanism for the recogni-
tion of the L:rI-1) substrate by 1DO. Clear electron density , was 
observed for heme and i-Trp in the active site based on the 
crystallographic analysis at 1.6-A resolution (Fig. 3a). The i.-Trp 
substrate is located in a pocket over the distal face of the heme, 
having interactions with residues in heices aB and aD, and the 
aD—nE and nJ—aK loops (Figs. lb and 3b). The carboxylate group 
of Trp is recognized by hidentate ion-pair interactions with the side 
chain of Arg 117 (in helix aD). The carboxylate group is also 
hydrogen-bonded to the side chain hvdroxyl of Tyr 113 (helix csD) 
and the main chain amide of Thr 254 (nJ-aK loop). The ammonium 
ion of i.-Trp is recognized by the 7-propionate side chain of the 
heme group (Fig. 3b), and it is also hydrogen-bonded to the side 
chain hydroxyl of Thr 254. The indole ring is located '=35 A above 
and perpendicular to the heme and is held in place by van der Waals 
interactions with the side chains of Phe 51 (helix aB) and several 
other hydrophobic residues, including Tyr 24. lyr 27. and Leu 2N 







Fig. 2. The structure of TOO. (a) Schematic representation of the structure 
of the monomer of X. campestris TOO. The -helices are shown in yellow and 
labeled. Heme is shown in gray, and t-Trp is shown in orange (labeled W). The 
water molecule is shown as a red sphere (labeled wat). (b) Schematic repre-
sentation of the tetramer of X. campestris TOO. The four monomers are 
colored in yellow, cyan, violet, and green. Helices in the tetramer interface are 
labeled. The Trp molecules in the tetramer interface are also shown. Produced 
with Molscript (35) and rendered with Raster3D (36). 
(Fig. 3b). In addition, the NI nitrogen of the indole ring is 
hydrogen-bonded to the side chain of His 55 (helix all) (Fig. 3h). 
A water molecule is present in the active site of this binary 
complex (Fig. 3a), hydrogen-bonded to the ammonium ion of 
L-Trp and the main-chain amide of residue (ily 125 (Fig. 3h). The 
water is 3.5 A from the ferrous atom in the heme, too far for 
ligating interactions. The iron atom is still 0.3 A out of the plane 
of the hemc. on the side of the proximal His 240 ligand (SI 
Fig. 5). 
The crystal was exposed to a solution saturated with nitric 
oxide (NO) before being flash-frozen, but we did not observe the 
binding of this dioxygen analog in the structure. This is con-
firmed by our structure of the binary complex with 6-flu oro-Trp, 
which was not exposed to NO but contained the same density for 
the water molecule (SI Fig. 6). The structure of the 6-fluoro-Trp 
binary complex is essentially identical to that of the L-Trp binary 
complex (SI Fig. 6). NO probably dissociated from the heme 
during the ci-yofreezing manipulations in the anaerobic box. 
Induced-Fit Behavior of TDO. Our structural information suggests 
that TDO is an induced-fit enzyme. Although the active site 
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Table 1. Summary of crystallographic information 
TDO TDO TDO TDO 504414 S04414 
Protein (holoenzyme) (holoenzyme) (holoenzyme) (apoenzyme) (holoenzyme) (apoenzyme) 
Ligand L-Trp 6-fluoro-Trp None None None None 
Maximum resolution, A 1.6 1.8 2.7 2.7 2.4 2.3 
%* 6.9 (52.7) 8.6 (60.9) 13.0 (32.3) 16.6 (74.0) 10.4 (63.0) 6.6 (30.6) 
Beam line ESRF BM14 ESRF BM14 NSLSX4A APS 21BM NSLSX4A NSLSX4A 
Completeness, % 87 (65) 87 (61) 72 (54) 82 (68) 83 (60) 87 (71) 
Rfactor, %t 17.1 (18.9) 16.6 (17.9) 25.7 (25.7) 25.0 (32.1) 21.7 (23.5) 23.4 (26.7) 
FreeR factor, % 18.9 (22.0) 18.4 (21.1) 26.3 (26.2) 29.4 (35.1) 22.5 (24.1) 27.5 (31.5) 
rms deviation in bond 0.005 0.005 0.008 0.011 0.007 0.006 
lengths, A 
rms deviation in bond 1.0 1.0 1.2 1.6 1.1 1.0 
angles,° 
Most-favored region, % 92 91 89 86 92 91 
*Rm.rge = 	Ihj-(I,l/,,Ih,. The numbers in parentheses are for the highest-resolution shell. 
tR = 	- Fh9/t,Fh°. 
pocket is well defined in the binary complex (Fig. 3b), the aJ-aK 
loop, which helps to form the walls of this pocket, is disordered 
in the free enzyme, and the aD-aE loop has a somewhat 
different conformation (Fig. 3c; and see SI Fig. 7). Moreover, the 
Arg 117 side chain assumes a different conformation in the free 
enzyme (Fig. 3c). Upon recognition of the L-Trp substrate, a 
complex and extensive network of interactions is established 
(Fig. 3b), thus stabilizing the active site region. Although this 
region is exposed to the solvent in the free enzyme, it is 
completely shielded from the solvent in the binary complex, and 
only the carboxylate group of the 6-propionate of heme is visible 
on the surface. 
Additional evidence for the induced-fit behavior is observed 
in the active site of the second TDO monomer in the asymmetric 
unit. The binding mode of the L-Trp substrate is very different 
in this monomer (Fig. 3d; and see SI Fig. 7). The Trp side chain 
is not positioned as deeply into the pocket, and the hydrogen 
bond between the ring nitrogen and the side chain of His 55 is 
lost (distance of 3.8 A). Both nitrogen atoms are instead 
hydrogen-bonded to a water molecule, located 3.5 A from the 
heme iron but at a position distinct from that of the water in the 
active site of the other monomer (Fig. 3d). This conformation 
may also be stabilized by crystal packing interactions, as the 
7-propionate of heme is ion-paired with an Arg residue from 
another TDO tetramer in the crystal. The main chain atoms of 
the Tip substrate appear to be disordered, because no clear 
electron densitywas observed for them (Fig. 3e). Consistent with 
this finding, the aJ-aK loop is disordered in this molecule, 
similar to that in the free enzyme (Fig. 3d). This complex may 
represent an initial stage in the formation of the Michaelis 
complex of TDO. Proper positioning of the L-Trp substrate for 
catalysis would lead to the recognition of its main chain atoms 
and the ordering of the aJ-aK loop. 
Implications for Substrate Binding by IDO. Our structure of the 
binary complex of TDO also has significant implications for 
substrate recognition by the IDOs. The rms distance for 201 
structurally equivalent Ca atoms between TDO and the large 
domain of human 11)0 (PDB entry 2D01) (14) is 3.1 A (SI Fig. 
8), calculated with the program Dali (17). Despite sharing only 
10% overall sequence identity, key active-site residues are 
similar in TDO and IDO (Fig. lb; and see SI Table 4), and L-Trp 
may have the same binding mode to the active site of 11)0 (SI 
Fig. 9). Ionic interactions that are important for recognizing the 
L-Trp ammonium ion and carboxylate group are conserved in 
11)0 (Arg 231 and 7-propionate), explaining why i.-Trp is a much 
better substrate than D-Trp for 11)0. At the same time, hydro- 
gen-bonding interactions to these atoms may be absent in 11)0, 
because Tyr 113 of TDO is replaced by Phe 226 in 11)0 (SI Fig. 
9), and the Thr 254 residue may not have an equivalent in 11)0 
because the nJ-aK loop, disordered in the IDO structure (SI Fig. 
9) (14), has highly divergent sequences in 11)0 compared with 
TDO (Fig. lb). Therefore, 11)0 may have weaker interactions 
with tryptophan, which may be the reason why it cannot com-
pletely distinguish among the indoleamine substrates. 
The structure comparison explains why 1-methyltryptophan is 
a micromolar inhibitor of IDO (18) but is essentially inactive 
against TDO (10). The Ni atom is directly hydrogen-bonded to 
the His 55 side chain in TDO (Fig. 3b), and its methylation will 
cause steric clash with this residue. In comparison, His 55 is 
replaced by Ser 167 in 11)0 (SI Table 4), which creates a small 
pocket that can accommodate the 1-methyl group (SI Fig. 9). 
Structural similarity is also observed with the S04414 protein 
from S. oneidensis (SI Fig. 8) (16), with an rim distance of 4.4 A 
for 206 equivalent Ca atoms, suggesting that S04414 may also 
be a dioxygenase. Moreover, the structure contains an extra 
domain that is formed by residues at the N terminus, similar to 
the small domain in human 11)0 (SI Fig. 8). In contrast to human 
11)0, S04414 is a tetramer but with a different organization 
compared with that of TDO (SI Fig. 10). Our biochemical efforts 
so far have not been able to demonstrate DO (or TDO) activity 
for this protein, suggesting that S04414 may prefer a different 
substrate for oxygenation. 
A Model for the Michaelis Complex. To help provide further insight 
into the catalysis by these enzymes, we built a model for the 
Michaelis complex, by placing one oxygen atom (01) of the 
dioxygen substrate directly over the heme iron, at a distance 
of 2.1 A (Fig. 4a). The distal oxygen atom (02) was placed such 
that the 01-02 bond is parallel to the C2-C3 bond of indole ring, 
giving a Fe-01-02 angle of 135°. This conformation places the 
02 atom within 0.5 A of the water molecule observed in our 
structure (Fig. 4a), suggesting that this water should be ejected 
from the active site upon dioxygen binding. The active site is 
therefore completely devoid of solvent molecules in this Michae-
his complex. 
The modeled dioxygen-binding mode reveals the activation 
mechanism of this substrate for the reaction. It has been 
established that TDO has an ordered catalytic cycle in which the 
protein first binds L-Trp to the ferrous form, and then binding 
of dioxygen is facilitated, and nucleophilic attack from the 
substrate C3 is initiated (3, 13, 19). In the model, the distal 
oxygen atom interacts with the L-Trp ammonium moiety and the 
backbone amide nitrogen of Gly 125 (Fig. 4a). The Lewis acidity 
Forouhar et al. 
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Fig. 3. Molecular basis for substrate recognition by TDO. (a) Final 2F0 F 
electron density at 1 .6-A retolution for heme, L-Trp, and a water in the active 
site. Contoured at 1r. (b) Stereo drawing showing the active site of X. 
cempestris TOO in the binary complex with i-Trp. The segment in cyan is from 
another monomer of the tetramer. Hydrogen-bonding interactions are indi-
cated with dashed lines in magenta. (c) Overlay of the structures of the free 
enzyme (in orchid) and the binary complex (yellow and cyan) in the active-site 
region. Regions of conformational differences are indicated with the red 
arrows. (ci) Overlay of the active-site region of the second monomer (in green) 
and that of the first monomer (in yellow). Only the side-chain atoms of Trp are 
shown in the second monomer (irs magenta). (e) Final 2 F0 - F electron density 
at 1.6-A resolution for heme, i-Trp, and a water in the active site of the second 
TOO molecule inthe crystal. Contoured at 11 7. Two conformations forthe main 
chain atoms are shown, but neither fit the density well. Forthe stereo version 
of c and d, please see SI Fig. 7. Produced with Molscript (35) and rendered with 
Raster3D (36). 
of the hydrogen-bonding donors, coupled with the electron-
withdrawing nature of the heme, would increase the electrophi-
licity of the bound dioxygen and render it more susceptible to 
nucleophilic attack by the substrate C3 atom. The increased 
hydrophobicity of the active site upon the exclusion of water 
would also aid the stabilization of an oxvferrous species. Studies 
with heme oxvgenase suggest that the hydrogen-bonding inter -
actions to the dioxygen substrate may also help to prevent its 
heterolysis (20), and the exclusion of water probably removes a 
hydrogen-bond competitor to the dioxygen. After the initial 
attack by the C3 atom, the reaction may proceed via a Criegee 
rearrangement or a dioxetane intermediate (SI Fig. 11). In the 
model, the 01-02 atoms are in a trans configuration relative to 
the C2—C3 atoms of L-Trp (Fig. 4a), which may favor the Cnegee 
rearrangement pathway (SI Fig. 11) (19). The Criegee pathway 
is also tavored based on chemical, thermodynamic, and quantum 
mechanical considerations (3). 
Our model for the Michaelis complex shows that the 01 atom 
is 2.6 A from the Ni atom of L-Trp and therefore can act as the 
general base to extract the proton from the Ni atom (SI Fig. 11) 
(19). The NI atom is hydrogen-bonded to His 55 in TDO. 
However, our biochemical studies show that the k of TDO is 
relatively insensitive to p1-I over the range examined (ph6 to pH 
8) (Fig. 4b), and the I-155A mutant had only a 10-fold decrease 
in the k 5 (Table 2), suggesting that this residue is not essential 
for catalysis, consistent with its replacement with a 5cr residue 
in IDO. On the other hand, the Km  shows a marked increase at 
lower pH (Fig. 4b), probably because of the protonation of this 
residue. 
An Allosteric Bitdiog Site In the Tetramer Interface. We also ob-
served the binding of four L-Trp residues to an allosteric site in 
the interface of the tetramer (Fig. 2b), with well defined electron 
density (SI Fig. 12). The L-Trp residue appears to be recognized 
specifically by the enzyme in this pocket (SI Fig. 12). There have 
been reports of allosteric activation by the substrate L-Trp (21, 
22), and our observations offer a possibility for this effector site. 
Unfortunately, our kinetic studies so far have not shown any 
allosteric effects with X cainpestris TDO. This site is not 
occupied in the 6-fluoro-Trp complex, possibly because of the 
lower concentration of this compound in the crystallization 
solution. 
Biochemical Studies Conf I'm the Structiral Observations. X. campes-
ens TDO has robust catalytic activity toward L-Trp and 6-fluoro-
Trp but is inactive toward D-Trp, tryptamine or indolepropionic 
acid (Table 2), confirming its designation as a TDO. In fact, 
D-Trp is a weak, competitive inhibitor of the enzyme at high 
concentrations (Table 2). Our binding data show that D-Trp has 
much lower affinity for the enzyme than L-Trp (Table 2), 
consistent with our structural information and explaining why 
D-Trp cannot be oxygenated by TDO. 
The biochemical studies also provide direct evidence for the 
induced-fit behavior of TDO. There is a large increase in the 
affinity of the enzyme for L-Trp when the heme iron is reduced 
(K4 [ferric Fe(HI) heme] = 3.8 mM, whereas K4 [ferrous Fe(I1) 
heme] = 4.1 j.M) (Table 2). The electrochemistry data show a 
large, positive shift in reduction potential (+ 136 mV) in the 
presence of 15 mM L-Trp (Fig. 4c). In fact, the shift in reduction 
potential almost perfectly correlates with the increase in affinity 
for L-Trp on reduction, both giving an estimated iXAG of 15 
kJ/mol. These data show that there is a significant stabilization 
of the ferrous form when substrate is bound. This stabilization 
could also play a physiological role to keep the protein reduced, 
and therefore active, when L-Trp is present. 
Our structural studies have defined the binding mode of the 
substrate L-Trp to TDO, revealing the structural basis for the 
stereospecificity of this important enzyme. The induced-fit 
behavior of TDO, confirmed by our biophysical studies, appears 
crucial for the exclusion of water from the active site and for 
stabilizing the enzyme in the presence of the substrates. Finally, 
structural comparisons among these enzymes reveal the striking 
evolutionary conservation of the heme-dependent dioxygenases. 
Materials and Methods 
The experimental protocols are summarized here. More de- 
tailed information can be found in SI Materials and Methods. 
Proteli Expression and Purification. Full-lengthX campesrris TDO 
(NESG II) XcR13) and S. oneidensis S04414 (NESG ID SoR52) 
were cloned into a pET-21d (Novagen, San Diego, CA) deriv-
ative, with a C-terminal hexahistidine tag, and overexpressed at 
17CC in Escherichia coli BL21(DE3) pMGK cells. Hemin (7 JLM 
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Fig. 4. Molecular insights intothe catalysis by TDO. (a) Model of the Michaelis complex. The water molecule is shown as a small sphere in green. Produced with 
Molscript (35) and rendered with Raster3D (36). (b) The pH dependence of the k,. t and K,,, values of X. campestris TDO. (c) The presence of L-Trp causes a large, 
positive shift in the reduction potential of 1DO. SHE, standard hydrogen electrode. 
final concentration) was included in the media for preparation 
of the holoenzyme samples (23). The protein was purified by 
using nickel-affinity and gel-filtration chromatography. 
Point mutations were created with the QuikChange H site-
directed mutagenesis kit (Stratagene, La Jolla, CA). The mu-
tations and their associated ORFs were verified by DNA se-
quence analysis. 
Protein Crystallization. To obtain the structure of TDO in the 
ferrous state, the protein was reduced by the addition of sodium 
dithionite. and all steps were performed in an anaerobic glove box 
(Belle Technology, Dorset, U.K.). with the 02 concentration main-
tained <2 ppm. Excess sodium dithionite was removed by gel 
filtration (Sephadex 625 column) before crystallization. Crystals of 
11)0 were grown by the sitting-drop vapor diffusion method with 
a well solution comprising l() mM Mes (p11 6.3), 10-12% (wt,'ol) 
PEG 4000, 60 mM MnCl2, 10 mM sodium dithionite. and 2 mM 
L-Trp. Before mounting in nylon loops and flash-freezing in liquid 
nitrogen, crystals were immersed in a cryoprotectant solution 
composed of mother liquor (with i.-Trp concentration increased to 
50 mM) supplemented with 2317e , (vol/vol) glycerol and bubbled 
with nilric oxide for 15 min bekire use. 
Data Collection and Proceing. X-ray diffraction data were col-
lected at the X4A beam line of National Synchrotron light 
Source (Brookhaven National L.aboratory, Upton. NY), the 
2IBM beam line at Advanced Photon Source (Argonne National 
Laboratory, Argonne, IL.), and the BMI4 beam line at the 
Table 2. Summary of kinetic data on X. campestris TDO 
Kd 
Ferric 	Ferrous 
Enzyme 	 Substrate 	 k(s -1 ) 	 Km. .sM 	heme, mM 	heme, j.sM 
Wild type 
c-Trp 19.5 = 1.2 114 	1 3.84 	0.14 4.12 	0.24 
D-Trp 0 16.5 mM 	33* >50' NC 
6-F.o L-Trp 37.3 	0.6 186 	12 2.45 	0.42 <1' 
5-F-p L-Trp 2.40 = 0.10 100 	6 1.51 	. 0.08 
Indolepropionic acid 0 0 >10' 126 	11 
35.40.9 119i2 0 NA 
H55A mutant 	i-Trp 2.86 	0.10 133 	7 ND 3.7: 	1.3 
NA, Kd for 02 cannot be measured in the absence of substrate because of oxidation or in the presence of 
substrate because of turnover; NC. No spectral change detected; ND, not done. 
* Inhibitory constant, K. 
tAlthough a spectral change was evident, substrate solubility prevented accurate measurement of Kd. Values were 
estimated based on the maximum substrate concentration attainable. 
Binding was too tight to be measured. Values quoted represent the minimum K.j that can be measured under 
standard assay conditions. 
tThe peak positions of the oxyferrous complex (02-TDO) are at 420 nm, 548 nm, and 578 nm. 
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European Synchrotron Radiation Facility (Grenoble, France). 
The diffraction images were processed and scaled with the IIIKL 
package (24). The data-processing statistics are summarized in 
Table 1, and more complete information can be found in 
SI Table 3. 
Structure Determination and Refinement. The structures of the apo 
enzymes of 1DO and S04414 were determined by the selenome-
thionyl single-wavelength anomalous diffraction method (15). 
The selenium sites were located with SnE (25), and the reflection 
phases were calculated with Solve/Resolve (26). The structures 
of the holoenzymes and the ternary complex were determined by 
the molecular-replacement method, with the programs COMO 
(27) and AMoRe (28). The atomic models were built with the 
program XtalView (29) and TURBO-FRODO (30), and the 
structure refinement was carried out with CNS (31). 
Electronic Spectroscopy, Steady-State Assays, and Dissociation Con-
stant Measurements. Electronic absorption spectra were recorded 
by using a Cary 50-Probe U V-Visible spectrophotometer at 
25°C. Assays for the steady-state turnover (at pH 7.5) of L-Trp 
and derivatives were performed as described (32,33), except that 
substrate concentrations of 0-15 mM were used. The kinetic 
data were fitted to the Michaelis-Menten equation. The pH 
Yoshida R, Hayaishi 0(1987) Methods Enzymol 142:188-195. 
Taklkawa 0(2005) Biochem Biophys Res Convnun 338:12-19. 
Sono M, Roach MP, Coulter ED, Dawaon JR (1996) Chem Rev 96:2841-
2887. 
Mellor A (2005) Biochem Biophys Res Commun 338:20-24. 
Munn DH, Thou M, Altwood if, Bondarev I, Conway SJ, Marshall B, Brown 
C, Mellor AL (1998) Science 281:1191-1193. 
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Grohmann U, Fallarino F, Puccetti P (2003) Trends Immunol 24:242-248. 
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Platten M, Ho PP, Youssef S, Fontoura P. Garren H, Hur EM, Gupta F., Lee 
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dependence of the steady-state kinetics was determined in the 
same manner, by using phosphate (pH 6.0-8.0) and Tris (pH 
8.0-9.0) buffers. The electronic absorption spectra of the steady 
state were recorded by using a stopped-flow spectrophotometer 
(SX.17MV; Applied-Photophysics, Surrey, U.K) in conjunction 
with a diode array detector, housed in an anaerobic glove box 
([OzI, <5 ppm; Belle Technology). 
O1TLE Electrodiemistry. Anaerobic potentiometnc titrations were 
carried out as described (34) at 25°C by using a modified quartz 
EPR OTTLE cell. Titrations were performed in both the 
absence and presence of L-Trp (15 mM), and the heme redaction 
potentials were determined by fitting the data to the Nernst 
equation for a single-electron process by using Origin software 
(MicroCal, Northampton, MA). Reduction potentials are 
quoted versus the standard hydrogen electrode. 
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Histidine 55 of Tryptophan 2,3-Dioxygenase Is Not an Active Site Base but 
Regulates Catalysis by Controlling Substrate Bindings 
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ABSTRACT: Tryptophan 2,3-dioxygenase (TDO) from Xanthomonas campestris is a highly specific heme-
containing enzyme from a small family of homologous enzymes, which includes indoleamine 2,3-
dioxygenase ([DO). The structure of wild type (Wi' TDO) in the catalytically active, ferrous (Fe 2 ) form 
and in complex with its substrate L-tryptophan (L-Trp) was recently reported [Forouhar et al. (2007) Proc. 
Nail. Acad. Sci. U.S.A. 104, 473-478] and revealed that histidine 55 hydrogen bonds to L-Trp, precisely 
positioning it in the active site and implicating it as a possible active site base. In this study the substitution 
of the active site residue histidine 55 by alanine and serine (H55A and H55S) provides insight into the 
molecular mechanism used by the enzyme to control substrate binding. We report the crystal structure of 
the H55A and H555 mutant forms at 2.15 and 1.90 A resolution, respectively, in binary complexes with 
L-Trp. These structural data, in conjunction with potentiometric and kinetic studies on both mutants, reveal 
that histidine 55 is not essential for turnover but greatly disfavors the mechanistically unproductive binding 
of L-Trp to the oxidized enzyme allowing control of catalysis. This is demonstrated by the difference in 
the Kd values for L-Trp binding to the two oxidation states of wild-type TDO (3.8 mM oxidized, 4.1 /1M 
reduced), H55A TDO (11.8 uM oxidized, 3.7 duM reduced), and H55S TDO (18.4 pM oxidized, 5.3 p.M 
reduced). 
Oxidative cleavage of the L-tryptophan (L-Trp)' pyrrole 
ring and the insertion of molecular oxygen to produce 
N-formylkynurenine is the first and rate-limiting step in the 
kynurenine pathway and is catalyzed by tryptophan 2,3-
dioxygenase (TDO) and mdoleamine 2,3-dioxygenase 
(1DO) (2, 3). The kynurenine pathway processes 95% of 
L-Trp utilized by humans, leading ultimately to the formation 
of nicotinamide adenine dinucleotide (NAD), an essential 
coenzyme (4). Kynurenine pathway metabolites have been 
implicated in a number of diseases ranging from neurological 
disorders, such as cerebral malaria and multiple sclerosis, 
to cataract formation (5, 6). Recent findings have implicated 
tryptophan catabolism via the kynurenine pathway in im-
mime tolerance, including immune suppression in maternal 
fetal tolerance and the immune escape of cancers (7-10). 
The atomic coordinates for H55A and H55S mutant enzymes of 
TDO have been deposited in the Protein Data Bank, entries 3BK9 and 
3E08, respectively. 
* To whom correspondence should be addressed. E-mail: 
S.K.Chapman@ed.ac.uk.  Tel: +44 131 650 4760. Fax: +44 131 650 
6453. 
University of Edinburgh. 
"Rutgers University. 
1 Columbia University. 
'Abbreviations: TDO. tryptophan 2,3-dioxygenase: IDO. indoleam-
me 2.3-dioxygenase; L-Trp, L-tlyptophafl; 5-F-Trp, 5-flu0ro-DL-tryp-
tophan; 6-F-Trp, 6-fluoro-DL-tryptophan; WT. wild type; H55A. 
histidine 55 - alanine; H55S. histidine 55 - serine; SHE, standard 
hydrogen electrode; OTTLE, optically transparent thin-layer electro-
chemistry. 
These properties make elucidation of the precise catalytic 
mechanism of these enzymes extremely important. 
TDO and [DO belong to a little-characterized family of 
dioxygenases that occurs in both prokaryotes and eukaryotes 
(11). These enzymes have homologous 3-D structures but 
dissimilar primary structures, with sequence identity often 
less than 10% between family members (12). First identified 
in 1936 (13), TDO is mainly found in the liver of mammals 
but has also been recently identified in mammalian mucous 
membranes, epididymis, and brain (14, 15). The enzyme 
discussed here is a prokaryotic TDO from Xanthomonas 
campestris (the causative agent of black rot in cabbages), 
which shares 34% sequence identity with human TDO. The 
enzyme is a homotetramer that displays high substrate 
specificity, catalyzing the oxidation of L-Trp, 5-F-Trp, and 
6-F-Trp (1). In contrast, [DO is found throughout the body 
in mammals, except for in the liver, and no prokaryotic [DO 
protein has yet been identified. [DO is monomeric and 
catalyzes the dioxygenation of L-Trp, n-Trp, serotonin, 
tryptamine, and 5-OH-Tip, displaying less substrate specific-
ity than TDO (11, 16). The crystal structures of WT X. 
campestris TDO (1, 17) and human [DO (12) have been 
published recently, revealing similarities between the two 
enzymes and allowing the identification of potentially 
important active site residues. 
The catalytic mechanisms employed by TDO and [DO 
have, as yet, not been elucidated, but two proposed mech-
anisms for tiyptophan dioxygenation are shown in Figure 1. 
10.1021/bi801202a CCC: $40.75 © 2008 American Chemical Society 
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FIGURE 1: Catalytic mechanism proposed for L-IryptOphan dioxy-
genation by TDO. The figure displays an ionic, base-catalyzed 
mechanism of L-Trp dioxygenation. The first substrate binds to the 
protein (1), followed by dioxygen binding to form the ternary 
complex (2). The mechanism proceeds by the formation of a 
hydroperoxide intermediate (3 and 6), which can undergo two 
different rearrangements to form the product, N-formylkynurenine 
(8), a Criegee rearrangement(4 and 5), or a dioxetane rearrangement 
(7). The product is then released leaving the protein in the active 
ferrous state. 
It is proposed that the catalytic mechanism involves the base-
catalyzed deprotonation of the mdole nitrogen of the 
substrate. However, the structures of TDO and DO show 
that while TDO contains a histidine residue in its active site, 
DO does not contain any residues in its active site capable 
of performing base-catalyzed deprotonation. Instead, it has 
been proposed that proton abstraction is facilitated by a 
bound dioxygen molecule (Figure 2). 
In the TDO active site histidine 55 hydrogen bonds to 
L-Trp and is implicated as the active site base. In this study 
we attempt to resolve the question of whether an active site 
base is necessary for catalytic activity in TDO. To ac-
complish this, histidine is replaced by alanine or serine 
(H55A and H55S mutants of TDO). These substitutions 
were chosen due to the inability of alanine to act as an active 
site base and the presence in DO of a serine residue in the 
analogous position to histidine 55. We report the crystal 
Thackray et al. 
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FIGURE 2: Proposed catalytic intermediates involved in proton 
abstraction of the indole nitrogen of L-tryptophan. The ternary 
enzyme — substrate — dioxygen complex can either undergo (a) a 
base-catalyzed proton abstraction or (b) proton abstraction by the 
bound dioxygen. 
structure of the H55A mutant to 2.15 A resolution and the 
crystal structure of the H55S mutant to 1.90 A resolution 
and relate these to electrochemical and kinetic data for the 
mutant enzymes. 
EXPERIMENTAL PROCEDURES 
Genetic Manipulation, Protein Expression, and Puri:fica-
tion. Full-length X. campestris TDO (NESG (Northeast Struc-
tural Genomics Consortium) ID XcR13) was cloned into a pEl'-
21d (Novagen, San Diego, CA) derivative with a C-terminal 
hexahistidine tag and overexpressed at 17 °C in Escherichia 
coli BL21(DE3) pMGK cells. Point mutations H55A and H555 
were created by employing the QuikChange II site-directed 
mutagenesis kit (Stratagene, La Jolla, CA). Oligonucleotide 
primers directing mutations were designed in an automated 
fashion by using the Primer Prim'er program, accessible at 
www-nmr.cabm.rutgers.edu/bioinformatics/Primer_Primer/ . The 
mutations and their associated ORF were verified by DNA 
sequence analysis (1). 
WT TDO and its mutant forms were purified using nickel-
affinity and gel-filtration chromatography. Protein and heme 
concentrations were determined by the Bradford and pyridine 
hemochrome methods, respectively (18, 19). For WT TDO 
extinction coefficients E1) and e43 1 ,, of 180.5 (±0.1) mM' 
cmm and 113.0 (±0.1) niM' cm per protomer were 
calculated for the ferric and ferrous enzymes, respectively 
(1). For the H55A mutant enzyme extinction coefficients 
E405. and E431. were 130.4 (±0.3) mlvt' n and 120.0 
(±0.1) mM' cm' per protomer. For the H555 mutant 
extinction coefficients E405m  and E431nnj were 132.0 (±0.3) 
mM 1 cm 1 and 116.0 (±0.2) mM cmm per protomer. 
Protein Crystallization and Data Collection. Crystalliza-
tion of H55A and H55S TDO was carried out by hanging 
drop vapor diffusion at 18 °C in Linbro plates. Crystals were 
obtained with well solutions comprising 9-10% (wlv) PEG 
1000, 80 mM MES buffer, pH 6.3, 20 mM bicine buffer, 
pH 9.0, 40 mM MnCh, 400 mM MgCl,, 8-15 mM NaCN, 
and 20 mM L-Trp. Hanging drops (4 uL volume) were 
prepared by adding 2 tL of 8 mg mL' protein (in 50 mM 
Tris-HC1 buffer, pH 8.0, 5 mM in EDTA) to 2 uL of well 
solution. Red tetragonal shaped crystals appeared after 
approximately 1 week, reaching fall size after 2 weeks. 
Crystals were immersed in mineral oil prior to being mounted 
in nylon ioops and flash cooled in liquid nitrogen. For crystals 
of both H55A and H555 enzymes, data sets were collected 
to a resolution of 2.15 and 1.90 A, respectively, at station 
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10.1 at SRS Daresbury (2 = 1.381 A for H55A 11)0, A = 
1.045 A for H55S). In both cases crystals belonged to space 
group P2 1 with unit cell parameters a = 78.2 A. b = 117.6 
A,c= l39.3A,and/'3=95.7°(H55A)anda=77.9A,b 
= 117.8 A, c = 139.1 A. and /3 = 95.7 0 (H55S). 
Data processing was carried out using the CCP4 package 
(20) and PHEN1X (21). The wild-type TDO apoenzyme 
structure (PDB H) IYWO), stripped of water, was used as 
the initial model. Electron density fitting was carried out 
using PI-IEN1X and Turbofrodo (22). and structure refinement 
was carried out using PHENIX and Refmac (23). 
Srec.dv-State Kinetic Analysis and Binding Constant As -
says. UV-visible spectra were recorded at 25 °C using a 
Cary 50-Probe UV-visible spectrophotorneter. Steady-state 
turnover assays (at pH 7.5) for oxidation of L-Trp and 
fluorinated derivatives were performed as described by 
Eshimura (24), except that substrate concentrations of up to 
15 mM L-Trp were used. The rate of formation of N-
formylkynurenine was monitored by measuring the change 
in absorbance at 321 nm (E 321 (N-formylkynurenine) = 3750 
M cm). Kinetic data were fitted to the Hill equation using 
Origin software (MicroCal, Northampton, MA). Dissociation 
constants (Kd) for binding to ferric and ferrous WT TDO 
and mutant enzymes were determined by established pro-
cedures in a Belle Technology anaerobic glovebox with [02] 
maintained below 5 ppm. The electronic absorption spectra 
we steady state were recorded by using a stopped-flow 
spectrophotorneter (SX. 1 7MV; Applied-Photophysics, Sur-
rey, U.K.) in conjunction with a diode array detector, housed 
in an anaerobic glovebox. The oxygen binding affinity (K 111 ) 
was measured by standard methods by adding varying 
concentrations of 02 ( 1 mM) to the L-Trp saturated (25 
mM) assay and by calculating the steady-state parameters 
as described above. Oxygen concentration was determined 
spectrophotometrically by titrating aliquots of oxygenated 
buffer into a solution of electrochemically reduced methyl 
viologen. The subsequent change in absorbance at 540 nm 
(E 0(methyl viologen) = 13000 M' cm') due to reduction 
of molecular oxygen was used to calculate [02] (h. 
O7TLE Elect rochemisrrv. Anaerobic potentiometric titra-
tions on WT TDO and mutant enzymes were carried out as 
previously described (1, 25) at 25 °C using a modified quartz 
EPR OTTLE cell, with the exception that 100 mM Tris-
HCI buffer, pH 7.5. and 300 mM KCI (with or without 10% 
glycerol) buffer was used. A range of mediators were added 
(2-hydroxy-1,4-naphthoquinone (-145 mV vs SHE), 5-hy-
droxy- 1,4-naphthoquinone (-3 mV), phenazine ethosulfate 
(+55 my), phenazine methosulfate (+82 mV), and 1.2-
naphthoquinone (+ 135 mV)) to ensure efficient reduction 
and reoxidation of the protein. Titrations were performed in 
both the absence and presence of substrate for WT TDO 
(15 mM L-Trp). the H55A mutant (5 mM L-Trp), and the 
l-155S mutant (10 mM i.-Trp). Heme reduction potentials 
were determined by fitting the data to a Nernst equation for 
a single-electron process using Origin software. Reduction 
potentials are quoted versus the standard hydrogen electrode. 
RESULTS AND DISCUSSION 
Cristal Structures of H55A and H55S TDO. It was 
possible to obtain crystals of the ferric H55A and H55S 
mutant enzymes in binary complex with the substrate due 
Table I: 1 ­155A and 1155S Data Collection and Refinement Statistics 
}l55A HS5S 
resolution (A) 59.66-2.15 17.56-1.90 
total no. of reflections 312593 362159 
no. of unique reflections 131764 189203 
completeness (%) 96.9 93.6 
I/Eu!)] 9.5 7.3 
R,,, (%)' 10.0 7.8 
R, 	in outer shell (2.27-2.15 A) (%) 47.4 48.0 
R., 1 M 6 20.5 17.8 
Rf,, 	(%)b 28.5 21.6 
nnsd from ideal values 
bond lengths (A) 0.022 0.007 
bond angles (deg) 2.004 0.952 
Ramachandran analysis 
most favored (%) 91.9 92.2 
additionally allowed )) 8.1 7.8 
average B-factor (overall) (A 2 ) 23.2 23.2 
average B-factor (substrate) 	A2 t 25.7 24.1 
R,, 	= y.LI1h1 - I,{h)t'LLI,(h,. where I,lh) and l(h) are the ith 
and mean measurement of reflection h. respectively. R, = LIF. - 
FC L'L,F,. where F. and F0 are the observed and calculated smcture factor 
amplitudes of reflection h. respectively. Re,,,,, is the test reflection data set. 
5fl, selected randomly for cross-validation dining ciystallographic 
refinement. 
a . 
L.Trp -. 	Arglll 	.Trp 	. Ai9117 
AlaSS - . .: 	 A1a55 	. 
to 
.: 	 .4 
Ssr55 	P' '' 	 S.r55 	2 
r 
FIGuRE 3: Stereoview of electron density around the heme. bound 
L-Trp, arginine 117, and residue 55 at the active site of (a) H55A 
TD() and fbI 1155S TDO. The electron density map was calculated 
using Fourier coefficients 2F,, - F0 . where F,, and F,, are the 
observed and calculated structure lactors, respectively, the latter 
based on the final model. The contour level is Ia. where a is the 
mss electron density. This figure was generated using PYMOL (30). 
to the much greater affinity of L-Trp for the oxidized mutant 
enzymes compared to WT 11)0 (see below and Table 3). 
For H55A 11)0 a data set to 2.15 A resolution was used to 
refine the structure to a final R-factor of 20.5% (R 1 , = 
28.5%), while for H55S TDO data to a resolution of 1.90 A 
were used to refine the structure to a final R-factor of 17.8% 
(Rins = 21.6%). Data collection and refinement statistics are 
summarized in Table 1. 
For each of the H55A and H55S mutant enzymes the final 
model consists of two TDO tetramers (I and 2), one of which 
(tetramer 1) is better defined than the other in the electron 
density map. The quality of the final electron density map 
around the active site of chain A of tetramer 1 of both mutant 
enzymes is shown in Figure 3. 
In both mutant enzymes each monomer also binds one 
herne group and one substrate molecule. Further to this, a 
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b 	Arglll 
L-Trp 	- 	 , 
\ Arglll 	 L-T,p 
HIAJ 55 	 Tyr113 
-- - 
WA! 55 
l'ioi iRE 4: An overlay of the active site region of \VT 1D() (yellow), 
l-155A '[DO (green). and 1455S TDO(orange viewed from the side 
(a) and from above (b. The L-Trp from the 1455A and H55S 
enzymes (in green and orange, respectively) are rotated toward 
alanine/serine 55 and the heme, relative to the position of the 
substrate in WT ThX) (yellow). The H-bond between histkline 55 
and the substrate is lost as a result of the substitution by alanine/ 
serine. The position of the water molecule twater A see Figure 5 
above the heme group in 1-155A and H55S TDOs is slightly different 
than in WT enzyme due to the altered substrate binding. This figure 
was generated using PYMOI. (30). 
a 	Wtwr 	 b 
AlaU \ 74 
Argl 17 	 q'• -.. 	.__._•-" 	4 ,ti17 
L. • 
7Ws—WA 	 - 	 WaterA 
FIGURE 5: The active site of (a) 1-155\ [IX) and (h) 1-155S Tl)O. 
1-lydrogen-bonding interactions are indicated by dashed lines. The 
subtly different positions of water B in the mutant enzymes can be 
seen. This figure was generated using PYMOL (30). 
second L-Trp molecule is observed at the intersubunit 
interface close to each of chains A, B. C, D. and E in the 
H55A TDO structure, and in the H55S model there is one 
interfacial L-Trp per monomer. in addition. the H55A and 
H55S models contain 1026 and 1955 water molecules, 
respectively. The atomic coordinates have been deposited 
in the Protein Data Bank, accession codes 3BK9 (l-l55A 
and 3E08 (H55S). 
Binding Mode of L-Trp to H55A and H55S Mutanis. The 
binding orientation of i-Trp at the active site of the H55A 
mutant enzyme is slightly different from that observed in 
the WT 11)0 structure. An overlay of the active sites of 
WT TDO and the H55A and H55S enzymes (based on a-C 
overlay) is shown in Figure 4. The bound L-Trp substrates 
belonging to the H55A and H55S mutant enzymes (in green 
and orange, respectively) are shifted toward the side chain 
of residue 55 relative to the position of L-Trp in the wild-
type enzyme (in yellow). Due to the substitution of histidine 
55 by alanine or serine the hydrogen-bonding interaction 
between residue 55 and the substrate indole nitrogen atom 
is lost. The remaining interactions between the substrate and 
active site residues that are observed in the wild-type enzyme 
are maintained in both mutant enzymes (Figure 5). 
The active sites of WT TDO and both of the H55A and 
HSSS mutant enzymes contain a water molecule above the 
distal face of the heme (water A in Figure 5). In all three 
enzymes this water is H-bonded to the ammonium group of 
L-Trp and the main-chain amide nitrogen of glycine 125 but  
is too far (—>2.7 M from the heme iron to be a ligand. Further 
to this, an additional water molecule is found in the active 
site of the H55A and H55S mutant enzymes (water B in 
Figure 5) in a position which would be sterically inhibited 
by the histidine 55 side chain in WT TDO. In the H55A 
mutant enzyme water B is H-bonded to the substrate indole 
nitrogen (Figure 5a), but in the H55S model water B is 
instead H-bonded to the side-chain hydroxyl group of serine 
55 (Figure Sb), too far away ('-3.4 A ) from L-Trp to maintain 
a hydrogen-bonding interaction. 
In WT 11)0 the histidine 55 imidazole moiety H-bonds 
to a water molecule in the substrate-free ferrous state, which 
is displaced upon binding of substrate. The removal of the 
histidine side chain in either mutant enzyme would almost 
certainly result in the absence of a water molecule in such a 
position. 
Stead'v-Stare Kinetics and Substrate/Substrate Analogue 
Binding. It has been previously reported that WT TDO shows 
catalytic activity toward i-Trp. 6-F-Trp, and 5-F-Trp. We 
have also observed activity toward 5-methyl-DL-tryptophan 
and 6-methyl-Di-tryptophan. H55A and H55S mutant en-
zymes show catalytic activity toward L-Trp. 6-F-Trp, 5-F-
Trp, 5-methyl-nL-uyptophan, and 6-methyl-DL-tryptophan but 
no activity with any other compounds investigated. Kinetic 
parameters are shown in Table 2, and there is about a 7-fold 
decrease in keaL values, compared to WT TDO, for both 
mutant enzymes. As previously reported. there is no inhibi-
tion of WT TDO catalytic activity on addition of l-Me-DL-
tryptophan, and the same result is obtained for the mutant 
enzymes (I). This contrasts with findings on 11)0, where 
l-Me-DL-tryptophan is a known inhibitor of L-Trp dioxy-
genation activity (11). Catalytic activity is observed only by 
the ferrous enzyme for both WT TDO and its mutant forms, 
in contrast to recent findings that show catalytic activity by 
ferric human 11)0. 
The substitution of histidine 55 may have been expected 
to render the enzyme inactive if a base is required in the 
catalytic cycle, but the possibility that a water molecule could 
be bound, in the vacant space made by the substitution of 
histidine 55, must be considered. This water molecule could, 
possibly. act as an active site base dependent on its pK a in 
the active site. A water molecule is found near this position 
in both of the mutant enzymes. but it is not optimally aligned 
for the deprotonation of L-Trp. It is also located 3.3 A away 
from the indole nitrogen atom. outside the range of a normal 
H-bonding interactions, and we propose that it plays no role 
in the catalytic cycle (Figure 1). These data, and the relative 
insensitivity of the WT TDO k to pH (Supporting Informa-
tion Table 1), support the idea that histidine 55 or a solvent 
molecule is not required to deprotonate the indole nitrogen 
atom. in 11)0 where the active site is devoid of solvent, the 
equivalent residue to histidine 55 is serine 167, which is 
incapable of acting as a catalytic base. Turnover still occurs, 
and like TDO k,,, is observed to be insensitive to pH (26). 
The decrease in k for L-Trp oxidation in both the H55A 
and H55S mutants may be explained by the movement of 
L-Irp in the active site. It can be seen from the crystal 
structures that for both mutants L-Trp has rotated toward the 
substituted amino acid (and away from the iron atom) relative 
to the position of L-Trp in WI TDO. The L-Trp indole ring 
has also shifted toward the heme (shown in Figure 4. These 
movements are accompanied by a slight increase in the 
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Table 2: Kinetic Parameters for X. cainpestris TDO Wild Type and Mutants 
WT TDO 	 H55A 	 H55S 
Ices (s) 	K. (uM) 	Ices/Km 	kcm (s) 	K. (jiM) 	kcm/Km 	Ices (s) 	Km (iiM) 	k, atIKm 
L-Trp' 	19.5 ± 1.2 	114 ± 1 	1.711 (100) 	2.86 ± 0.10 	133 ± 7 	0.215 (100) 	2.6 ± 0.01 	197 ± 2 	0.132 (100) 
6-F-o/L-TrV 	37.3 ± 0.6 186 ± 12 2.005 (117) 3.78 ± 0.10 195 ± 1 0.194 (90) 3.80 ± 0.04 546 ± 36 0.070(53) 
5-F-o/L-Trp'1 2.40 ± 0.10 	100 ± 6 	0.240 (14) 	0.68 ± 0.14 	194125 	0.035 (16) 	0.80 ± 0.01 	183 ± 12 	0.044 (33) 
6-Me-OIL-TIp" 	41.0 ± 1.2 975 ± 48 0.421 (25) 1.65 ± 0.03 386 14 0.0443 (21) 4.66 ± 0.18 1980 ± 170 	0.024 (18) 
5-Me-o/L-Tip" 3.59 10.05 	357 ± 12 	0.101(6) 	0.40 ± 0.01 	395 ± 20 	0.010 (5) 	1.45 ± 0.01 	1302 ± 21 0.0110) 
Experiments were performed at 25 "C in 100 mM phosphate buffer, pH 7.5, by varying the concentration of the substrate. It should be noted that 
these rates are determined under normal atomospheric conditions; therefore, the rates determined are "apparent" for Ices as oxygen is not present at a 
saturating leveL The peak positions of the oxyferrous complex (02-TDO) are at 420, 548, and 578 nm. and V, Km, and K1 are calculated using L-Trp. 
Table 3: Substrate Binding to Oxidized and Reduced X. campestris TDO Wild Type and Mutants" 
TDO WT (K,j) 	 H55A (Ka) 	 H55S (Kd) 
substrate 	Fe3 (mM) 	Fe2 (tiM) 	Fe3 (uM) 	Fe2 (uM) 	Fe3 (aM) 	Fe2 (uM) 
L-Trp 	 3.84±0.14 	4.1±0.2 11.8±0.2 	3.711.3 	18.4±3.0 	 5.3± 1.0 
6-F-&i.-Trp 	1.51 10.08 < 1.001, 	 165 ± 44 73 ± 3 86 ± 12 6.2 ± 0.9 
5-F-D/L-Trp 2.45 ± 0.42 	<1.00 67 ± 20 	9.0 ± 1.7 	 73 1 5 	 <5.00k 
Experiments were perfonned at 25 "C in 100 mM phosphate buffer, pH 7.5. Absorbance changes upon substrate binding are small (-.5- 10% of 
initial peak absorbance) but easily quantifiable due to tight substrate binding. "Binding was too tight to be measured. Values quoted represent the 
minimum K,, that can be measured under standard assay conditions. 
substrate K. values, implying a small decrease in the stability 
of the Michaelis complex. The rotation has resulted in the 
displacement of the toyptophan indole ring from the dioxygen 
binding site, thus decreasing overlap of the molecular orbitals 
involved in catalysis. The transition state for the reaction 
will be less stable, thus increasing the activation energy for 
catalysis. This will decrease the turnover rates for both 
mutants compared to WT TDO. 
In WT TDO there is a large increase in the affinity of the 
enzyme for L-Irp for ferrous vs ferric enzyme (K,,(Fe 3 ) = 
3.8 mlvi, Kd(Fe2 ) = 4.1 4uM) (Table 3). This is in contrast 
to recent findings for human TDO, where there was found 
to be little discrimination of binding between the ferric and 
the ferrous enzymes (27). For both mutant proteins this effect 
is essentially destroyed, with only a small increase shown 
in the affinity of the ferrous enzyme for L-Trp relative to 
ferric (Table 3). This trend in 'Cd  is repeated for other 
substrates. These findings suggest that one role of histidine 
55 is to disfavor substrate binding to the oxidized protein, 
and its removal increases binding affinity by a factor > 300. 
II can therefore be hypothesized that histidine 55 is respon-
sible for controlling the binding affinity of the active site 
for L-Trp, effectively gating the binding of substrate to WT 
TDO. In this way histidine 55 greatly disfavors the mecha-
nistically unproductive binding of L-Trp to the oxidized 
enzyme, promoting the productive binding of L-Trp to the 
reduced enzyme. 
Elecrrochernicai Studies. Electrochemical data for WT 
TDO and the H55A mutant are shown in Figure 6, and the 
measured midpoint potentials are displayed in Table 4. There 
is a much smaller shift in the reduction potential upon 
binding of substrate (/\E,,,,, H55.k = +23 mV) (AEd H55S = 
+57 mV) for the mutant enzymes compared to WT TDO 
(/XE1njwr = + 136 mV). The shift in reduction potential of 
23 mV for the H55A mutant enzyme almost perfectly 
correlates with the increase in affinity for L-Trp for the 
ferrous vs the femc form (lCd (Fe(H)) = 3.7 uM vs K,, 
(Fe(1I1)) = 11.8 uM), both giving an estimated tLG of 3.5 
Id mol. In fact, the difference in these LtG values 
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FIGURE 6: OTTLE potentiometric curves for wild-type TDO (open 
circles), H55A mutant (closed circles), and H55S mutant (open 
triangles) with (right-hand plots) and without (left-hand plots) L-TIp 
substrate present (±L-Trp). Each curve is produced from both 
reduction and oxidation of the layer of interest. 
Table 4: Electrochemical Midpoint Potentials 
potential (mV vs SHE) 
no L-Trp +L-Trp change 
TDOWT 	 8 ± 5 144±6 +136 
H55A 64±3 87±2 +23 
H55S 	 44±2 101±2 +57 
rITDO" 100 160 +60 
rhIDO" 	-30±4 16±3 +46 
See ref 29. "See ref 26. 
approximately 11.5 Id mol, within the range of energies 
for a single hydrogen bond. The data are less clear for H55S, 
with a 57 mV shift in the reduction potential on L-Trp 
binding. The increase in affinity for L-Trp to the ferrous H555 
vs the fenic give an estimated LAG of 5.5 Id mol'. It is 
possible that the lower affinity of oxidized WT TDO for 
substrate may be attributed to subtle changes in the structure 
of the active Site (in terms of the hydrogen-bonding pattern) 
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FIGURE 7: Plot of the observed steady-state turnover rate (k) versus 
02 concentration for wild-type TDO (top) and H55A (middle) and 
H55S (bottom) mutant forms. The maximum turnover rate 
the Michaeis constant (K,,J, and the inhibition constant (K, (for 
oxygen)) are reported. 
accompanies expulsion of solvent from the active site and 
results in the formation of a hydrogen bond between histidine 
55 and the pyrrole nitrogen of the indole L-Trp moiety. 
In the H55A mutant enzyme the alanine side chain is 
unable to form the same hydrogen bonds that histidine 55 
can in WT TDO. Consequently, there may be less rearrange-
ment of the active site hydrogen-bonding interactions neces-
sasy to allow L-Trp binding, and the K<, for substrate binding 
to ferric enzyme is correspondingly low. All other amino 
acid interactions binding L-Trp to the active site are 
analogous to WT TDO. Consequently, the absence of 
significant oxidation-state-dependent changes in the active 
site in H55A TDO results in decreased specificity of binding 
to the oxidized or reduced enzyme. 
The case is sinillar for the H55S mutant enzyme as the 
serine side chain is unable to form the same hydrogen bonds 
that histidine 55 can in WT TDO. It is possible that the serine 
could form a bonding interaction with a nearby solvent 
molecule (water 250), but the data suggest that less rear-
rangement of active site hydrogen-bonding interactions is 
necessary to allow L-Trp binding than for WT TDO. 
Stability of the Michae!is Complex. Figure 7 shows how 
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FIGURE 8: Production of the wild-type TDO oxyferrous ternary 
complex. The peak positions of the oxyferrous ternary complex 
are at 420, 548, and 578 nm. This decays back to ferrous enzyme 
and product (N-forrnylkynurenine, peak position 321 nm). 
on dioxygen concentration, [02], under saturating L-Trp 
concentrations (25 mM). in phosphate buffer (pH 7.5) at 25 
°C, K,(02) is approximately 120 1uM and k for WT TDO 
is only 60% of maximum; however, in the case of the H55A 
and H55S mutant enzymes, kapp is nearly maximal (Table 
2). These data seem contrary to the Michaelis model (based 
on steady-state kinetics) that predicts a lower 02 binding 
affinity for the mutant forms. 
WT TDO has an ordered catalytic cycle in which the 
reduced enzyme—substrate complex must be formed prior 
to 02 binding for turnover to occur (11, 28). No ferrous—oxy 
complex is observed, and addition of oxygen to ferrous WT 
TDO or the mutant forms in the absence of subs-
trate leads to direct decay to the ferric state. This is also the 
case for human TDO (27), suggesting that instability of 
the ferrous— oxy species may be common in TDO species. 
The similar L-Trp binding affinity of the reduced mutant 
enzymes compared to WT TDO (3.7 and 5.2 1uM versus 4.1 
1tiM) and similar K, values for substrates (Table 2) show 
that all enzymes can bind substrate and then dioxygen in 
productive ternary complex formation. Structural data indi-
cate that movement of the indole moiety of L-Trp in the 
active site is responsible for the decrease in k for H55A 
and H55S. The increased L-Trp binding affinity to the 
oxidized H55A and H55S enzymes, compared to WT TDO, 
will lead to a higher probability of nonproductive oxidized 
enzyme— substrate complex formation, possibly decreasing 
k, but this effect would be small compared to the effect of 
the destabilized transition state. 
Formation and decay of the oxyferrous ternary species 
generated (Figure 8) for WT TDO show that the (Fe 2 —L-Trp) 
complex displaying a Soret peak at 432 nm binds 02, producing 
(Fe2 —L-Trp-02), with a corresponding shift in the Soit peak 
to 419 run. This then decays to N-formylkynurenine (shown 
by an increase in absorbance at 321 nm) and ferrous enzyme. 
(displaying a Soret peak at 432 nm). This is also observed with 
6-F-Trp as the substrate, but for 5-F-Trp some uncoupling is 
seen, leading to production of the inactive ferric enzyme and 
the superoxide anion (02) and release of the substrate. These 
trends are repeated for H55A and H555, with uncoupling 
observed only with 5-F-Tsp as substrate. However, the initial 
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Table 5: Oxygen Dependence of Steady-State Turnover of L-TryptOphan 
by X. cwnpestris TDO Wild Type and Mutants 
TDO WT 	H55A H55S 
k 	(s') 35.4 ± 0.9 	3.86 ± 0.26 7.88 ± 0.60 
Km (UM) 119±2 45.7±5.6 99±16 
K1 (pM) 1380±140 480150 
rates of formation of the temaiy complexes are slower, with a 
rate constant of approximately 50 s compared to 100 s' for 
WT TDO. Oxyferrous decay parallels this with rate constants 
of 0.4 s and 2 s for the mutant enzymes and WT TDO, 
respectively. This indicates that both mutations do not desta-
bilize the teniaty complex significantly, but as the rate of decay 
is decreased compared to WT TDO, this correlates with a higher 
activation energy for catalysis due to the movement of the 
tiyptophan indole ring destabilizing the catalytic transition state. 
Substrate inhibition is observed at high oxygen concentrations 
for both mutant forms (Table 5), while none is observed for 
WT TDO. This unexpected result may be plausibly explained 
by the lower rate of decay and subsequent slower expulsion of 
product from the active site by the mutant enzymes. As the 
active site cavity is larger due to the removal of histidine and 
its replacement by alanine or serine in the mutant forms, the 
product, N-formylkynurenine, may be less readily expelled at 
high oxygen concentrations and dioxygen may be able to bind 
before the product has left. This would trap the product in the 
active site, causing inhibition of catalytic activity. 
CONCLUSIONS 
In this study we have investigated whether a putative active 
site base, histidine 55, is necessary for catalytic activity in 
TDO. The data we have presented show that in the mutant 
enzymes H55A and H55S turnover still occurs. This indicates 
clearly that histidine 55 is not an essential base. Instead, a 
different role for histidine 55 in controlling substrate binding 
at the active site has been revealed. On the basis of structural, 
kinetic, and electrochemical data we have proposed that the 
role of histidme 55 is to prevent the formation of the 
nonproductive ferric enzyme-substrate complex. This is 
most likely achieved by histidine 55 controlling the water 
content of the substrate-free active site. 
SUPPORTING INFORMATION AVAILABLE 
A table presenting data on the pH dependence of L-Trp 
dioxygenation by wild-type TDO and the H55A and H55S 
mutant forms of the enzyme. This material is available free 
of charge via the Internet at http://pubs.acs.org . 
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